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QUILL ON SCALPEL
This section provides a medium through which Canadian 
surgeons can declare themselves, briefly and informally, on 
the day-to-day affairs of surgery.
The Treatment of Osteogenic Sarcoma
The management of osteogenic sarcoma 
has undergone many alterations in recent 
years. There have been many changes in 
adjunctive chem otherapy and an 
increased emphasis on limb-sparing sur­
gery rather than amputation. Controversy 
continues regarding the safety of these 
newer treatments. The general public is 
also much more aware of this condition 
as a result of the publicity surrounding 
Terry Fox and his “ Marathon of Hope” . 
On page 29, Chowdhury and colleagues 
describe a patient who had a late recur­
rence following local excision of a telan­
giectatic osteosarcoma of the ulna. The 
telangiectatic type is one of the rarest 
forms of osteogenic sarcoma and is con­
sidered by many to be one of the most 
lethal varieties. Chowdhury’s article 
emphasizes many of the problems in diag­
nosing and treating this tumour.
Most osteogenic sarcomas are stage 1IB 
lesions at the time of diagnosis (i.e., they 
are high-grade extracompartmental sar­
comas).1 The best opportunity for local 
control is by radical resection or ampu­
tation. A local recurrence following
definitive surgery decreases the chance of 
survival by half so it is a serious compli­
cation indeed. Most limb-salvage opera­
tions for osteogenic sarcoma are wide- 
excision procedures at best and many are 
marginal excisions. The risk of local 
recurrence following limb-salvage surgery 
ranges from 15% to 20%.2 Amputation 
with a wide or radical margin of normal 
tissue has not always prevented stump 
recurrence.3-4 This has been attributed to 
the existence of skip lesions, which are 
tumour deposits in the affected bone 
separated from the primary tumour by 
several centimetres of normal bone. Most 
local recurrences occur during the first 1 
to 2 years after resection and it is very 
unusual for an osteogenic sarcoma to 
recur almost 6 years later. This is partic­
ularly true when the tumour is excised 
marginally as in the case Chowdhury and 
colleagues describe. In their article they 
state that telangiectatic osteosarcoma has 
a higher local recurrence rate than clas­
sic osteogenic sarcoma. Almost certainly 
this is related to the type of resection per­
formed. They point out that these lesions
are often mistaken for aggressive aneurys­
mal bone cysts and lesional or marginal 
excisions are performed. It is often only 
after the tumour recurs that the diagno­
sis is made. If this entity is recognized ini­
tially and an appropriate excision per­
formed, the local recurrence rate should 
be the same as for standard osteogenic 
sarcoma. It is known that chemotherapy 
can delay the appearance of lung 
metastases and local recurrences. This is 
unlikely to have caused the late recurrence 
in Chowdhury’s patient since the initial 
chemotherapy was one of the early adju­
vant regimens and considered to be quite 
mild by current standards. Many patients 
with osteogenic sarcoma die with 
widespread lung metastases before a local 
recurrence becomes manifest. Since 
autopsy is seldom performed in these cir­
cumstances, the true local recurrence rate 
is unknown and is likely higher than 
presently believed. This creates difficul­
ties in comparing the safety of limb­
sparing procedures to that of amputa­
tions.
There has been marked improvement
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in the survival of patients with osteogenic 
sarcoma. Before 1972 only 20% of 
patients survived 5 years or more.5 Now 
the 5-year survival is 60% or greater. The 
increase in disease-free survival was 
attributed to chemotherapy which was 
thought to treat the micrometastases that 
are present in 80% of patients at diagno­
sis.6 The picture became clouded when 
the Mayo Clinic published a review of 
their experience with osteogenic sarcoma 
treated between 1963 and 1974.7 Survival 
during the first few years of the study was 
similar to that of other published reports 
(i.e., 20%), but by 1972 the 3-year sur­
vival of patients treated by surgery alone 
had improved to 50%. Their data sug­
gested that the natural history of the dis­
ease itself had changed and their recent 
results were not statistically different 
from the results of treatment with adju­
vant chemotherapy. The validity of using 
historical control data as a comparison to 
treatment with adjuvant chemotherapy 
was questioned. There was speculation as 
to why more patients were surviving when 
treated by surgery alone. The most impor­
tant factors were believed to be earlier 
detection of lung metastases by computed 
tomography and aggressive removal of 
lung nodules by thoracotomy. It became 
apparent that the issue could only be 
resolved by a prospective randomized 
study comparing patients treated with and 
without chemotherapy. This was under­
taken by the Pediatric Oncology Group, 
which is a multicentre children’s cancer 
study group. Patients were randomized 
into two groups. In one the patients were 
treated immediately after surgery by a 
modified Rosen T-7 chemotherapy pro­
tocol. The other group received no 
chemotherapy after surgery unless the 
tumour recurred or metastasized to the
lungs. The study was closed after review 
of the initial 36 randomized patients 
demonstrated significantly poorer sur­
vival of patients who did not receive 
immediate chemotherapy.8
The current thrust for adjuvant 
chemotherapy in most centres is to give 
it preoperatively and modify the 
chemotherapy postoperatively according 
to the response of the tumour to the 
preoperative agents. The approach was 
instigated at the Memorial Sloan- 
Kettering Cancer Center.9 Patients who 
underwent limb-salvage procedures were 
waiting up to 12 weeks for their cus­
tomized prosthesis to be fabricated. Dur­
ing this period they were treated with the 
T-7 regimen, which consisted of high-dose 
methotrexate, bleomycin, cyclophospha­
mide and actinomycin C. The response of 
the tumour to the chemotherapy was 
graded pathologically and the poor 
responders were identified. This informa­
tion led to the development of the T-10 
protocol where the poor responders were 
treated by different agents such as cispla- 
tin postoperatively.10’11 Variations on 
this theme have been developed using 
intra-arterial injection of doxorubicin or 
cisplatin for local tumour perfusion as 
well as systemic intravenous chemo­
therapy.
For the treatment of osteogenic sar­
coma in the future, more studies will be 
done with different preoperative 
chemotherapy regimens to find more 
effective agents. Limb-salvage procedures 
appear to be firmly established, and work 
is being done to find better solutions for 
limb reconstruction with prostheses that 
have a greater longevity. As the survival 
rate improves, thoughts are being directed 
to the patients’ quality of life. The utili­
zation of multicentre trials and the shar­
ing of information make the future more 
promising for patients with osteogenic 
sarcoma.
Kenneth L.B. Brown, md, frcsc
Department of Orthopedics,
The Montreal Children’s Hospital,
2300 Tupper St.,
Montreal, PQ 
H3H 1P3
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The Adrenal Incidentaloma
Before the development of computed 
tomography (CT), difficult and often 
dangerous procedures such as venography 
and arteriography were necessary to 
visualize the adrenal glands. These inves­
tigations were therefore limited to patients 
with clinical and biochemical evidence of 
adrenal disease. Now CT scanners visual­
ize the normal adrenal glands in 95% of 
patients1 and can identify adrenal ade­
nomas as small as 1.0 cm in diameter.2 
Although this simplifies the investigation 
of adrenal disease, it creates a new 
problem — what to do with an inciden­
tally discovered adrenal mass, the so-
called incidentaloma? About 0.6% of 
upper abdominal computed tomograms 
reveal these incidentalomas,3 the ma­
jority of which are benign and require no 
treatment.
Discovery of an incidental adrenal mass 
frequently sparks concern about an 
adrenocortical carcinoma and leads to 
surgical resection, but, as more experience 
is gained, a conservative approach is 
proving to be more appropriate. Of the 
95 cases of adrenal incidentalomas 
described in the literature,2'12 71 were 
managed surgically, revealing diverse con­
ditions — adrenocortical adenomas (30
cases), metastases (17), pheochromocy- 
tomas O), cysts (9) and myelolipomas (5). 
But no case of adrenocortical carcinoma 
presenting as an incidentaloma has been 
reported.
Benign, nonfunctioning adrenocortical 
adenomas make up the majority of 
adrenal incidentalomas. Their natural his­
tory is obscure. Adrenocortical adenomas 
2 mm or larger in diameter have been 
found in 8.7% of autopsies.13 Cortical 
adenomas greater than 5 mm (the optimal 
resolution of the best CT scanners) were 
found in 1.4% of 1495 autopsies.14 The 
frequency of adrenocortical carcinoma is
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only 1 in 400 000,15 indicating that 
malignant transformation is extremely 
rare. The infrequency of clinically impor­
tant adrenocortical adenomas further sug­
gests that few of these lesions would 
progress and thus require surgical 
excision.
The second commonest adrenal 
incidentaloma reported in the literature 
is a metastasis from a known primary 
tumour — especially the breast and lung, 
and lymphomas. The adrenal glands are 
a favoured site for malignant spread, with 
as many as 26% of cancer patients hav­
ing adrenal metastases at the time of 
death.16 These metastases, presenting as 
adrenal incidentalomas, may even precede 
the detection of the primary tumour.12
About 10% of adrenal incidentalomas 
are cystic lesions. Asymptomatic adrenal 
cysts are found in 0.06% of autopsies.17 
One half of these are true cysts with an 
endothelial lining, the others are cystic 
degenerated adenomas or pseudocysts,18 
which are often the result of hemorrhage 
into benign or malignant tumours.19
Pheochromocytomas have fortuitously 
been discovered as adrenal incidenta­
lomas in several recent reports.2'3'6 The 
high frequency of this diagnosis among 
incidentalomas is supported by a recent 
study demonstrating unsuspected pheo­
chromocytomas in 0.3% of autopsies.20 
Correct diagnosis of this condition 
preoperatively substantially reduces peri­
operative morbidity.
The investigation of the adrenal 
incidentaloma includes three main steps: 
a review of the computed tomogram, a 
review of clinical data and results of 
investigations, and performance of hor­
monal studies (Fig. 1). The information 
thus obtained may suggest other diagnos­
tic maneuvers.
A review of the computed tomogram 
may provide some answers. Lipomas and 
myelolipomas have very low attenuation 
coefficients due to their high fat con­
tent.21 Simple cysts can often be confi­
dently identified from their characteris­
tic homogeneous water density, round
FIG. 1—Algorithm for investigation of 
adrenal incidentaloma.
shape, sharp margins and lack of contrast 
enhancement.2 When there is doubt, 
needle aspiration may be useful. Aspira­
tion of clear fluid strongly supports the 
diagnosis of a benign simple cyst,22 but 
a bloody aspirate may be found in benign 
and malignant lesions. The confident 
diagnosis of other kinds of adrenal 
incidentalomas is usually not possible by 
computed tomography alone, and further 
investigation is indicated.
A review of all available clinical and 
investigational data is essential at this 
point. If a specific endocrine syndrome 
such as pheochromocytoma, hyperandro- 
genic state, Cushing’s or Conn’s syn­
drome is suspected, then following the 
standard diagnostic protocols for these 
conditions is the most efficient approach. 
If the clinical setting suggests the presence 
of metastatic disease and the primary is 
occult, needle biopsy is the best way to 
make the diagnosis. Tissue obtained by 
percutaneous needle biopsy under com­
puted tomographic guidance established 
the diagnosis in 94% of adrenal tumours 
in a recent study.8 However, it is very 
difficult to differentiate adrenocortical 
adenoma from carcinoma in these speci­
mens. Therefore, needle biopsy is most 
valuable when an adrenal metastasis is 
suspected.
Screening hormonal studies are neces­
sary even when the clinical features of 
endocrine syndromes are absent, since 
even occult hormonal secretion may exact 
a metabolic price from the patient. Sub- 
clinical hypercortisolism still leads to 
osteoporosis and increased susceptibility 
to infections. The clinical effects of 
pheochromocytomas are characteristi­
cally paroxysmal but are life-threatening.
Adequate screening for excess steroid- 
hormone production includes measure­
ment of serum cortisol, dehydroepian- 
drosterone sulfate and testosterone levels, 
as well as a minimum of two 24-hour 
urine collections to measure free cortisol. 
Urine collections can reliably be obtained 
on an outpatient basis with simultaneous 
measurement of the urinary creatinine 
value to assess the completeness of the 
collection. Since adrenocortical tumours 
with normal basal steroid excretion may 
show lack of dexamethasone suppression 
the measurement of steroid hormones 
should be repeated during 2 days of dex­
amethasone suppression (2.0 mg every 6 
hours).
No aldosterone-secreting incidentaloma 
has been reported so far in the literature. 
However, the presence of hypertension or 
hypokalemia with inappropriate kaliure- 
sis is an indication that plasma renin 
activity and aldosterone levels should be 
measured.
When the three main steps have failed 
to produce a diagnosis, the lesion is likely 
a benign cortical adenoma. Although
adrenocortical carcinoma is rare, it has 
to be kept in mind since early resection 
provides the only chance of cure. Further 
investigations are rarely helpful. Other 
imaging techniques such as ultrasonogra­
phy and angiography provide little new 
information. The role of radioisotope 
scanning with iodocholesterol for 
adrenocortical tumours or with iodoben- 
zylguanidine for pheochromocytoma has 
not been studied in this clinical setting. 
Therefore, with respect to computed 
tomography, the question is: Does the 
lesion appear sufficiently benign to allow 
nonsurgical management? Comparison of 
the computed tomographic appearance of 
adrenocortical carcinomas and adenomas 
has revealed certain characteristic fea­
tures. Criteria suggesting an adenoma 
include a round or oval shape, diameter 
of less than 5 cm and clear delineation 
from surrounding structures.10 The 
criterion of 5 cm is useful since adenomas 
are almost always smaller than this while 
more than 90% of carcinomas are 
larger.23 Close clinical follow-up and 
repeat computed tomography at 3 
months, 6 months and 1 year is necessary. 
Mitnick and colleagues10 followed up 12 
patients who satisfied the above criteria 
and found no evidence of progression. 
Enlargement of the lesion calls for surgi­
cal resection.
The management of the adrenal 
incidentaloma presents a new challenge 
in medicine. Few lesions investigated 
will be clinically important, yet they 
will cause patients and their physicians 
much anxiety. On the basis of our 
review of 95 cases of incidentaloma in the 
literature, we recommend a conservative 
approach to management of these lesions.
T im  J . O ’Le a r y , m d , fr c pc  
T.C. Ooi, MB, BS, FRCPC, FRACP
Division of Endocrinology 
and Metabolism,
Ottawa Civic Hospital,
1053 Carling Ave.,
Ottawa, Ont.
K1Y 4E9
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SESAP IV Question
130. During operation, a 2-cm incision is accidentally made in the dome o f 
the bladder o f a patient with a normal lower urinary tract. The opening should 
be closed and
(A ) a suprapubic cystostomy performed
(B) the cystotomy should be converted into a suprapubic cystostomy
(C) a Foley catheter should be left in the bladder for two to three weeks 
and removed after a cystogram shows that the bladder has sealed
(D) the bladder should be drained with a Foley catheter for three to five 
days
(E) the lower abdomen should be drained and bethanechol chloride (Ure- 
choline chloride) administered postoperatively
For the incomplete statement above select the best completion o f the five 
given. For the critique o f Item 130 see page 71.
(Reproduced by permission from SESA P I V  Syllabus; Surgical Education and 
Self-Assessment Program No. 4. For enrolment in the Surgical Education and 
Self-Assessment Program No. 4, please apply to the American College o f Sur­
geons, 55 East Erie St., Chicago, IL  60611.)
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CORRESPONDENCE
Contributions to the Correspondence section are welcomed. 
They should be typewritten and double spaced.
Radiation Exposure 
and the Surgeon
To the editors.—Sometimes different sur­
geons will look at the same data and come 
to opposite conclusions. In their recent 
article on Ender’s nailing of hip fractures 
(Can J  Surg 1985; 28: 25-26), Moreau 
and Ashmore stated that “ the radiation 
received by the operating team is well 
within the acceptable limits” . I disagree 
with this statement. In their table of 31 
patients (Table I), the radiation dosage 
received by the operating team varied 
from 0 to 69 mrem per case for the sur­
geon, 0 to 14 mrem for the nurse and 0 
to 12 mrem for the anesthetist. Since 62 
patients received this operation over 18 
months, the case and exposure load might 
be approximately 40 patients per year for 
the institution or approximately 15 
patients per surgeon, since the table indi­
cated that three surgeons performed the 
procedure. Thus, one surgeon might 
reasonably average 290 mrem exposure 
per year for Ender’s nailing procedures 
alone (excluding all other exposures he 
might receive from other procedures). 
Another surgeon would probably average 
180 mrem and the third might average 130 
mrem per year. One would need more 
information to calculate individual nurse 
and anesthetist doses. One assumes that 
the criterion for “ acceptable limits” is the 
official Canadian government standard 
for “ acceptable” radiation exposure: a 
Canadian maximum of 500 mrem per 
year for an individual in the general popu­
lation and 5000 mrem per year for an 
individual whose livelihood involves radi­
ation risks (e.g., doctors, radiographers, 
uranium miners, nuclear power plant 
workers).
A threshold below which damage from 
radiation does not occur has never been 
demonstrated, and many now believe that 
a threshold does not exist. What seems 
clear is that the greater the exposure to 
radiation the more likelihood there is of 
incurring serious side effects such as 
cancer, cataracts and birth defects. There 
is no good scientific evidence to demon­
strate that 500 mrem is “ safe” . Many 
would argue that the limits of 500 and 
5000 mrem are unreasonably high and 
should be set lower. While Canadian 
authorities use one of the international 
standards, some countries, the United 
States in particular, use lower exposure 
limits. On the other hand, intertrochan­
teric fractures will continue to occur and 
patients need to be treated properly.
At the relatively small hospital where 
I work (fewer than 100 beds), I use 
Richards’ sliding compression lag screws. 
We do not have an image intensifier for 
the operating room and we use a standard 
portable x-ray machine that gives us 
anteroposterior and lateral views as 
required. It is inconvenient having to wait 
several minutes to see the films, but our 
patients have not suffered because of the 
extra anesthetic time required. We gener­
ally, but not always, leave the room dur­
ing roentgenography. My radiation badge 
has not detected any exposure in the 5 
years that I have worked at this hospital 
and we serve an older population so we 
treat fractured hips frequently. In fact, 
the radiology equipment at our hospital 
is modern enough and the practice of the 
radiologist and radiographers diligent 
enough that x-ray exposure for all medi­
cal purposes in our hospital is at a far 
lower level per individual per year than 
that incurred by the surgeons in Moreau’s 
article. A full-time radiologist with almost 
30 years’ service who is diligent about 
wearing his exposure badge has less than 
700 mrem of life-time exposure which 
means that he is being exposed to less 
than 25 mrem of additional radiation per 
year because of his job. The radi­
ographers on our staff have exposures in 
the same range. The surgeon’s radiation 
badge indicates even lower exposure, and 
this includes performance intraoperatively 
of roentgenography for many fractures 
both closed and open, as well as routine 
operative cholangiography during 
cholecystectomies.
In Nova Scotia the average background 
radiation is 110 mrem per year and this 
is of course an irreducible risk in that you
cannot be alive and have no radiation 
exposure and thus no risk. The radiation 
exposure of health professionals at our 
hospital is so small per year that we are 
not concerned.
Radiation exposure of patients is not 
restricted by government regulation, and 
diagnosis and treatment are handled on 
an individual risk versus benefit basis for 
each case. Most health professionals at 
our hospital are reasonably healthy and 
require very few diagnostic roentgeno­
grams during the year; thus, our medical 
diagnostic and treatment radiation levels 
are extremely low and these people receive 
less total radiation exposure than that 
received in the performance of Ender’s 
nailings by the surgeons in Moreau’s 
paper. Presumably these surgeons have 
additional exposure from other proce­
dures in addition to background radiation 
within their location.
While no one can say how many side 
effects, such as cancers and cataracts, 
may be incurred by the extra exposure of 
Moreau’s surgeons, I believe that it is a 
risk a surgeon should not take if there are 
alternative ways to treat the patients. 
More important, I think that it is unethi­
cal for surgeons to subject anesthetists 
and nurses to additional exposure. Were 
participating nurses in Moreau’s series 
advised of the exposure involved? Have 
any of them read the current best theo­
retical calculations in “ Radiation and 
Human Health” ?1
In conclusion, although patients should 
receive the best treatment available, such 
treatment should present the minimum 
risk to patients and staff alike. The treat­
ment studied by Moreau and Ashmore 
does not appear to fulfil this criterion.
W . THURLOW, MD, FRCSC, FACS
McCleave Medical Centre,
Digby, NS 
BOV 1A0
Reference
1. GOFMAM JW: Radiation and Human Health, Sierra Club 
Bks, San Francisco, 1981
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Preoperative Embolization 
of Supratentorial Meningiomas
To the editors.—Rutka and associates 
(Can J  Surg 1985; 28: 441-443) are to be 
congratulated for their series.
They do not state how long after the 
embolization the surgery was performed 
except that all patients but one were oper­
ated on within 4 days. Our own 
experience has been that the reduction of 
blood flow is greatest immediately after 
embolization or after the occlusion of a 
vessel. Almost within minutes, expansion 
of visible collaterals can be seen, as for 
example during a scalp incision for a 
craniotomy when the external carotid 
artery is ligated or embolized. We embo- 
lize these extremely vascular meningiomas 
intraoperatively using serial angiography 
to direct catheter placement and subse­
quent embolization through the external 
carotid artery branches.1 In their conclu­
sions, Rutka and colleagues point out that 
the overall reduction in vascularity 
depends on the relative contributions of 
the internal and external feeders. Unless 
a meningioma arises close to the carotid 
artery to which its meningeal branches 
have access, virtually none of its supply 
comes from the internal carotid. The 
reduction in blood supply after emboli­
zation, followed immediately by the sur­
gical exposure, is dramatic. If the emboli­
zation is carried out during the turning 
of the flap or afterwards, the field 
becomes virtually dry under the surgeon’s 
eyes.
We agree that total tumour removal 
must be the objective in cases of menin­
gioma and almost invariably the best way 
to control the bleeding is by total removal 
of the tumour, particularly its point of 
attachment.
We would suggest to the authors that 
they try intraoperative embolization. 
They will be delighted by the enormous 
reduction in vascularity that will last for 
several hours.
Dwight Parkinson, md, frcsc, facs
Professor of Neurosurgery,
Health Sciences Centre,
700 William Ave.,
Winnipeg, Man.
R3E 0Z3
Reference
1. P arkinson D, legal J, Holloway AF, et al: A new
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for intraoperative serial angiography. Technical note. J
Neurosurg 1978; 48: 1038-1041
To the editors.—Dr. Parkinson’s obser­
vations that intraoperative embolization 
of highly vascular meningiomas results in 
a marked reduction in tumour vascular­
ity is an extremely important observation. 
With one exception all our patients under­
went operation within 4 days of emboli­
zation, but none on the day of emboliza­
tion. We demonstrated the computed 
tomographic and angiographic changes 
that occurred after embolization but 
avoided speculating as to the efficacy of 
reduction in tumour vascularity. It might 
be noted from the results that the amount 
of intraoperative blood loss did correlate 
with tumour diameter.
Dr. Parkinson’s observation that 
intraoperative embolization results in a 
visible reduction in tumour vascularity is 
a very welcome and important obser­
vation.
Paul J. Muller, md, m sc, frcsc 
Chief,
Division of Neurosurgery,
St. Michael’s Hospital,
38 Shuter St.,
Toronto, Ont.
M5B 1A6
Medical Management 
of Endometriosis
To the editors.—The interesting report by 
Buckspan and associates on endometrio­
sis (Can J  Surg 1985; 28: 447-449) raised 
two issues: the cause of endometriosis and 
its management at unusual sites.
It has been well established experimen­
tally and clinically that retrograde men­
struation does occur in humans and that 
the endometrium shed at that time can 
grow in ectopic sites. Sampson, espe­
cially, spent most of his professional life 
demonstrating this phenomenon. The 
serosal metaplasia theory dates back to 
Rokitansky in 1860 and should perhaps 
now be considered a historical curiosity.
With respect to the management of 
endometriotic deposits in unusual sites, 
the diagnosis is frequently made at 
laparotomy (as in the case described by 
Buckspan and colleagues), and the temp­
tation to remove the lesion is often 
irresistible. However, medical treatment, 
particularly with Danazol, is often effec­
tive in decreasing the size of the 
endometriotic deposit and in reducing the 
inflammatory process caused by the cycli­
cal localized bleeding. In Buckspan’s 
case, a histologic diagnosis and the deci­
sion concerning management was made 
at the time of surgery. Possibly ureteric 
catheterization immediately followed by 
medical treatment would have been suc­
cessful. The point, however, is that this 
ubiquitous disease is now frequently 
managed successfully and conservatively 
by suppressing ovulation.
P.T. Hewlett, mb, bs, frcsc
Women’s College Hospital,
76 Grenville St.,
Toronto, Ont.
M5S 1B2
Simple Stapling Technique 
to Fashion 
an Intestinal Valve
To the editors.—Recently there has been 
a resurgence of interest in recreation of 
the ileocecal valve after its resection. 
Below, I describe a simple technique I 
have devised; by using available stapling 
devices, very little extra time is added to 
the original operation.
Before handling, segments of the large 
and small bowel are isolated with non­
crushing clamps about 30 cm from the 
divided edges and contents are milked 
into sponges, which are immediately dis­
carded. An EE A stapler (Auto Suture 
Company, Division of US Surgical Corp., 
Norwalk, Conn.), without the anvil, is 
inserted through the open end of the 
colon (Fig. 1). Alternatively, a distal 
colotomy may be used. The centre rod 
dents the antimesenteric side about 5 cm 
from the cut edge. A small nick with a
FIG. 1—Stapler without anvil is passed 
through colon.
FIG. 2—Anvil of stapler is inserted into 
ileum and purse-string suture around cut end 
is tied tight.
FIG. 3—Anastomosis of ileum to colon is 
intussuscepted into colon and fixed with 
sutures.
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scalpel is made here and the centre rod 
is pushed through and the anvil attached. 
A purse-string suture is placed around the 
cut end of the small intestine, which has 
had the distal 4 cm of mesentery removed. 
The anvil is inserted into the small gut and 
the purse-string tied tight (Fig. 2). The 
EEA stapler is closed and fired. Without 
opening the instrument, the anastomosis 
is now intussuscepted into the colon for 
about 3 to 4 cm and fixed in place with 
seromuscular sutures around the invagi­
nation (Fig. 3). The stapler is now opened 
and removed, and the rings obtained are 
inspected. Hemostasis of the intus­
suscepted anastomosis is confirmed. The 
distal colon is closed with a TA-55 stapler.
Andrus J. Voitk, md, frcsc
178 Mississaga St. W,
Orillia, Ont.
L3V 3B5
Localization of 
Occult Breast Tumours
To the editors.—Neither in his letter (Can 
J  Surg 1985; 28: 300) nor in his original 
article on the intraoperative localization 
of occult breast tumours (Can J  Surg 
1985; 28: 329-330) does Mahoney address 
the major flaw in his technique, namely 
the lack of mammographic evidence 
preoperatively to establish the relation­
ship of the needle to the lesion. The needle 
is your guide even if you replace it with 
dye. It is not uncommon for a needle to 
be off the mark sufficiently to require 
reinsertion and, even with acceptable 
placement, it may be a centimetre or so 
out in either plane. We make the neces­
sary corrections at surgery, based on our 
estimate of the distance and direction the 
needle may be off the mark. Not know­
ing where the needle is in relation to the 
lesion makes Mahoney’s procedure rela­
tively blind. His very meticulous excision 
is being performed without knowing the 
exact site of the lesion.
Most patients, in whom we find carci­
noma in an occult mammographic lesion, 
are treated as Mahoney indicates. When 
we stated in our editorial (Can J  Surg 
1985; 28: 297-298) that these mammo­
graphic lesions should be managed 
aggressively, we did not refer to the extent 
of surgery, but rather the timing. We 
believe that biopsy should be performed 
early, using a proper localizing technique 
rather than waiting a few months and 
repeating the mammogram to see if there 
is any change.
Mahoney discusses our use of a cir- 
cumareolar incision. Obviously if the 
lesion is well away from the areola, we 
do not attempt to excise it through the 
areola, but when the areola is fairly large 
and the lesion not more than 2 or 3 cm 
from its margin, the lesion can be
removed easily through an areolar inci­
sion, excising mainly the distal part of the 
dye-stained tract, thus giving excellent 
cosmesis.
Knowing exactly where the lesion is in 
relation to the needle simplifies the oper­
ation and allows me to remove much less 
tissue than would be necessary if I was 
operating “ blind” . Because about 85% 
of these lesions are benign, removal of a 
minimal amount of tissue is possible and 
this maintains better breast form.
Surgeons attem pting  to  follow 
Mahoney’s technique, with omission of 
the vital preoperative needle-localization 
mammogram, are going to miss many 
lesions at surgery, in spite of a wide and 
frequently inappropriate excision of nor­
mal breast tissue. Although it appears to 
work quite well in Mahoney’s hands, I 
would not recommend it as an explora­
tion technique. You will not get marks for 
performing a meticulous wide excision in 
the wrong direction. My advice is that you 
get acquainted with your radiologist and 
take the extra step.
Alan A. Bassett, md, frcsc, facs
Director, Breast Treatment Unit,
Department of Surgery,
Mount Sinai Hospital,
600 University Ave.,
Toronto, Ont.
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exam can measure the skills and 
knowledge needed to practise medicine.
“ If you want to measure how well 
someone examines a patient’s chest, 
there’s no point in asking him or her to 
write an essay; you are measuring the per­
son’s ability to write clear, lucid English 
in an organized fashion. You aren’t meas­
uring anything about what the person 
does with his or her hands on the patient’s 
body. At one time I could write a superb 
description about how to remove some­
one’s appendix but I wouldn’t under any 
circumstances ever let me do an appen­
dectomy.
“ If you want to find out how well s ti^  
dents write and organize their thoughts, 
there’s no reason you can’t ask them to 
write a short essay in one station; in the 
next station you might ask them to do 
something with their hands — examine a 
chest, feel for the patient’s liver; at the 
next station you might ask them to do a 
lumbar puncture in a rubber model; in the 
next station you might ask them to sit and 
talk to a patient whose daughter has died 
of some genetic disease and is worried 
about having more children —'a counsel-
Contributions to this column are welcome. 
Please send your material to: Mrs. Amy 
Chouinard, Canadian Journal o f Surgery, PO 
Box 8650, Ottawa, Ont. K1G 0G8.
Interpreting x-ray films is part of the OSCE that is being used in the Department of Surgery 
at the University of Ottawa to test medical students’ skills. Dr. F. Shamji (left) is one of the 
department’s examiners.
OSCE Is Effective, Efficient and Not Too Painful
“ It’s practical and reasonably efficient, 
and better-structured than oral exams,” 
says Walter Waddell, FRCSC, “ and it 
allows us to look at things that are impos­
sible to test by other means.”
An exciting new diagnostic technique? 
In a way, yes, but the objective-structured 
clinical examination (OSCE) is to find out 
how well students, rather than patients, 
perform. Waddell, who is the coordina­
tor of undergraduate education for the 
Department of Surgery at the University 
of Ottawa, was talking to CJS about the 
exam, which is being used for the first 
time in the department this academic 
year. In July the first batch of 4th-year 
students faced OSCE (pronounced like a 
nickname for Oscar) as part of the surgi­
cal rotation; the second batch completed 
the exam in November and early next 
month a third will follow suit.
Students move through “ stations” that 
test their skills rather than their recall; for 
example, the test in November incorpo­
rated 21 stations in which, among other 
activities, the students examined the back 
of one patient and the vascular system of 
another, studied x-ray films to come up 
with a differential diagnosis and wrote 
orders for a patient with acute pancrea­
titis.
Says Waddell, “ We also asked them to 
close a 5-cm laceration; now this is pig’s 
skin, but the history was for a 16-year- 
old girl who had fallen on the school yard 
and sustained a clean, sharp wound on 
broken glass. In addition to the prac­
tical thing, we asked about tetanus 
prophylaxis, choice of suture material, 
wound debridement and when to bring 
her back to take out the sutures.” Each 
station was designed to take 5 minutes, 
and the 20 students taking the exam had 
completed the test in just 2 hours. As
Waddell points out, “ 10 students in half- 
hour orals would take 300 minutes — 5 
hours. The exam takes more preparation 
than an ordinary oral but less than a mul­
tiple choice test with 100 to 150 ques­
tions.”
In fact, as long as the numbers of stu­
dents are fewer than 100, OSCE proba­
bly takes less time than any other format 
now being used extensively, says Ian 
Hart, FRCPC, the man who introduced 
the concept to North America just 6 years 
ago. Hart chairs the Department of Medi­
cine at the Ottawa Civic Hospital and has 
been an active advocate of reforms in 
methods of assessing clinical competence.
Says Hart, “ OSCE is a format rather 
than a type of examination; it allows 
examiners to use many different methods 
of testing students but encourages them 
to consider exactly what they want to 
measure and how best they might do so. 
OSCE was developed because no single
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ling station; the next station might be one 
in which they take some information 
from an x-ray film, interpret it and make 
a treatment decision.”
In the most recent medical exam, stu­
dents were asked to advise an AIDS 
patient (simulated) on the changes in life­
style demanded by the disease. Says Hart, 
“ Counselling is not normally tested, but 
we feel it’s important because most phy­
sicians spend a majority of their time 
advising and counselling patients.”
The patients in the University of 
Ottawa surgical OSCE were volunteers 
from the Civic Hospital’s day-care pro­
gram, and Hart notes that most Canadian 
medical schools have little difficulty 
recruiting patients to assist in the testing. 
“ In the US, patients seem to feel, ‘I pay 
doctors; why shouldn’t they pay me?’ ” 
How can OSCE be used to judge a stu­
dent’s ability to perform an appendec­
tomy? That’s a good question says Hart 
and he doesn’t feel it’s possible or realis­
tic to set up a station to assess one’s capa­
bility to operate. However, as OSCE 
spreads to surgical departments, clearly 
Hart is correct when he says: “ With 
innovative thinking, the potential for test­
ing surgical techniques is vast.”
For some reason, however, surgical 
departments have been somewhat slower 
than others to adopt the approach: of the 
16 medical schools in Canada, 12 now 
have some form of OSCE, but until this 
year the University of Toronto was the 
only school whose surgery department 
was using the format regularly. Ironically, 
the group in Dundee, Scotland, who 
pioneered OSCE, published results of its 
use for surgery almost immediately.
Says Hart, “ I don’t want to sound as 
if the surgeons are behind — they are not 
the only group not using OSCE. Word is 
just now spreading: when the concept was 
new, it mainly appeared in articles for 
journals of medical education,” but the 
body of journal articles and conferences 
as well as experience with the format is 
growing rapidly. Hart’s department in 
Ottawa hosted an international confer­
ence in July 1985; they expected about 60 
participants but ended up with more than 
200. They are planning a follow-up meet­
ing in 1987. Also the most recent annual 
meeting of the Royal College of Physi­
cians and Surgeons of Canada included 
a session about assessing clinical compe­
tence and Hart was one of the speakers.
Reflecting the growing interest is an 
expanding databank of stations housed 
by the University of Ottawa. At present 
the databank includes five complete 
20-station examinations, available for a 
nominal charge to cover handling and 
postage. Any medical school can access 
or add to the databank.
Students do not have access to the 
information, says Hart, mainly because 
the databank is incomplete. “ If they have
access to what is there now, they may 
think that’s all they need to know. When 
the bank adequately covers all facets of 
medical practice, then I have no problem 
with giving students access.” Anyway, 
“ they know the stations that have been 
used and word gets around” .
Waddell agrees. “ The first group of 
students had no idea what to expect, so 
they weren’t as happy about the exam as 
the next group who had an opportunity 
to talk to the first group and were better 
prepared. Overall, however, the first 
group scored higher than the second. 
With this examination, we are able to give 
immediate feedback and that helps. If 
you provide instant feedback, the exami­
nation — if not accepted with pleasure — 
is at least not too painful.”
Research Workshop to Be 
Regular Event of CAGS
“ Surgeons who spend all their time in 
clinical practice seem to feel that surgi­
cal investigators or research fellows are 
wasting their time,” says Max M. Cohen, 
FRCSC, Associate Professor, University 
of Toronto.
Combatting this attitude, according to 
Cohen, is what 25 general surgeons had 
in mind when they met last year at 
Chateau Montebello to discuss the 
problems peculiar to surgical research. 
The group were all actively involved in 
research and were anxious to draw into 
their midst other members of the Cana­
dian Association of General Surgeons. 
They decided to convene annually and 
have chosen the Rocky Crest Resort in 
Muskoka District, Ontario, as the site for 
their meeting June 2 and 3 this year.
The group plans to come up with posi­
tive steps to remedy the low status, low 
pay and shortage of operating funds that 
they say combine to limit interest and, 
hence, numbers of surgeons doing 
research.
Grant applications to the Medical 
Research Council seem to support their 
claims. According to Lewis Slotin, PhD, 
Director of the Council’s Program 
Branch, applications from surgeons are 
few: “Although we don’t have exact 
statistics, the overall impression is that 
applications from surgeons are not that 
plentiful. The success rate for surgeons 
in the competition was higher in the late 
1970s and early 1980s; then there was a 
dip; and there seems to be a slight 
upswing now.”
Slotin spoke to the CAGS group that 
met in Montebello and outlined MRC’s 
objectives, review process and priorities. 
As the first deadline for applications in 
1986 is Feb. 1, he gave CJS a recap.
“ I pointed out that there was no bias 
in the Council against clinical research. 
In fact, it has a strong interest in en­
couraging clinicians to become involved 
in research. At present 60% of the funds 
we provide for operating grants are held 
within clinical departm ents. This 
represents a shift from 15 years ago when 
80% of funds went to basic science 
departments. The milieu in which bio­
medical research is going on in this coun­
try is changing. There has been an expan­
sion of hospital-based research.
However, Slotin admitted that the 
Medical Research Council is biased 
against poorly written applications. 
“ There’s no question that the way an 
application is written is important. All 
applicants need to interact with people 
who have been successful as well as to 
interact with people who sit on the review 
committees. You need to know a priori 
what will be looked for and how to struc­
ture the application. Across the country, 
there should be grant-preparation days at 
which MRC personnel or people from 
other grant agencies come and explain 
what is useful. The very obvious require­
ments are to begin with a single, broad 
statement of where you want to be in 
knowledge in 20 years or so. Then follow 
with specific objectives or milestones 
along the route. Do a good, thorough 
literature search to pick out those things 
that suggest your hypothesis has merit or 
that the methods you plan to use will 
answer the questions you are posing. If 
a portion of the research proposal 
requires techniques that you don’t have, 
you need letters from collaborators who 
attest to the fact they will assist you.”
Appointments and 
Changes in Kingston
Dr. Dale Mercer, a general surgeon 
with particular interest in managing 
problems of the esophagus and upper gas­
trointestinal tract, has just joined the staff 
of the Hotel Dieu Hospital in Kingston 
after 2 years studying in Seattle, 
Washington.
Dr. Ronald Pace, a graduate of the 
University of Western Ontario, has been 
appointed general surgeon on the staff of 
the Kingston General Hospital. He is 
researching splenic function.
J.R. McCorriston, FACS, FRCSC, 
head of the Department of Surgery at 
Queen’s University from 1963 to 1978, 
retired from active practice June 30, 1985. 
During his term as head of the depart­
ment, Dr. McCorriston also served on the 
editorial board of CJS.
Amy Chouinard
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B. fragilis, the most prevalent anaerobe in intra-abdominal infections, 
was responsible for up to 60% of mortalities in patients with B. fragilis 
bacteremia when inappropriate treatment was given1. And recent 
North American studies show23 B. fragilis is becoming resistant to 
newer antibiotics such as clindamycin or cefoxitin.
Average resistance C lindam ycin C efoxitin M oxalactam M etron idazo le
B. fragilis 4.8% 8.8% 17.9% 0%
No proven resistance to metronidazole
Flagyl 500 Inj. (metronidazole) remains unaffected by B. fragilis 
resistance23. Flagyl 500 Inj. is active, regardless of bacterial concentra­
tion or growth stage4-5. It has an excellent record of safety, and it is 
compatible with most antibiotics6 used for aerobic coverage in intra­
abdominal and pelvic surgery.
Whenever B. fragilis cannot be ruled out
FLAG
metronidazole
a selective anaerobicide
RHONE POULENC PHARMA Inc. 
8580 Esplanade 
Montreal, Quebec 
^authorized user ,P RHONE POULENC I 11 IVWII
Whenever B. fragilis cannot 
be ruled out
FLAGYL 5 0 0
(metronidazole)
a selective anaerobicide
Therapeutic Classification
Antibacterial-Antiprotozoal
Actions
Flagyl (metronidazole) is bactericidal against 
anaerobic bacteria, it exerts trichomonacidal 
activity and is also active against Giardia 
lamblia and Entamoeba histolytica. Its exact 
mechanism of action has not been entirely 
determined as yet. It has been proposed that 
an intermediate in the reduction of metronidazole, 
produced only in anaerobic bacteria and 
protozoa is bound to deoxyribonucleic acid 
and proteins, and inhibits subsequent nucleic 
acid synthesis.
INDICATIONS AND CLINICAL USES 
Bacterial infections
The treatment of serious anaerobic abdominal 
infections due to susceptible anaerobic bacteria, 
such as Bacteroides fragilis (and other species 
of Bacteroides), Clostridium, Fusobacterium, 
Peptococcus, and Peptostreptococcus species. 
Culture and susceptibility studies should be 
performed to determine the causative organisms 
and their susceptibility to metronidazole.
Based on clinical judgment and anticipated 
bacteriological findings, therapy may be 
started while awaiting the results of these 
tests.
In mixed aerobic and anaerobic infections, 
consideration should be given to the con­
comitant administration of an antibiotic 
appropriate for the treatment of the aerobic 
component of the infection. (See Warnings). 
Flagyl (metronidazole) has also been used in 
the treatment of a small number of cases of 
brain or lung infections (some with abscesses) 
caused by anaerobic bacteria.
CONTRAINDICATIONS
Flagyl (metronidazole) is contraindicated in 
patients with a prior history of hypersensitivity 
to metronidazole or other nitroimidazole 
derivatives.
Flagyl should not be administered to patients 
with active neurological disorders or a history 
of blood dyscrasia, hypothyroidism and 
hypoadrenalism.
Warnings
Flagyl (metronidazole) has no direct activity 
against aerobic or facultative anaerobic bacteria. 
In patients with mixed aerobic-anaerobic 
infections appropriate concomitant antibiotics 
active against the aerobic component should 
be considered.
Known or previously unrecognized moniliasis 
may present more prominent symptoms after 
treatment with Flagyl.
Studies in rats and mice have provided some 
evidence that metronidazole may cause tumors 
in these species when administered orally for 
a long period at high doses. The relevance of 
these findings in humans is not known.
Severe neurological disturbances (i.e. convulsive 
seizures and peripheral neuropathy) have 
been reported in patients treated with Flagyl 
(administered orally or intravenously). These 
have been observed very infrequently.
Precautions
Patients taking Flagyl (metronidazole) should 
be warned against consuming alcohol, because 
of a possible disulfiram-like reaction. For the 
same reason, patients receiving Flagyl should 
not be administered disulfiram concomitantly. 
Transient eosinophilia and leukopenia have 
been observed during treatment with Flagyl. 
Regular total and differential leukocyte counts 
are advised if administration for more than
10 days or a second course of therapy is 
considered to be necessary.
Metronidazole crosses the placental barrier. 
Although Flagyl has been given to pregnant 
women without apparent complication, it is 
advisable that oral administration be avoided 
in pregnant patients and Flagyl be withheld 
during the first trimester of pregnancy. In 
serious anaerobic infections, if the adminis­
tration of Flagyl to pregnant patients is 
considered to be necessary, its use requires 
that the potential benefits be weighed against 
the possible risks to the fetus.
Metronidazole is secreted in breast milk in con­
centrations similar to those found in plasma. 
Intravenous or oral administration of Flagyl 
should be avoided in the nursing mother. 
Metronidazole has been reported to potentiate 
the anticoagulant effect of warfarin resulting 
in a prolongation of prothrombin time. This 
possible drug interaction should be con­
sidered when Flagyl is prescribed for patients 
on this type of anticoagulant therapy.
Clinical experience in children is very limited. 
The monitoring of this group of patients is 
particularly important. The safety and effec­
tiveness of intravenous Flagyl in children has 
not been established.
A rare case of reversible but profound 
neurological deterioration has been reported 
following a single oral dose of Flagyl; it is 
therefore advisable that a patient taking 
Flagyl for the first time not be left unattended 
for a period of two hours. The appearance of 
abnormal neurologic signs demands prompt 
discontinuation of Flagyl therapy and, when 
severe, immediate medical attention. Gastric 
lavage may be considered if no more than 
two or three hours have elapsed since 
administration of the drug.
Treatment with Flagyl should be discontinued 
if ataxia or any other symptom of CNS 
involvement occurs.
Patients with severe hepatic disease metabolize 
metronidazole slowly with resultant 
accumulation of metronidazole and its 
metabolites in the plasma. Accordingly, for 
such patients, doses of Flagyl below those 
usually recommended should be 
administered and with caution. The 
determination of serum glutamic oxaloacetic 
transaminase (SGOT) by the Technicon SMA 
12/60 system in blood samples from patients 
receiving Flagyl may give abnormally low 
values. This abnormality is artifactual and 
caused by the absorption of metronidazole at 
the wavelength where the enzymatic reaction 
is monitored spectrophotometrically.
Adverse reactions
Gastrointestinal: diarrhea, nausea, vomiting, 
anorexia, epigastric distress, dyspepsia, 
constipation.
Mouth: furred tongue, dry mouth, unpleasant 
metallic taste.
Hematopoietic: transient eosinophilia or 
leukopenia.
Dermatologic: rash and pruritus. 
Cardiovascular: palpitation and chest pain. 
Central Nervous System: convulsive 
seizures, peripheral neuropathy, transient 
ataxia, dizziness, drowsiness, confusion, 
insomnia and headache.
Peripheral neuropathies have been reported 
in a few patients on moderately high to 
high-dose prolonged oral treatment with 
metronidazole. It would appear that the 
occurrence is not directly related to the daily 
dosage and that an important predisposing 
factor is the continuation of oral and/or I.V. 
medication for several weeks or months.
Profound neurological deterioration, within 2 
hours after Flagyl administration has been 
reported. The occurrence is not directly 
related to the dosage level.
Metabolic: An antithyroid effect has been 
reported by some investigators but three 
different clinical studies failed to confirm this. 
Local Reactions: Thrombophlebitis has 
occurred with I.V. administration.
Other: Proliferation of Candida albicans in 
the vagina, vaginal dryness and burning; 
dysuria; occasional flushing and headaches, 
especially with concomitant ingestion of 
alcohol; altered taste of alcoholic beverages. 
Darkening of the urine has been reported.
This is probably due to a metabolite of 
metronidazole and seems to have no clinical 
significance.
SYMPTOMS AND TREATMENT OF
OVERDOSAGE
Symptoms
Massive ingestion may produce vomiting and 
slight disorientation.
Treatment
There is no specific antidote. Early gastric 
lavage may remove a large amount of the 
drug; otherwise, symptomatic treatment.
DOSAGE AND ADMINISTRATION 
Treatment of anaerobic infections
Treatment should be initiated by the I.V. 
route. Oral medication may be substituted 
when it is feasible and/or practical. Duration 
of therapy depends upon clinical and 
bacteriological assessment. Treatment for 
seven days should be satisfactory for most 
patients. However in cases where infection 
sites cannot be drained or which are liable to 
endogenous recontamination by anaerobic 
pathogens, a longer treatment may be 
required.
I.V. Administration
100 ml_ (500 mg) by intravenous infusion 
every 8 hours. The injection should be 
infused intravenously at the rate of 5 mL per 
minute.
Flagyl Injection is compatible in a volume 
ratio of 1:5 with normal saline, dextrose- 
saline, dextrose 5 per cent w/v or potassium 
chloride injections (20 mmol and 40 mmol). 
These admixtures will remain stable for a 
period of 24 hours when kept in the dark or 
in combined daylight and artificial light. Not 
to be mixed with sodium lactate injection 
5% w/v, or dextrose injection 10% w/v.
AVAILABILITY
Injection 0.5% w/v Viaflex* plastic bags of 
100 mL (500 mg) for i.v. infusion.
'Trademark of Baxter Travenol Laboratories Inc.
Complete information available on 
request.
1. Tally FP, Gorbach SL. J Inf 1979; (Suppl 1):25-37.
2. Cuchural GJ, Tally FP et al. Antimicrob Agents 
Chemother 1984; 26:145-148.
3. Lamothe, F, Bourgault AM et al. Union Med 
Can 1984; 113:485-488.
4. Bartlett JG et al. Arch Surg 1983; 118:181-184.
5. Corrodi P, Bush DF et al. In Metronidazole: 
Selected Proceedings of the International 
Metronidazole Conference. Excerpta Medica 1979; 
161-168.
6. Bisaillon S, Sarrazin R.J Parent Sci Tech 1983; 
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ROYAL COLLEGE SYMPOSIUM
Symposium on Venous Disease
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1. Diagnosis of Thrombophlebitis
* There is overwhelming evidence that a
clinical diagnosis of venous thrombosis is 
Ft nonspecific and that patients suspected 
clinically of having venous thrombosis
From the Department o f  Pathology, 
McMaster University Medical Centre, 
Hamilton, Ont.
Summary o f a paper presented as part of a 
symposium on venous disease at the 53rd 
K *■ annual meeting o f  the Royal College of
Physicians and Surgeons o f Canada, by the 
' Royal College in cooperation with the
Canadian Society fo r  Vascular Surgery,
+  Montreal, PQ, Sept. 12, 1984
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University Medical Centre, PO Box 2000,
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should be investigated by more reliable 
objective tests. The reference standard for 
the diagnosis of the disease has been 
venography. If a venogram is adequate 
and the results are negative, then an alter­
native diagnosis should be sought and 
anticoagulants may safely be omitted. It 
should be stressed, however, that before 
a venogram can be read as negative, all 
of the veins normally seen by ascending 
venography (peroneal and posterior tibial 
veins and the popliteal, superficial and 
common femoral, and external and com­
mon iliac veins) should be visualized and 
seen to be free of intraluminal filling 
defects. In our experience, approximately 
15% of all venograms are technically 
unacceptable, in which case the procedure 
should be repeated.
Clinical studies have shown that veno­
graphy can be replaced by less invasive 
procedures. Noninvasive tests that have 
been evaluated clinically and shown to 
be reliable are: the combination of 
impedance plethysmography and iodine 
125 fibrinogen leg scanning, serial 
impedance plethysmography alone, serial 
Doppler ultrasonography and other 
plethysmographic techniques.
The plethysmographic and Doppler 
techniques are sensitive and specific for 
proximal vein thrombosis but less sensi­
tive for calf vein thrombosis. They can 
be used in patients with clinically sus­
pected venous thrombosis provided that, 
when the result is negative, the test is 
repeated serially over the next 7 days to 
detect an extending calf vein thrombosis.
J o seph  G . Sl a d e n , m d , frcsc
2. Complicated Deep Venous Insufficiency: 
Conservative Management
An understanding of venous 
pathophysiology is helpful in managing 
deep venous insufficiency. Examination 
of the patient after standing for 10 
minutes by searching for perforator
From the Division of GeneraI Surgery, 
Department o f  Surgery, University o f
* '  British Columbia, Vancouver, BC
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tenderness and milking away the edema 
will reveal incompetent perforators. A 
sponge pump improves calf pumping and 
reduces local tissue damage from the 
systolic peak pressures of walking. It is 
an invaluable aid in treatment. The com­
bination of high ligation of the superficial 
system and compression sclerotherapy 
for the perforators gives excellent con­
trol. Compression sclerotherapy can be 
readily repeated as necessary. Patients 
with severe deep venous insufficiency 
should always be advised to wear a sur­
gical support stocking indefinitely.
Une bonne connaissance de la physiopa- 
thologie veineuse est utile au traitement 
de I'insuffisance veineuse profonde. La 
permgabilite des veines perforantes est
evalude en cherchant chez le patient 
laisse en position debout pendant 10 
minutes la sensibilite des veines perfo­
rantes et en verifiant la resorption de 
I'oedeme apres massages. Une pompe a 
eponge ameliore le pompage des mollets 
et reduit les dommages tissulaires locaux 
causes par les pointes de pression systo- 
lique a la marche. II s'agit d'une aide 
therapeutique considerable. D'excellents 
resultats sont obtenus en associant la 
ligature haute du systeme superficiel et 
la sclerotherapie par compression des 
veines perforantes. Au besoin. la sclero­
therapie par compression peut etre faci- 
lement repetee. On devrait conseiller aux 
patients souffrant d'insuffisance veineuse 
profonde de toujours porter un bas de 
soutien chirurgical.
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I would like to introduce my portion of 
this symposium with a description of the 
anatomy and pathophysiology of the deep 
venous system.
The normal calf pumps blood when we 
walk. In the standing position venous 
pressure at the ankle is about 120 cm 
H20  (120 cm being roughly the distance 
between the heart and the ankle). In the 
normal limb this pressure drops to about 
40 cm H20  on walking but rises to the 
resting value when exercise ceases. The 
limb with deep venous insufficiency has 
an inconsequential drop in pressure with 
walking whereas the limb with superficial 
venous disease alone has a reduction in 
pressure that is about half way between 
the two. Anatomically both the superfi­
cial and deep systems have valves so 
placed that they prevent reflux of blood 
from groin to calf. Additionally, there are 
one to three valves in each perforator 
vein, located deep to the fascia, directing 
the blood from the superficial to the deep 
venous system. The perforator veins do 
not join the saphenous veins directly but 
through connecting or communicating 
veins.
Mechanically there are two types of 
deep venous insufficiency — obstructive 
and incompetent. In both cases, the deep 
venous pressure rises, perforator valves 
become incompetent and blood in the calf 
vein stagnates and is directed to the sur­
face through the incompetent perforators. 
(Dr. Bergan will discuss new approaches 
to the surgery of deep venous insuffi­
ciency, which are aimed at bypassing 
obstructed veins and providing valves in 
the incompetent group.)
The deep system may be obstructed by 
throm bus that has not lysed but 
progressed to fibrosis or by tumour. 
Patients with obstruction present with 
swelling and bursting pain that may 
increase to the point of venous claudica­
tion on walking as the calf “ loads up” 
because of increased inflow and 
obstructed outflow. Incompetent veins 
can be familial or may be acquired secon­
dary to valvular damage associated with 
deep phlebitis. These limbs are character­
ized by signs of tissue damage that 
develop a little later in the disease process 
and are secondary to the water-hammer 
effect of systole with walking. Pressure 
is directed from the deep system through 
the perforators to the superficial tissues 
and skin, bruising them from within. The 
three perforators most often affected are 
referred to as Cockett’s perforators. They 
are unsupported by muscle, situated 
posteriorly at the level of the medial 
malleolus and 7 and 12 cm above it.
What is the role of the superficial sys­
tem in deep venous insufficiency? Browse 
and colleagues stated that if this system 
is incompetent, it contributes more than 
50% of the pressure, as measured at the 
ankle.1 We must be aware of this as
more than half of the patients with deep 
venous insufficiency have an incompetent 
superficial system.
Examination
Before examination patients stand for 
10 minutes to load up the venous system 
and remain standing during examination. 
Saphenofemoral incompetence must be 
noted and may be checked easily with a 
Doppler. We search for perforators and 
control points using the “ sliding finger 
technique” , milking away the edema over 
perforator sites to display high-pressure 
veins, palpating particularly for tender­
ness over Cockett’s perforators. Findings 
are recorded on an appropriate form.2
The patient is prepared for more defini­
tive treatment by fitting a below-knee sur­
gical stocking. My own preference is the 
Sigvaris (S.H. Camp & Co. of Canada 
Ltd., Trenton, Ont.). To gain patient 
compliance, we prescribe the 30 to 40 mm 
Hg compression and use a “ sponge 
pump” over the Cockett perforator area. 
The pump is made from 1.25 cm soft 
latex foam, about 20 x 8 cm, and 
bevelled so that the edges do not indent 
the tissue. This pump is wrapped on, 
using half of a 10-cm tensor bandage, 
applied tightly below by crisscrossing and 
easing the pressure proximally. The 
patient is directed to walk 3 km daily and 
given a handout on deep venous insuffi­
ciency and compression sclerotherapy.
Treatment
If the long saphenous vein is incompe­
tent, I do high ligation of the vein and its 
branches under local or general anesthe­
sia on a day-care basis. Although there 
may be temporary improvement of 
saphenofemoral incompetence after treat­
ment of the perforators by compression 
sclerotherapy, it has been my experience 
that each long saphenous vein that was 
incompetent before compression 
sclerotherapy was again incompetent 2 to 
3 years later. The expedient treatment is 
to tie the vein off initially. Both Douglas 
and associates3 and Hobbs4 agree with 
the indication for surgery under these cir­
cumstances.
We treat the perforators by compres­
sion sclerotherapy. This treatment and its
Tab le  1 -P r im a ry  C o m p la in t o f 1 0 0  P a t ie n ts  W ith  
C o m p lic a te d  D eep  V e n o u s  I n s u f f ic ie n c y  T re a te d  
b y  C o m p re s s io n  S c le ro th e ra p y
C o m p la in t
N o . o f
p a t ie n ts
B u rs t in g  p a in 2 5
D e rm a t it is 5
P ig m e n ta t io n 14
Indu ra tion 2 8
U lc e ra t io n 2 8
complications are well described in the 
literature but I wish to emphasize a few 
points. The vein is needled most readily 
when the patient is standing and the vein 
is “ loaded up” , but the leg must be 
elevated and the vein empty when the 
sclerosant is injected. Trapping the 
sclerosant by wrapping the leg (i.e., the 
compression) and compliance with it are 
important despite a report5 that it is not 
possible to keep compression on the leg 
for more than 6 to 8 hours. Pressure over 
the needle puncture site in the vein 
reduces the occurrence of “ injection 
ulcer” . The bandage is protected by an 
old nylon stocking at all times and pres­
sure is maintained by applying the Sig­
varis stocking over the nylon stocking 
whenever the limb is dependent. We keep 
the legs wrapped with the initial bandage 
and sponge for 3 weeks, tightening the 
bandage if it loosens. This is followed by 
3 weeks in the surgical stocking supported 
by the sponge pump. Incidentally, if the 
patient cannot tolerate the sponge pump 
during the preparatory period, we do not 
carry out compression sclerotherapy. This 
eliminates the occasional patient who has 
a totally inadequate deep system.
One hundred patients who had 
presented initially with complicated deep 
venous insufficiency (Table I) were fol­
lowed up at an average of 4 years after 
compression sclerotherapy. Of these, 95 
were pleased with the treatment and 
would repeat it. Of 229 incompetent per­
forators that had been injected, about 
20% were again incompetent. One third 
of the patients underwent repeat compres­
sion sclerotherapy or were advised to do 
so. All patients were advised to continue 
wearing a surgical support stocking; 
about two thirds complied. Of interest is 
that at least one third of these patients 
would have been poor candidates for 
operation because of age or obesity. Ideal 
patients for compression sclerotherapy 
are those with the majority of the disease 
below the knee. Perforators, very large 
veins and stasis ulcers are well treated by 
this method which should be part of the 
armamentarium of every surgeon treat­
ing venous disease.
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Varicose veins are a very common 
problem, affecting women more than 
men. The major concern is usually the 
unsightly appearance of the veins. Vari­
ous options to deal with this problem are 
discussed — compression stockings, 
compression sclerotherapy and surgery. 
For good results and patient satisfaction, 
the cause and natural history of varicose 
veins must be understood. Depending on 
the type of varicose vein, different 
modalities of treatment are required and 
may need to be combined. "Cosmetic" 
varicosities can usually be managed con­
servatively with compression stockings. 
Sclerotherapy is best used for dilated 
superficial or residual varicose veins, 
recurrent varicosities or leg perforators. 
Operation should be reserved for very 
large varicose veins or an incompetent 
long or short saphenous vein.
A sound understanding of the 
problems and discussion of anticipated 
results with the patient will prevent 
unrealistic expectations.
Les varices, un probleme courant, affec- 
tent davantage les femmes que les hom­
ines. La principale inquietude a leur sujet 
concerne habituellement leur aspect ines- 
thetique. On commente les diverses 
options qui s'offrent pour faire face a ce 
probleme: bas de soutien, sclerotherapie 
par compression et chirurgie. Pour obte- 
nir de bons resultats a la satisfaction du 
malade, la cause et I'histoire naturelle 
des veines variqueuses doivent etre bien 
comprises. Selon le type de varices,
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diverses modalites de traitement sont 
necessaire et doivent parfois etre asso- 
ciees. Les affections variqueuses dites 
"cosmetiques" peuvent habituellement 
etre traitees de facon conservatrice a 
I'aide de bas de soutien. La sclerothera­
pie convient davantage aux varices 
superficielles dilatees ou residuelles, aux 
varices recidivantes ou aux varices des 
veines perforantes. L'operation doit etre 
reservee pour les varices tres grosses ou 
dans les cas d'insuffisance des saphenes 
longues ou courtes.
Une solide comprehension des proble- 
mes et une bonne discussion des resul­
tats escomptes avec les patients permet- 
tra d’eviter les attentes irrealistes.
Varicose veins are the commonest vascu­
lar condition, affecting 20% of the popu­
lation. There is a preponderance of 
females and a 20% familial incidence of 
varicose veins.
Current management is based on a 
sound knowledge of the anatomy, 
pathophysiology, treatment alternatives 
and cost of therapy.
Pathophysiology
In the ambulatory person, venous 
drainage is inward to the deep veins 
through the perforating veins.1 Integrity 
of the valves in the perforating veins is 
essential to prevent high-pressure leaks, 
leading to local venous hypertension upon 
exercise. There is disagreement on how 
much of a pressure rise is necessary before 
varicosities will develop.2’3 Even a slight 
rise may be sufficient in a susceptible 
person.
Primary varicose veins are associated 
with defective valves and a congenital 
weakness in the vein walls. Congenital 
incompetence of perforators is rare.1 
Damaged valves in the perforators, per­
mitting high-pressure leaks to occur, may 
be due to minor episodes of phlebitis or 
thrombosis in the deep veins.
An unusual type of varicose veins is 
seen on the lateral aspect of the lower 
limb. They usually occur in women and 
have no obvious communication with the
long or short saphenous veins. Probably 
there is a congenital abnormality of the 
vein wall and although “ points of con­
trol” may be demarcated, they do not 
necessarily correlate with perforators.
History, Physical Examination 
and Investigation
The main complaint of women with 
varicose veins is of their cosmetic appear­
ance, although these women may also 
complain of discomfort, tiredness and 
heaviness aggravated by menstruation. 
Men tend to wait until they have large 
varicosities or complications thereof. 
Swelling in primary varicosities is unusual 
and, if present, should alert the physician 
to the possibility of deep venous throm­
bosis. Pigmentation and ulceration indi­
cate incompetent perforators and do not 
occur in primary varicose veins.
The patient is examined standing and 
in good light. The configuration of the 
varicose veins is assessed, including their 
association with the long or short 
saphenous system, their distribution 
above or below the knee or atypically on 
the lateral aspect of the limb. Incompe­
tence at the saphenofemoral junction is 
elicited by the cough test. An impulse is 
normal, but a thrill indicates incompe­
tence and can be verified by a bidirec­
tional Doppler.
Perforators can be assessed using tour­
niquets or digital compression to deter­
mine points of control. Other methods 
that are used are photoplethysmography, 
bidirectional Doppler, ultrasonography, 
venography and invasive pressure meas­
urements.4 The bidirectional Doppler is 
used to record abnormal flow patterns in 
the superficial venous system and to 
assess the integrity of the deep venous sys­
tem. Venography should be reserved for 
patients suspected of having deep venous 
thrombosis.
Management of Varicose Veins
Conservative
Many women complain of visible veins 
that they find unsightly. It is important
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to reassure them that these are normal 
veins and no treatment is required. 
Patients with early or primary varicose 
veins should be assured of the benign 
nature of their condition. Many have a 
friend or relative in whom an ulcer has 
developed, and they are scared that this 
may happen to them.
Low-pressure stockings are of dubious 
benefit to patients with minor varicose 
veins, but they may be helpful during preg­
nancy. With larger varicose veins, 
properly fitting elastic stockings (Jobst or 
Sigvaris) can control the condition 
indefinitely. These stockings are used if 
the patient refuses invasive treatment or 
is not a suitable candidate for surgery. 
Theoretically, the stockings should cover 
the varicose veins and points of control; 
however, patient compliance is poor with 
the high-level stocking or panty-hose. 
Below-knee varicosities are the ones most 
likely to give problems and may be con­
trolled with a below-knee stocking. Men 
tolerate the stocking better than women 
mainly because it is not visible.
In patients with varicose veins above 
and below the knee, below-knee stockings 
are advised for two reasons: better patient 
compliance and the lower limb varicosi­
ties are subjected to higher pressures, 
which must be controlled.
The patients with secondary varicose 
veins due to post-phlebitic conditions 
must wear below-knee elastic stockings 
indefinitely. Compression by elastic 
stockings reduces peak systolic venous 
pressure during exercise in the post- 
phlebitic limb.5 Lateral varicosities on 
the thigh should be treated conservatively 
whenever possible. These veins have a 
very high recurrence rate no matter what 
type of treatment is used. If the patient 
insists on some form of therapy, then 
compression sclerotherapy is recom­
mended.
Compression Sclerotherapy
In 1963, Fegan6 was responsible for 
renewed interest in sclerotherapy. He 
combined injections with compression 
and exercise and achieved good results. 
The aim of compression sclerotherapy is 
to restore normal pressure patterns within 
the superficial venous network.7 Current 
sclerotherapy uses 3% sodium tedradecyl 
sulfate (Thrombovar); 0.5-mL boluses are 
injected into points of control that do not 
necessarily correlate with perforators.8'10 
Three to 10 injections per leg are made
and up to three visits may be needed to 
get a good result. A pad or dental pledgets 
are taped in place over the injection site. 
A crepe or rubberized bandage is worn 
for 2 to 3 weeks and the patient is urged 
to walk at least 3 km daily. This relatively 
low-risk, low-cost procedure can be 
repeated. The most annoying complica­
tions of the procedure are pigmentation, 
and residual and recurrent varicose veins. 
Allergic reaction, arterial injury and deep 
venous thrombosis are very rare.
Hobbs8 carried out a prospective trial 
of surgery versus sclerotherapy in 1977. 
His results after 5 years are summarized 
in Table I, which shows that surgery gave 
a better result for incompetence of the 
greater and lesser saphenous vein system, 
while sclerotherapy gave a good result for 
dilated superficial varicosities and vari­
cose veins due to incompetent perforators 
in the leg. Good results have also been 
reported by Sladen9 and Douglas and 
colleagues11 in Canada, and the proce­
dure was shown to be cost effective.9'11
Some areas of controversy remain. 
They include the strength of the scleros­
ing solution that should be used and the 
length of time that bandaging is neces­
sary. Raj and colleagues12 showed that a 
crepe bandage had to be reapplied every 
8 hours to be effective. Batch and 
associates13 did a randomized trial on 
bandaging for 3 to 6 weeks with no result­
ing difference. Compression sclerother­
apy is useful for dilated superficial veins, 
the atypical lateral varicosities and for 
residual tributaries and recurrent varicos­
ities after surgery.
Surgery
With a better understanding of the 
pathophysiology, the surgical approach 
to varicose veins has undergone change. 
An important consideration is the use of 
the long saphenous vein in the surgical 
treatment of coronary artery disease and 
vascular reconstruction. Stripping the 
long and short saphenous veins should be 
restricted to patients with incompetence 
of these veins. Patients with sapheno- 
femoral incompetence must undergo 
flush ligation and division of all the tribu­
taries of the long saphenous vein in the 
groin to prevent recurrence.
Those with incompetent leg perforators 
may be treated by compression sclerother­
apy. With very large subcutaneous vari­
cosities a surgical approach may be indi­
cated. The decision will be based on the
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likely final cosmetic and functional 
results.
For subcutaneous, residual and recur­
rent varicose veins, compression sclero­
therapy is the best palliation. Rarely are 
multiple ligations required.
With stripping, various methods have 
been used to remove subcutaneous vari­
cosities. These include large incisions, 
small multiple incisions, coagulation 
probe,14'15 cautery and subcuticular liga­
tion with Dexon.16 The most appropriate 
method and one that gives a good cos­
metic result is multiple incisions 0.3 to 0.5 
mm closed by one or two 5-0 nylon 
sutures. Of patients who undergo surgery, 
33% to 45% subsequently need injections 
for residual or recurrent varicosities. 
Thus, a combined approach to these var­
icosities (surgery and sclerotherapy) is 
successful.8,17
The most annoying complications of 
operation are scars, nerve injury, which 
occurs in 5% to 20% of patients, and 
residual varicose veins.18 To obviate the 
possibility of having a good technical 
result and an unhappy patient, the vari­
ous treatment alternatives should be dis­
cussed with the patient, with emphasis on 
the advantages, disadvantages and pos­
sible complications of operation.
Conclusions
A better understanding of the 
pathophysiology of varicose veins, alter­
native treatments and improved results 
have allowed surgeons to give better 
advice to their patients. A frank discus­
sion with the patient will prevent unrealis­
tic expectations. Varicose veins do not 
have a single cause and no one treatment 
is better than all others. Good judgement 
and a sound knowledge of the problem 
are essential for good management. 
“ Cosmetic” varicose veins are best dealt 
with conservatively and if necessary by 
compression sclerotherapy. Varicosities in 
many patients can be managed adequately 
by compression stockings. Surgery should 
be restricted to patients who have an 
incompetent long or short saphenous vein 
or very large subcutaneous varicose veins. 
In patients with dilated superficial vari­
cose veins, residual varicose veins, recur­
rent varicosities or leg perforators, com­
pression sclerotherapy is recommended.
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Direct reconstruction of veins is being 
applied to patients with chronic venous 
stasis. Crosspubic bypass and 
saphenopopliteal bypass have proven 
satisfactory, and valve reconstruction 
by valvuloplasty, segment transfer and 
autotransplantation is being explored. 
These procedures add to the surgeon's 
armamentarium in dealing with chronic 
venous stasis. The results of their appli­
cation are summarized.
Des reconstructions veineuses directes 
sont effectuees chez les patients souf- 
frant de stase veineuse. Les derivations 
pubiennes et sapheno-poplitees se sont 
averees satisfaisante et Ton explore 
maintenant les reconstructions valvulai- 
res par valvuloplastie, les transferts seg- 
mentaires et i'autotransplantation. Ces 
operations elargissent les moyens d'inter- 
vention du chirurgien dans les cas de 
stase veineuse chronique. On resume les 
resultats de leur utilisation.
The patient with chronic, intractable, 
venous stasis that prevents gainful 
employment or the enjoyment of leisure 
activities may be a candidate for surgical 
therapy. Many of these patients have 
incompetent distal deep veins but they 
account for less than 15% of patients with 
documented proximal, major venous
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thrombosis.1 It remains to be shown 
whether thrombolytic therapy or direct 
surgical intervention prevents sequelae of 
venous stasis. In some patients these 
sequelae develop without known previous 
occurrence of deep vein thrombosis.
Which Patients Have 
Intractable Disease?
While it has been noted that conven­
tional interruption of subfascial perfora­
tors and varicose-vein stripping both fail 
to prevent recurrence of venous ulcera­
tion in about 20% of patients, it is also 
true that such conventional therapy can 
produce healing in the remaining 80%. 
Patients who do not respond to treatment 
with graded elastic compression, careful 
attention to skin hygiene, avoidance of 
allergenic medications and removal of 
superficial varicosities may be considered 
for venous reconstruction. The patient 
with intractable disease is one in whom 
surgery is unsuccessful, particularly when 
removal of superficial varicose veins is 
combined with subfascial interruption of 
perforating veins and when the pho­
toplethysmography tourniquet test or 
venography has revealed the presence of 
incompetent perforating veins.
Methods of Venous Reconstruction
Palma and Esperon2 described an 
ingenious method of venous bypass using 
a single venous anastomosis. This tech­
nique of decompressing a limb obstructed 
by a proximal iliac occlusion was modi­
fied by Gruss,3 who added a distal arteri­
ovenous fistula. Subsequently, the use of 
externally reinforced polytetrafluoroethy- 
lene grafts, with or without arteriovenous 
fistulas, provided another alternative. In 
addition, free venous bypasses as 
described by Danza and colleagues4 may 
find application in selected cases.
Experimental venous valve autotran­
splantation was used in the 1960s, but
reports of follow-up studies have been 
contradictory. The most important break­
through has been direct venous recon­
struction using valvuloplasty, introduced 
by Kistner5 in 1968. His operation has 
only recently become generally recog­
nized. The technique enables surgeons to 
evaluate patients for direct venous recon­
struction by selecting those who had 
failed a course of conservative care and 
conventional subfascial interruption of 
perforating veins. Investigation of these 
patients by ascending and descending 
venography gave surgeons the opportu­
nity to perform crosspubic bypass (the 
Palma operation), saphenopopliteal 
bypass or valvuloplasty. Kistner’s contri­
bution should also be recognized for the 
use of venous-segment transfer, which 
enables the venous stream to be redirected 
through a competent proximal valve. His 
methods produced excellent long-term 
results in over 80% of patients and he 
noted that “ When interruption of 
incompetent perforators was performed 
in addition to femoral vein reconstruction 
an excellent result was achieved in 12 of 
25 cases. In comparison, in 16 cases of 
repair of the incompetent deep system 
without treatment of incompetent perfo­
rators, good results were achieved in 11, 
and excellent results in only one.” The 
cautionary message from Kistner is that 
primary valve repair alone is not suffi­
cient in the management of chronic 
venous stasis. Moreover, there is an 
urgent need for objective evaluation of 
venous reconstructive surgery because 
clinical results alone do not provide an 
acceptable method of assessment. If 
direct venous reconstruction is to succeed, 
objective scientific data must be provided.
Future Directions
The availability of direct venous recon­
struction, and the accuracy of evaluation 
by noninvasive techniques and ascending 
and descending phlebography have
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resulted in the establishment of surgical 
services whose prime interest is the treat­
ment o f venous disease. This must be 
regarded as a step forward. When such 
clinics are established in institutions where 
scientific methods of evaluation are used, 
knowledge of venous physiology could be 
updated, the natural history of venous 
disease processes recorded and the long­
term results of direct surgical reconstruc­
tion properly evaluated. Only in this way 
can rational methods of modern surgical 
treatment be planned. Until such infor­
mation becomes available, the best 
method of managing severe venous sta­
sis remains the application of conserva­
tive and standard techniques, reserving 
more modern direct venous reconstruc­
tion for patients who do not respond to 
conventional therapy.
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ORIGINAL ARTICLES
J.R. Moore, md, frcsc, facs*
Gastric Carcinoma: 30-Year Review
The records of 1030 patients with gas­
tric carcinoma seen between 1941 and 
1970 were analysed. A 10-year follow­
up was available for 1024. The overall 
operability and resectability rates were 
80.9% and 53.5% respectively, and in 
the two decades 1951 to 1960 and 
1961 to 1970, the rates increased sig­
nificantly, as did the subtotal gastrec­
tomy rate of 46.9%. Subtotal resection 
for cure was done in 59.5%, and for pal­
liation in 40.5%. Fifty-six patients under­
went a total gastrectomy.
There was no significant increase in 
consecutive decades in either overall 
5-year survival or survival following sub­
total gastrectomy. The 5- and 10-year 
survival rates of 15.1% and 6.6%. Of 
the 5-year survivors, 54% had no lymph- 
node involvement and 35.2% had nodes 
positive for tumour spread.
Gastroesophagectomy was associated 
with a high morbidity and extremely low 
survival. Of 56 patients having a total 
gastrectomy, 37 lived 1 year or more 
while only 5 survived 5 or more years. 
Linitis plastica occurred with equal fre­
quency in men and women. Operability 
and resectability rates were lower and 
there was a 90.6% 1-year death rate.
On a analyse les dossiers mddicaux de 
1030 patients qui ont souffert de cancer 
de I'estomac entre 1941 et 1970. Pour 
1024 d'entre-eux, on possede un suivi 
de 10 ans. Pour I'ensemble, les taux 
d'operabilite et de resecabilite ont ete de
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80.9% et de 53.5% respectivement et, 
aux cours des decennies de 1951 a 
1960 et de 1961 & 1970, ces taux ont 
augmente de facon importante tout 
comme le taux de gastrectomie partielle 
de 46.9%. Resection partielle a visee 
curative fut accomplie pour 59.5%, et 
pour resection a visee palliative 40.5%. 
Cinquante-six patients ont subi une gas­
trectomie totale.
Au cours des decennies consecutives, 
on n'a observe aucune augmentation 
significative de la survie a 5 ans ou de la 
survie apres gastrectomie partielle. Aprds 
resection a visde curative, les taux de 
survie a 5 et 10 ans ont ete de 34% et 
20.5%. Les resections a visee palliative 
ont donne des taux de survie a 5 et 10 
ans de 15.1% et 6.6%. Parmi les survi- 
vants a 5 ans, 54% n'avaient pas 
d'atteinte des ganglions lymphatiques 
alors que 35.2% avaient des signes gan- 
glionnaires d'envahissement tumoral.
Les gastro-oesophagectomies ont £te 
reliees a une morbidity elevee et b une 
survie extremement faible. Des 56 
patients qui ont subi une gastrectomie 
totale, 37 ont survecu 1 an ou plus, 
alors que seulement 5 ont depasse 5 
ans. Les epitheliomas squirrheux de 
I'estomac ont ete observes aussi fr6- 
quemment chez les hommes que chez 
les femmes. Les taux d'operabilite et de 
resecabilite etaient faibles et on a cons­
tate une mortalite a 1 an de 90.6%.
This study reviews the records and follow­
up of 1030 patients with gastric carcinoma 
admitted to the Royal Victoria Hospital, 
Montreal, from 1941 to 1970. A review 
of 427 patients admitted between 1941 
and 1950 was presented previously.1 The 
results of that study are included here to 
expand the follow-up and survival data 
and to compare the results obtained for 
each of the three decades.
Methods
Follow-up o f the 1030 patients was car­
ried out by the central tumour registry of
the Royal Victoria Hospital. Six patients 
were lost to follow-up, leaving a total of 
1024 who were followed up for more than 
5 years. Significance was tested statisti­
cally using the x2 test with Yates’ correc­
tion for continuity with a 2 x  2 contin­
gency table.
Findings
Figure 1 demonstrates the annual inci­
dence o f carcinoma o f the stomach at the 
Royal Victoria Hospital from 1941 to 
1983. The numbers o f new cases for each 
decade between 1941 and 1970 were 427, 
363 and 240 respectively.
Thirty-six patients had two primary 
tumours and 3 a triple primary. One 
patient, in addition to her gastric lesion, 
had a right breast carcinoma, a lung car­
cinoma and a carcinoma of the bladder.
Fifty-three (5.2%) patients (28 women) 
had linitis plastica. The youngest was 26 
years old and the oldest 80; only 9 were 
over 70 years o f age. Weight loss was a 
symptom in all but seven o f these 
patients. Forty (75.5%) were operated 
upon, with 18 (34%) having resections. 
Subtotal resections were done in 10 and 
total gastrectomies in 8. Seventeen had an 
exploratory procedure only while 5 had 
miscellaneous operations in an attempt to 
achieve palliation. Forty-eight (90.6%) 
died within 1 year. The survival times and
FIG. 1—Incidence of gastric carcinoma at 
Royal Victoria Hospital, by year, 1941 to 1983.
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the type of operation in the five patients 
who lived longer than 1 year are set forth 
in Table I.
Sex
Of the 1030 patients, 678 (65.8%) were 
men (Fig. 2). In the first and second 
decades, the women constituted 34.2% 
and 29.2% of the total group. However, 
in the third decade, the proportion of 
women had risen to 41.3% (p<0.01).
Age
The youngest patient was 21 years of 
age and the oldest 90 years. There were 
68 patients between the ages of 20 and 39 
years (Table II), and 54 between 40 and 
44 years of age. The incidence of gastric 
carcinoma continued to increase with 
advancing age without reaching a plateau, 
with 186 cases in the 65 to 69-year age 
group. Patients 70 years of age and older 
made up 21.8% of the total. Forty-two 
patients were 35 years of age or younger 
and 35 (83%) of those died within 1 year 
of diagnosis.
Signs and Symptoms
Signs and symptoms in order of fre­
quency are noted in Table III. All but two 
patients presented with symptoms of gas­
trointestinal disturbance. In one, the dis­
ease was discovered during the course of 
a “ check-up” . The second patient was 
investigated for prostatic obstruction and 
found to have an epigastric mass. Sym­
ptoms were present for 3 months or less 
in 339 patients, while 122 had symptoms 
for 2 or more years. Of the 120 patients 
who survived 5 years or more, 29 (24.2%) 
had had symptoms for 3 months or less, 
while 37 (30.8%) had a symptom- 
duration time of 2 or more years. Weight 
loss was present in 688 (67%) patients. Of 
these, 141 (20.5%) underwent subtotal 
resection for cure. They made up over 
half of the 244 patients who underwent 
resection for cure. An epigastric mass was 
present in 73 (8.4%) of the 874 patients 
who were operated upon and 28 of these 
underwent a subtotal resection for cure, 
with 18 patients surviving 5 years or 
longer.
Nausea and vomiting as a symptom of 
obstruction occurred in 98 (9.5%). The
tumour was located in the prepyloric area 
in 74 of these patients, at the cardia in 20 
and in the body of the stomach in 1 
patient. Three patients had colonic 
obstruction due to tumour spread.
Forty-five of the 58 patients admitted 
with acute bleeding were operated upon. 
Twenty-six (44.8%) had subtotal resec­
tion and 5 underwent total gastrectomy. 
Fourteen patients survived 1 year, 10 
patients 2 years and 4 patients survived 
5 years. One patient lived for 12 years. 
All of the patients who were not operated 
on died within 1 year.
Perforation occurred in 19 (1.8%) 
patients. Suture closure was used in 13 
and 6 underwent subtotal resection. The 
longest survivors were two patients who 
had subtotal gastrectomies and who lived 
2 years. Twenty-four patients had a 
documented history of duodenal ulcer 
before the gastric carcinoma developed. 
Surgery for peptic ulcer had been per­
formed on eight previously. A subtotal 
resection had been carried out in four 
patients at 3, 6, 7 and 24 years before the 
gastric carcinoma was diagnosed.
Diagnostic Investigations
One hundred and fourteen patients 
(44.2%) of 258 whose blood group was 
recorded were of blood group A. Eighty- 
seven (33.7%) were of blood group O. 
Gastric analysis, done in 494 instances, 
revealed 332 (67.2%) who were achlor­
hydric. The blood protein level was re­
corded in 170 patients; in 65 (38.2%), the 
albumin-globulin ratio was reversed, in 49 
(28.8%), the serum albumin level was 
below 30 g/L  and in 56 (32.9%) it was 
normal. Pernicious anemia was present in 
10 (1.7%) of 603 patients whose records 
included sufficient data to establish the 
diagnosis.
The findings of an upper gastrointes­
tinal barium examination were recorded 
in 843 patients. The examination was 
unsatisfactory or incomplete in four 
patients (0.5%). The malignant lesion 
was diagnosed in 762 (90.4%); no lesion 
was seen in 51 (6.0%). In 26 patients 
(3.1%) the findings, although not con­
clusive, indicated that operation was 
necessary, during which the diagnosis 
of gastric carcinoma was made.
In the decade 1941 to 1950, endoscopy 
was done in 21 (4.9%) of the 427 patients,
in 33 (9.1%) of 363 in the following 
decade, and in the last decade there were 
85 (35.4%) endoscopic examinations in 
240 patients. The diagnostic accuracy 
increased from 71.4% to 72.7% in the 
second decade and 78.8% in the final 
decade. Overall, 139 endoscopic exami­
nations were carried out with a positive 
diagnosis in 106 (76.2%).
Operations
Operability increased significantly 
(p < 0.05) during the last two decades 
(Table IV), in which there was also a
Table II—Age Distribution 
of the 1030 Patients
Age
group, yr No. %
20-24 2 0.2
25-29 11 1.1
30-34 17 1.7
35-39 38 3.7
40-44 54 5.2
45-49 82 8.0
50-54 106 10.3
55-59 151 14.7
60-64 158 15.3
65-69 186 18.1
>  70 225 21.8
Table Ill-Signs and Symptoms in Order of 
Frequency of Occurrence
Sign/symptom No. %
Weight loss 688 67
Abdominal pain 650 63
Weight loss and abdominal pain 422 41
Nausea and vomiting 412 40
Anorexia 335 33
Abdominal tenderness 293 28
Weakness 272 26
Abdominal fullness 171 17
Pallor 166 16
Epigastric mass 165 16
Cachexia 129 13
Constipation 119 12
Nausea (without vomiting) 115 11
Gaseous eructations 68 7
Acute bleeding 58 5.5
Dysphagia 56 5
Ascites 11 1
Table I—Data on Five Patients With Linitis Plastica 
Who Survived Longer Than 1 Year
Nodal Duration of
Type of operation involvement survival, yr
Exploratory only Negative 1
Subtotal resection Negative 1.1
Laparotomy only No gross involvement 2.8
Hemigastrectomy Positive 3.5
Subtotal resection Negative 8
26 VOLUME 29, NO. I, JA N U A R Y  1986 /  THE CANADIAN JOURNAL OF SURGERY
small, but significant (p < 0.05), increase 
in the resectability rate (Table IV). The 
rate for all decades was 53.3% of patients 
operated on or 45.2% of all patients in 
the series. Exploration only was done in 
238 (27.2%) of the 874 patients. The inci­
dence of exploration without resection fell 
significantly (p < 0.001), from 34.7% in 
the first decade to 29.4% in the second 
decade to 11.2% in the third. Subtotal 
gastrectomy was performed on 410 
(46.9%) of the patients operated upon 
(Table V), 39.8% of the total series. The 
increase in the last two decades was sig­
nificant (p < 0.05).
Subtotal resection was carried out for 
cure in 244 (59.5%) patients operated 
upon and for palliation in 166 (40.5%) 
(Table V). This relationship did not 
change significantly during the three 
decades, relative to either the number of 
patients operated upon or the total popu­
lation of the series (Table V). Gastroen­
terostomy was done in 90 (10.3%) of 874 
instances. In the years 1941 to 1950, the 
rate was 12.9%. In the following two 
decades, it was 8.1% and 9.3% respec­
tively. These differences were not statisti­
cally significant.
Survival
The overall 5-year survival rate was 
11.7%. Although it increased in the con­
secutive decades (Table VI), the increase
was not significant. Of the patients who 
underwent subtotal resection, 108 
(26.3%) survived for 5 years or longer, 
and 61 (14.9%) were alive at 10 years 
(Table VII). There was no significant 
difference between decades. Of the 244 
patients who had subtotal resection for 
cure, 93 (38.1%) survived 5 years, and 
50 (20.5%) lived for 10 years or longer. 
The operating surgeon described the 
resection as palliative in 166 of the 410 
resections and 25 (15.1%) of these 
patients lived for 5 years or longer, while 
11 (6.6%) survived for more than 10 
years. The operative death rate for 
patients who underwent subtotal resection 
was 8.8% (36 patients). A proximal sub­
total gastrectomy with distal esophagec­
tomy was performed in 34 patients, with 
an operative death rate of 23.5% (8 
patients). Only two patients survived 
longer than 5 years; one for 7 years and 
the other for 9 years.
Of 56 patients (6.4% of those operated 
on) who underwent total gastrectomy, 37 
died within 1 year, 5 lived 5 or more years 
and 3 lived 19 years. Four of the patients 
living longer than 5 years had positive 
nodes.
Pathological Features
Thirty-eight (35.2%) of the 5-year sur­
vivors following subtotal resection had 
positive nodes. In 59 (54.6%) patients,
there was no lymph-node involvement. 
There was no record of nodal disease 
in 11 patients.
Table VIII describes the gross patho­
logical features of the lesions in 701 
patients. A papillary lesion was present 
in 46.2% and these tumours usually 
showed some degree of ulceration. There 
was a primarily ulcerative tumour in 
33.1%.
The peripheral nodes were occasionally 
involved. Fourteen patients had a Vir­
chow’s node, and 14 had positive neck 
nodes. The axillary nodes were the site of 
metastases in eight. One patient had a 
positive right supraclavicular node.
Discussion
For unknown reasons, the incidence of 
gastric carcinoma in the United States 
began to decrease in the early 1930s.2 
That this decrease has continued has been 
well documented.3,4 Except for a slight 
increase between 1941 and 1949, and 
between 1975 and 1980, there was a 
downward trend in our series. There was 
a preponderance of men except in the 
decade from 1961 to 1970, although the 
relative number of women in the last two 
decades of the study has increased signifi­
cantly.
Gastric cancer is primarily a disease of 
the elderly, but a sufficient number of 
cases occur in young people to make one 
wary of symptoms of gastrointestinal 
tract disease. The 83.3% death rate at 1 
year in those 35 years old or younger, 
which corresponds exactly with the figure 
of Bloss and associates,5 makes for a 
particularly discouraging outlook in this 
age group.
Special emphasis should be given to 
weight loss as a symptom. It is frequently 
a late occurrence in other malignant con­
ditions, indicating an advanced stage of 
disease. In gastric lesions, however, it is 
often among the initial complaints or 
findings. Constipation is another symp-
Table IV--Operability and Resectability by Decade
Operability Resectability
Years No. %* No. %t
1941-50 349 81.7 163 46.7
1951-60 320 88.2 170 53.1
1961-70 205 85.4 133 64.9
1941-70 874 84.9 466 53.3
•Percentage of total series.
tPercentage of patients operated on in the respective decade.
Table V-Number of Subtotal Gastrectomies Performed by Decade
Years
Cure Palliation Total
No.
% of 
operations
%
of total 
series No.
% of 
operations
%
of total 
series No.
% of 
operations
%
of total 
series
1941-50 81 55.1 19.0 66 44.9 15.5 147 42.1 34.5
1951-60 92 62.2 25.3 56 37.8 15.4 148 46.2 40.7
1961-70 71 61.7 29.6 44 38.3 18.3 115 56.1 47.9
1941-70 244 59.5 23.7 166 40.5 16.1 410 46.9 39.8
Table VI—Overall 5-Year Survival
Patients 
available for 
follow-up Years No. %
427 1941-50 44 10.3
360 1951-60 44 11.6
237 1961-70 32 13.5
1024 1941-70 120 11.7
Table VII—End Results After Subtotal Resection
Years No.
Alive 5 yr Alive 10 yr
No. % No. %
1941-50 147 39 26.5 26 17.6
1951-60 148 39 26.4 18 12.2
1961-70 115 30 26.1 17 14.7
1941-70 410 108 26.3 61 14.9
Table VIII—Gross Pathological Features
Type No. %
Papillary 324 46.2
Ulcerative 232 33.1
Local infiltration 92 13.1
Linitis plastica 53 7.6
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tom deserving emphasis since it was the 
chief complaint of 12% of the patients in 
our series. A finding of interest is that an 
epigastric mass did not always preclude 
resectability. Eighteen 5-year survivors 
had a palpable abdominal tumour.
The number of patients in blood group 
A so closely approximates the usual num­
ber in that blood group in the general 
population that it was of no prognostic 
importance, in keeping with the findings 
of Hartmann and Stavem.6
Some7'9 believe that there is a risk fac­
tor for “ stump carcinoma” following 
remote subtotal resection for duodenal or 
gastric peptic ulcer. Recently, however, 
Fischer and associates10 concluded that 
individuals previously subjected to Bill­
roth II resection for duodenal ulcer were 
at no higher risk for gastric carcinoma 
than the general population. Also, 
Schafer and colleagues11 found that their 
group of patients who had surgical treat­
ment for benign peptic ulcer disease had 
no evidence of gastric cancer during the 
subsequent 5 years. Only four patients in 
our series had had subtotal resection for 
duodenal ulcer previously. Although the 
development as a carcinoma usually 
occurs after a 15-year interval, in three 
cases it occurred within 8 years. 
Nicholls9 in his large series, however, 
encountered cancers that appeared as 
early as 3 years later. A rather surprising 
finding was the well-documented history 
of duodenal ulcer in 24 patients.
When the duration of symptoms was 
correlated with 5-year survival, it was 
found that 24.2% of patients who under­
went subtotal resection had had their 
symptoms for 3 months or less, while 
30.8% had a symptom-duration time of 
2 or more years. This is not surprising 
since it has been demonstrated by 
others12'14 that patients with gastric car­
cinoma — including those who do not 
undergo resection — who had the longest 
duration of symptoms had the longest 
survival.
Although gastric cancers may occur in 
patients who have normal acid produc­
tion ,15 the finding of achlorhydria must 
certainly raise the possibility of carcinoma 
— more than half of the patients tested 
in our series had no free acid.
Diagnostic accuracy by barium contrast 
roentgenography remained in the vicin­
ity of 92%, while that of the endoscopy 
was 76%. The increased accuracy for the 
latter procedure as well as an increase in 
its use is probably due to the introduction 
and more frequent use of fiberoptic 
endoscopic instruments and biopsy.
Although there was a small significant 
increase in operability and resectability in 
the second and third decades of this 
study, there was no significant change in 
the survival rates following subtotal gas­
trectomy. The long-term survival at 
present attained after resection is due
mainly to subtotal gastrectomy, either 
proximal or distal, depending on the site 
of the lesion. This routinely includes 
resection, in continuity, of the greater 
omentum and adjacent lymph nodes. A 
30% 5-year survival rate for patients 
operated on for cure correlates well with 
the operator’s assessment at the time of 
resection.
An important correlation exists with 
node involvement. Following subtotal 
resection, the 5-year survival was 54% for 
those without involved nodes and 35.2% 
for those with involved nodes.
When the operation was described as 
palliative by the operating surgeon, 15% 
of the patients were alive 5 years later and 
6.6% 10 years later. Palliative resection 
is worthwhile because it provides better 
palliation than a bypass operation for a 
potentially bleeding or obstructive lesion. 
Also, nodes originally thought to be 
metastatic may, in fact, not be.
Gastroesophagectomy for lesions of the 
cardia invading the esophagus results in 
a disappointingly low survival rate, as 
Dupont and colleagues16 found. The real 
value of the resection of the tumours may 
well be the palliation it provides. This was 
the conclusion reached by Ellis and 
Gibb,17 and is supported by the findings 
in our series. In addition, debulking of 
the tumour mass may be of value should 
chemotherapy be used.
Total gastrectomy is still associated 
with poor survival. Only 18 of our 56 
patients survived 1 year, and only 5 lived 
5 years or longer. This procedure should 
be used selectively and only when there 
is a reasonable chance of resecting all dis­
eased tissue. Because of its high morbidity 
and risk of early mortality, it has little 
place as a palliative procedure.
Linitis plastica, an uncommon type of 
diffuse infiltrating tumour, had some fea­
tures that differ from the more usual 
types of adenocarcinomatous lesions. It 
occurred with almost equal frequency in 
men and women. Weight loss was the 
chief symptom in a high percentage (86%) 
of the patients. Operability and resecta­
bility rates were lower and the 90.6% 
death rate at 1 year was particularly dis­
couraging.
The overall survival rate for patients 
with gastric adenocarcinoma in North 
America has changed little for many 
years. The results from subtotal gastrec­
tomy have also reached a plateau as is 
shown in this and other series.18'21 
Whether future improvement will depend 
on the use of chemotherapy, radiother­
apy or a combination of these, remains 
to be seen.
I am indebted to Dr. H.M. Shizgal for sig­
nificance testing, and to Drs. H.M. Shizgal and 
J.L. Meakins for reviewing the manuscript.
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Telangiectatic Osteosarcoma: Unusual Behaviour
The telangiectatic variant of osteogenic 
sarcoma is rare. Its biologic behaviour, 
treatment and prognosis are controver­
sial. The case of a 15-year-old girl with 
this tumour is described. Both the loca­
tion and clinical behaviour of the tumour 
were unusual. The tumour, which in­
volved the distal ulna, was initially 
treated by a limited resection of the dis­
tal 8 cm of ulna. Sixty-nine months later 
the tumour recurred locally; there was 
no evidence of metastases. The forearm 
was amputated and the patient was then 
treated aggressively by chemotherapy. 
She was well 42 months later.
This case illustrates the tendency for 
telangiectatic osteosarcoma to recur 
locally if it is not radically excised.
Le sarcome osteogene de type telangiec- 
tasique est rare. Son comportement bio- 
logique, son traitement et son pronostic 
font I'objet de controverse. On en decrit 
un cas chez une fille de 15 ans. La loca­
lisation et le comportement Clinique de la 
tumeur furent inhabituels. La tumeur 
affectant la partie distale du cubitus fut 
tout d'abord traitee par resection limitee 
de 8 cm du cubitus distal. Une recidive 
locale apparut 69 mois plus tard; il n'y 
avait pas de signes de metastase. 
L'avant-bras fut ampute et on ajouta une 
chimiotherapie agressive. Quarante-deux 
mois plus tard, la patiente demeurait en 
bonne sante.
Ce cas illustre la tendance que montre 
I'osteosarcome telangiectasique de reci- 
diver localement s'il n'est pas excise 
completement.
Despite the early recognition of the telan­
giectatic variant of osteogenic sarcoma by 
Paget in 1854* and its subsequent clas-
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sification as a variant of osteogenic sar­
coma by Ewing in 1922,2 there is still dis­
agreement regarding the incidence, 
clinical behaviour, optimal treatment and 
prognosis o f this entity.3-10 We report a 
case o f telangiectatic osteosarcoma in 
which the site o f the lesion and clinical 
course were unusual. The tumour deve­
loped in the ulna and the patient’s course 
was complicated by local recurrence. This 
case has therapeutic implications concern­
ing the use o f limited resection for the 
treatment o f this condition.
Case Report
A previously healthy 15-year-old girl was 
admitted to hospital with a 3-month history of 
progressive pain in the right wrist. Movement 
was so limited that she could no longer type 
or play the piano. Initial roentgenograms rev­
ealed a lytic, 5.0-cm expansile defect involv­
ing the distal epiphysis and metaphysis of the 
right ulna. The cortical margin was irregular 
and there was an associated pathologic frac­
ture (Fig. 1). Diagnostic possibilities included 
an aneurysmal bone cyst with fracture, a 
benign or malignant giant cell tumour and 
osteogenic sarcoma. Biopsy showed cystic 
blood-filled spaces separated by trabeculae of 
cellular tissue containing polygonal and 
spindle-shaped cells with anaplastic nuclear fea­
tures (Fig. 2, a and b). There were many mitotic 
figures (Fig. 2c). Scant, lacy osteoid was 
present in a few areas (Fig. 2d). Benign giant 
cells and hemosiderin containing histiocytes 
were also noted. Outside consultation (D.C. 
Dahlin) confirmed the diagnosis of telangiec­
tatic osteosarcoma. Results of investigation for 
metastatic involvement were negative.
A limited resection of the distal 8 cm of ulna 
was performed. This decision was based in part 
on the family’s wishes and in part on the con­
flicting information available in the literature 
at the time (1976) — one group indicating a 
uniformly grave prognosis and recommending 
radical excision8 and the other group indicat­
ing that results of local resection combined with 
systemic chemotherapy paralleled those of 
amputation.11 Examination of the operative 
specimen revealed a soft, hemorrhagic mass 
(5.0 x 2.5 x 2.0 cm) replacing the distal ulna 
and extending to the articular surface of the 
wrist. The proximal surgical margin of exci­
sion was free of tumour. Postoperatively, Adri- 
amycin (30 mg/m2 for 3 consecutive days 
every 4 weeks) was given over a period of 6 
months.
The patient remained well for 69 months,
when pain developed at the previous resec­
tion site. Roentgenograms showed bone resorp­
tion of the distal end of the ulnar stump (Fig. 
3) and bone scans revealed increased activity 
in the same region. There was no evidence of 
metastatic disease. Biopsy and subsequent dis­
articulation through the elbow confirmed 
recurrence of the tumour. The tumour mass 
(3.0 x 2.5 x 2.5 cm) involved the distal ulnar 
stump and surrounding soft tissue and 
extended into the medullary cavity of the ulna 
for 6.5 cm (Fig. 4). No skip lesions were 
present.
Postoperatively, a modified Rosen regimen 
(high-dose methotrexate and vincristine with 
citrovorum factor recovery)11'12 was followed 
at 6 weeks by a protocol comprising bleomy­
cin, cyclophosphamide and actinomycin D. At 
9, 10, 14 and 15 weeks she received methotrex­
ate with citrovorum factor recovery, then, at 
20 weeks, two cycles of cisplatinum followed 
by another course of bleomycin, cyclophospha­
mide and actinomycin D. To date, 42 months 
after her second operation, there is no evidence 
of recurrence and her biochemical findings are 
normal. Clinically, she is doing well and has 
been fitted with a myoelectric prosthesis.
Discussion
The clinical features of telangiectatic 
osteosarcoma have been well defined. As 
with the standard form, the tumour is 
more common in men (60%), but the 
telangiectatic form occurs in a slightly 
younger person (mean age 20 years). With
FIG. 1—Primary tumour showing lytic 
destructive lesion involving distal end of ulna.
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the exception of the proximal femur and 
tibia, which are less frequently involved, 
the distribution of this neoplasm is gener­
ally similar to that of standard osteogenic 
sarcoma: most tumours involve the 
metaphysis of major tubular bones.7-9 
Symptoms are nonspecific, consisting of 
local pain and swelling. Roentgeno- 
graphic findings show a large, lytic lesion 
with cortical erosion and an occasional 
“ blown-out” appearance. A permeative 
pattern of destruction may also be 
seen.13 Extension to the epiphysis and 
pathologic fracture occur more frequently 
with telangiectatic osteosarcoma than 
with the standard type.8 To establish the 
diagnosis, some authorities require that 
the lesion be purely lytic throughout, but 
others accept a predominantly lytic lesion 
with minimal sclerosis.9 The roentgeno- 
graphic picture is frequently less specific 
than that of standard osteogenic sarcoma. 
The differential diagnosis includes 
aneurysmal bone cyst and benign or 
malignant giant cell tumour.
The tumour in our case fulfilled the 
diagnostic criteria used by Dahlin:13-14
radiologically, the tumour appears to be 
a lytic destructive lesion with no apprecia­
ble areas of sclerosis; grossly, the tumour 
forms a cavity with little solid tumour tis­
sue and no apparent sclerosis; and, histo­
logically, the tumour consists of single or 
multiple cystic cavities containing blood 
and necrotic tumour, often traversed by 
septae composed of anaplastic cells.
Our case is unusual in several respects. 
First, telangiectatic osteosarcoma of the 
ulna has seldom been reported. In a ser­
ies of 124 cases,7 2 involved the distal 
forearm, but whether these primarily 
involved the radius or ulna is not clear. 
In other series, involvement of the ulna 
has not been reported. Second, this 
patient’s clinical course was unusual in 
that it was characterized by late local 
recurrence and prolonged survival (9 
years). Local recurrence is an infrequent 
finding in standard osteogenic sarcoma 
but has been noted in approximately 20% 
of cases of telangiectatic osteosarcoma, 
usually as a terminal event.8 Had disar­
ticulation, rather than limited resection of 
the distal ulna, been carried out initially,
Fig. 2a
#■ l  ^  r>
jtm J 0  *
-&* *  f t  *  V 
* >'
•  ;
A1 0  J *  
i  1 1  %  -•
#  % r , & H *  SK
% l . ■ &
^  ■ 9 *  S '  
, ?
*  "  if
«  %  < ® .  ,19 €
x  #  , s  %'$W' /m, " 
-
Fig. 2c
‘ i  '
> * % mi
<§» » * ,
' - ‘ * s
• a  t : * V
t I *
* * jr  t *• #  ^ *
, * m M ft %0 * - . f t t
\ %*• ' •  , j> *ft♦ v ■’ t  ,
#  > r ' " ♦ # \
*
• ♦if A '
♦ m
i§#
* *
r  H
.. 3#
Fig. 2b
*>« ~ *f  * ft
a  ~ -mm m 4> *  *«■> v
»  «, m
•». * m  *  n  :,J <#
% % * f t  ' ♦  s
*  v
:.w  *».\ -* .%%
i *  *  >' ?
m  %
*  V  *  *
> X  % %
% ♦  f tv  %
Fig. 2d
FIG. 2—(a) Cystic filled spaces separated by trabeculae of cellular tissue (hematoxylin and 
eosin, original magnification x 25). (b) Cellular area composed of polygonal and spindle-shaped 
cells with frequent mitotic figures (hematoxylin and eosin, original magnification x 100). (c) 
Higher magnification showing pleomorphic cellular features with high mitotic rate (hematoxy­
lin and eosin, original magnification x 400). (d) Neoplastic cells separated by scant lace-like 
osteoid (hematoxylin and eosin, original magnification X 400).
local recurrence might have been 
prevented. The initial decision favouring 
local resection over disarticulation was 
based on the family’s wishes and conflict­
ing information in the literature at the 
time. The distal location of the tumour 
suggested that it would be possible to 
excise tissue proximal to the lesion and 
eradicate the tumour by local resection as
Fig. 3a Fig. 3b
FIG. 3—(a) Appearance immediately 
postoperatively. Border of ulna is sharply 
defined at resection line, (b) With local recur­
rence there is resorption of distal ulna.
FIG. 4—Surgical specimen showing locally 
recurrent tumour involving ulna. Hemorrhagic 
mass is present at previous resection line and 
extends proximally within medullary canal for 
6.5 cm.
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effectively as by amputation. The clini­
cal course, however, confirmed the previ­
ously reported tendency for this tumour 
to recur locally and illustrates the poten­
tial danger of performing limited re­
section.
The clinical importance and prognosis 
of telangiectatic osteosarcoma are con­
troversial. In the Memorial Hospital ser­
ies,7 in which focal minimal sclerosis was 
accepted in an otherwise lytic lesion, 124 
(11%) of 1129 osteogenic sarcomas 
were classified as telangiectatic and these 
were associated with a similar or even bet­
ter prognosis than that for conventional 
osteogenic sarcoma. In the same study, 
when only 43 purely lytic tumours were 
analysed, the survival was the same as 
that of standard osteogenic sarcoma. By 
contrast, in other series8 in which the 
criteria outlined in our case were used, the 
relative incidence was lower (2.5%) and 
was associated with a much worse prog­
nosis, 23 of 25 patients dying of the dis­
ease with a mean survival of 16 months. 
In other reports,10,15 the relative inci­
dence of telangiectatic osteosarcoma to 
standard osteogenic sarcoma ranged from 
0.4% (1 out of 242 cases) to 12% (21 out 
of 170 cases).
Although it is a rare entity and ques­
tions still remain about the precise criteria 
for diagnosis, incidence relative to stan­
dard osteogenic sarcoma and prognosis, 
the telangiectatic variant has sufficiently 
distinctive clinical and histologic features 
to warrant recognition as a separate 
clinicopathologic entity. The radiologic 
and pathological findings are notorious 
for mimicking benign bone tumours, par­
ticularly aneurysmal bone cyst.1618 Com­
pared with standard osteogenic sarcoma, 
the telangiectatic variety more frequently 
involves the epiphysis, has a higher inci­
dence of pathologic fracture and tends to 
recur locally more often. Our case illus­
trates this last feature and emphasizes the 
potential risk of performing limited resec­
tions of high-grade osteosarcomas.
We acknowledge the assistance of Dr. D.C. 
Dahlin in reviewing both the original and recur­
rent tumours. We also thank Dr. D .A .E. 
Shephard for editorial assistance.
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Loop Ileostomy for Anorectal Crohn’s Disease
The treatment of symptomatic Crohn's 
disease of the anorectum can be 
challenging. Medical therapy may fail and 
local surgery may be complicated by 
delayed healing or incontinence. The 
authors report the clinical course of 12 
patients with this condition treated by 
fecal diversion with a loop ileostomy.
Seven patients had a rectovaginal 
fistula. At the time of review, one of 
them had restored intestinal continuity 
following successful fistula repair, three 
had minimal or no symptoms, one had 
an active perianal fistula after closure of 
the ileostomy and two had undergone a 
proctocolectomy for recurrent symp­
toms. Five patients with Crohn's procti­
tis or anorectal sepsis were treated by 
loop ileostomy. One was asymptomatic, 
one had recurrent symptoms and three 
underwent a proctocolectomy.
From their experience the authors con­
clude that construction of a loop 
ileostomy will temporarily improve the 
symptoms of anorectal Crohn's disease. 
Fecal diversion does not appear to alter 
the long-term course of the disease, and 
successful restoration of intestinal con­
tinuity is uncommon.
Le traitement de la maladie de Crohn 
symptomatique avec atteinte de I'anus et 
du rectum represente tout un defi. Le 
traitement medical peut echouer et la 
chirurgie locale peut se compliquer d'un 
retard de guerison ou d'incontinence. Les 
auteurs decrivent revolution clinique de 
12 patients souffrant de cette maladie 
qui ont ete traites par detournement de 
I'evacuation fecale a I'aide d'une boucle 
d'ileostomie.
Sept patientes souffraient d'une fistule 
rectovaginale. Au moment de preparer ce 
rapport, une d'entre-elles avait eu un 
retablissement de la continuite intestinale 
apres reparation reussie d'une fistule, 
trois presentaient peu ou pas de sympto-
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mes, une avait une fistule perianale 
active apres fermeture de I'ileostomie et 
deux avaient subi une proctocolectomie 
apres r6cidive des symptomes. Cinq 
patients prdsentant une rectite de Crohn 
ou une infection anorectale ont ete trai­
tes par boucle d'ileostomie. Un etait 
asymptomatique, un montrait des signes 
de rechute et trois avaient subi une proc­
tocolectomie.
Suite a leur etude, les auteurs con- 
cluent que la construction d'une boucle 
d'ileostomie ameliore temporairement les 
symptomes de la maladie de Crohn ano­
rectale. La derivation de I'ecoulement 
fecal ne semble pas modifier revolution 
a long terme de la maladie et le retablis­
sement de la continuite intestinale reus- 
sit rarement.
Crohn’s disease involving the anorectum 
may present with a variety of lesions 
including hemorrhoids, edematous skin 
tags, anal fissures and simple or complex 
fistulas. The treatment of symptomatic 
patients can be challenging. Medical ther­
apy may be unsuccessful, and surgery 
may be complicated by delayed healing 
or incontinence,1 prompting surgeons to 
consider alternative methods of treat­
ment. External diversion of the fecal 
stream by means of a split or loop 
ileostomy appears theoretically to offer 
several advantages: to relieve the symp­
toms of diarrhea and anal discomfort, to 
reduce anorectal sepsis and to prevent or 
delay proctocolectomy.
In 1965, Truelove and associates2 
reported on five patients with Crohn’s 
colitis treated by split ileostomy. Subse­
quent papers have suggested that up to 
90% of patients with Crohn’s colitis are 
temporarily improved after external fecal 
diversion.3-5 The effect of an ileostomy 
on the long-term course of anorectal 
Crohn’s disease is less clear. Although 
Harper and colleagues6 found initial 
improvement in 72% of patients with 
perianal Crohn’s disease treated by a split 
ileostomy, intestinal continuity was 
restored in only 20%.
We undertook the present review to 
analyse our own experience with loop 
ileostomy in patients with anorectal 
Crohn’s disease.
Patients (Table I)
Twelve patients (3 men, 9 women) with 
anorectal Crohn’s disease were treated by 
loop ileostomy. They ranged in age from 
21 to 46 years. The clinical diagnosis 
was confirmed by a combination of 
endoscopic, radiologic and histopatho­
logic examinations. The average duration 
of C rohn’s disease until the loop 
ileostomy was done was 6 years.
Seven women (group 1) had rectovagi­
nal fistulas associated with Crohn’s dis­
ease. All complained of the passage of 
stool or flatus through the vagina. Two 
had perineal pain and four had abdomi­
nal pain, diarrhea or anorexia. Rectovagi­
nal fistulas were associated with Crohn’s 
disease of the small intestine in two 
patients, the colon in one and both the 
small intestine and colon in four. The rec­
tum was uninvolved macroscopically or 
was minimally diseased in all the women. 
All had received prednisone or sulfasala­
zine and five had completed at least one 
course of m etronidazole w ithout 
improvement. In three women, the loop 
ileostomy was combined with small-bowel 
resection.
Three patients (group 2) had anorectal 
sepsis due to complex fistulas. Symptoms 
in these patients included crampy 
abdominal pain, severe perianal pain and 
diarrhea. All had colonic disease, which 
was associated with small-bowel disease 
in two. In addition to prednisone or sul­
fasalazine, two had previously been 
treated with metronidazole with only 
minimal improvement.
The remaining two patients had severe 
proctitis (group 3). Both had crampy 
pain, diarrhea, tenesmus and weight loss. 
Radiologic and endoscopic investigations 
revealed severe Crohn’s disease confined 
to the colon and rectum. In addition to 
sulfasalazine and prednisone, one patient 
was treated with metronidazole without 
improvement.
Surgical Technique
Preoperatively, the site of the proposed 
ileostomy is marked appropriately in the 
right lower quadrant. Under general 
anesthesia, a laparotomy is performed
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and the small bowel examined. A loop of 
normal bowel closest to the ileocecal valve 
is chosen for the ileostomy. A stomal 
aperture is made that will admit two 
fingers. The ileum is delivered through the 
abdominal wall and secured over a small 
plastic ileostomy rod to prevent retraction 
of the stoma (Fig. 1). After the abdomi­
nal incision has been closed, an eccentric 
opening is made in the distal portion of 
the ileal loop (Fig. 1). The stoma is 
matured by everting the distal end 
towards the proximal end and suturing 
the ileum to the skin with interrupted 
absorbable sutures as described by Turn- 
bull and Weakley7 (Fig. 2). An ileostomy 
appliance is placed, although the 
ileostomy usually does not begin to func­
tion for several days postoperatively. The 
ileostomy rod is removed 5 to 7 days after 
operation. The stoma functions as if it 
were an end ileostomy and patients use 
standard ileostomy appliances.
Results
Complications
The mean hospital stay after loop 
ileostomy was 14 days (range from 10 to 
25 days). Five patients had complications 
postoperatively that responded to medi­
cal management; they included incom­
plete small-bowel obstruction in two and 
high ileostomy output in three. One 
patient had wound dehiscence requiring 
reoperation.
Two patients suffered late complica­
tions. One had peristomal skin irritation
due to mucous discharge from the distal 
limb of the loop ileostomy. This problem 
was eventually solved by converting the 
loop to a split ileostomy. The other 
patient had a bowel obstruction caused 
by a loop of small intestine that became 
twisted about the undersurface of the 
ileostomy site. She required laparotomy, 
at which time the loop ileostomy was 
closed.
Only one group 1 patient had the loop 
ileostomy successfully closed. Three still 
have the loop ileostomies but have 
minimal or no symptoms from the rec­
tovaginal fistula. One patient is sympto­
matic with a perineal fistula that deve­
loped after the loop ileostomy was closed.
FIG. 1—Loop of distal small bowel is 
brought through stomal aperture in right lower 
quadrant. It is maintained in position by plas­
tic ileostomy rod. Enterotomy is made in dis­
tal portion of this loop of bowel. Stoma is 
matured by everting distal end toward prox­
imal end.
Two patients required proctocolectomy.
One month after loop ileostomy, the 
three group 2 patients had reduced their 
medications and were free of perineal 
pain. On examination, however, the 
fistulas rem ained unhealed  and 
endoscopy showed active rectal disease. 
At the time of review only one patient in 
this group is asymptomatic, 30 months 
postoperatively. One patient required a 
proctocolectomy 4 months after construc­
tion of the ileostomy because of recurrent 
perianal infection, frequent bowel move­
ments and crampy abdominal pain. The 
third patient had similar complaints 21 
months after- construction of the loop 
ileostomy. He remains symptomatic but
FIG. 2—At completion, proximal limb of 
ileum forms protruding stoma while distal limb 
is flush with skin.
Table I— Patient Data and Clinical Course After Treatment of Anorectal Crohn's Disease by Loop Ileostomy
Subsequent surgery
Age, Site of (mo after loop Current status (mo
Group Sex yr disease Previous treatment ileostomy) after loop ileostomy)
1 -  rectovaginal F 34 SB Metronidazole, small-bowel Repair RVF (10) Asymptomatic (13)
fistula resection Closure loop ileostomy
(13)
F 26 SB/LB Sulfasalazine, prednisone, Repair RVF (12)
small-bowel resection Repair loop ileostomy
(X 2) (16)
46
Repair RVF (18) 
Proctocolectomy (26)
F LB Sulfasalazine, prednisone, — Asymptomatic (29)
metronidazole
F 23 SBILB Prednisone, metronidazole Proctocolectomy (6)
F 26 SB Sulfasalazine, prednisone, Ileostomy revision Asymptomatic (20)
small-bowel resection (18)
F 37 SB/LB Metronidazole, small-bowel - Asymptomatic (14)
resection (X 2)
F 27 SB/LB Metronidazole, small-bowel Closure loop ileostomy Active anorectal disease
resection (22) (fistula) (25)
2 -  anorectal F 27 LB Prednisone — Asymptomatic (30)
sepsis M 27 SB/LB Sulfasalazine, prednisone, — Active anorectal disease
metronidazole, small-bowel 
resection
(fistula) (21)
M 28 SB/LB Prednisone, metronidazole Proctocolectomy (4)
3 -  severe M 21 LB Sulfasalazine, prednisone Proctocolectomy (6)
proctitis F 19 LB Sulfasalazine, prednisone, Proctocolectomy (181
metronidazole
SB -  small bowel, LB = large bowel, RVF -  rectovaginal fistula.
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has so far refused a proctocolectomy.
The two patients in group 3 had less 
pain and were able to reduce their medi­
cations 1 month after operation. Sig­
moidoscopy still showed active disease. 
At 6 and 18 months, they required a proc­
tocolectomy for recurrent abdominal 
pain, frequent bowel movements and 
tenesmus despite the fecal diversion.
Discussion
The anorectal manifestations of 
Crohn’s disease include edematous skin 
tags, fissures, abscesses, fistulas, stric­
tures and proctitis. Large painless anal 
ulcers, multiple fistulas and edematous 
indurated perianal skin with a dusky 
colour are typical perianal findings in 
these patients.8
Anorectal involvement is common in 
C rohn’s disease. Fielding9 reported 
abscesses, sinuses, fistulas, tags and fis­
sures in 109 of 156 patients with Crohn’s 
disease. These lesions were found in 76% 
of patients with small-bowel disease, 94% 
of patients with large-bowel disease, but 
in only 38% of a control population. 
Others, however, have found a lower rate 
of involvement. Of patients in the 
National Crohn’s Cooperative Disease 
Study, only 36% gave a history of peri­
anal complications at the time of entry.10 
Marks and colleagues11 reported that 
anal fistula occurred in 112 of 329 
patients followed at St. Mark’s Hospital 
during a 10-year period. Similarly, Heu- 
man and associates12 reported that 40% 
of their patients suffered from perianal 
manifestations during a 6-year follow-up. 
These differences are likely owing to the 
variable criteria used to diagnose perianal 
Crohn’s disease. Most authors do agree, 
however, that the prevalence of perianal 
disease is higher in patients with colonic 
and rectal involvement.9'10
No treatment is required if the anorec­
tal disease is asymptomatic. The initial 
management of symptoms should include 
a full assessment of proximal disease and 
institution of appropriate medical or sur­
gical therapy. If this is effective, the 
anorectal disease may resolve spontane­
ously.13
Brandt and colleagues14 found that 
metronidazole was effective in 26 patients 
with persistent anorectal Crohn’s disease 
that failed to respond to conventional 
medical or surgical therapy. The only 
major side effect was paresthesia that 
developed in 50% of the patients, and this 
resolved when the dose was reduced. 
However, when the drug was discon­
tinued, the disease recurred in 72%. 
Metronidazole has been reported to be a 
carcinogen in animals,15 so prolonged 
use by humans may be hazardous. This 
risk should be considered when prescrib­
ing the drug in large doses and for 
long periods. Eight of our patients
had been treated with metronidazole in 
doses ranging from 750 mg to 1000 mg 
daily for at least 1 month, including five 
patients with rectovaginal fistulas, two 
patients with complex fistulas and one 
with severe proctitis. All failed to improve 
and one patient had to discontinue the 
medication because of paresthesia.
The surgical treatment of symptomatic 
anorectal Crohn’s disease that has not 
responded to medical therapy is challeng­
ing. Wound healing may be delayed and 
radical local surgical treatment may cause 
fecal incontinence. Thus, experienced 
surgeons9,13 have advocated a conserva­
tive approach. Two principles guide the 
surgical management of anorectal 
Crohn’s disease — sepsis should be con­
trolled by incision and drainage of 
abscesses, and division of a large portion 
of sphincter muscle should be avoided.16 
Fistulas with internal openings low in the 
anal canal can safely be laid open. Com­
plex fistulas with internal openings near 
the top of the anorectal ring should be 
treated by laying open the external parts 
of the fistula to establish drainage, curet­
ting the tract to remove granulation tis­
sue and perhaps instituting catheter 
drainage. This approach may relieve 
symptoms and minimize the risk of incon­
tinence as a complication of surgical 
drainage.
External diversion of the fecal stream 
by means of an ileostomy is an alterna­
tive surgical treatment for Crohn’s dis­
ease.2-5 Unfortunately, relapse after loop 
ileostomy is common, and it is difficult 
to restore intestinal continuity. Burman 
and associates,17 Zelas and Jagelman,3 
and Mcllrath4 found that colitis recurred 
in one third to one half of patients after 
construction of a loop ileostomy and that 
intestinal continuity was restored in less 
than one third. Six of 22 patients in the 
series of Zelas and Jagelman3 who 
underwent loop ileostomy for anorectal 
disease remained well for 3 to 5 years. 
Harper and colleagues5 reported that 21 
(72%) of 29 patients with anorectal 
Crohn’s disease treated by split ileostomy 
had early improvement. However, only 
6 patients had intestinal continuity 
restored, 8 had undergone a proctocolec­
tomy and 15 remained defunctioned.
Our results following the treatment of 
anorectal Crohn’s disease with a loop 
ileostomy have been disappointing. One 
quarter of the patients had early or late 
complications requiring reoperation. 
Although all initially improved after fecal 
diversion, this was often a transient 
response. At the time of review (average 
follow-up of 17 months), intestinal con­
tinuity has been successfully restored in 
only one patient and five are asympto­
matic following construction of a loop 
ileostomy. Five patients have subse­
quently required proctocolectomy.
In patients with proctitis or anorectal 
sepsis, loop ileostomy should be viewed 
as a temporary measure since it does not 
appear to alter the course of the disease. 
Nevertheless, there may be some merit in 
constructing a loop ileostomy. Perianal 
sepsis may become quiescent, at least tem­
porarily, so proctectomy is easier to per­
form. Consequently, perineal wound 
complications may be reduced. In this ser­
ies, three of five patients had primary 
wound healing after proctectomy. 
Although this is a small group, satisfac­
tory results were achieved in these high- 
risk patients. The second benefit is that 
it may allow patients to adjust psycholog­
ically to an ileostomy. Some patients will 
agree to a temporary ileostomy whereas 
they would be reluctant to undergo a 
definitive procedure initially.
Rectovaginal fistulas due to Crohn’s 
disease can be extremely difficult to 
manage. Although patients are usually 
distressed by their symptoms, few will 
readily agree to proctocolectomy and 
ileostomy or proctectomy and colostomy. 
Again, construction of a loop ileostomy 
may temporarily alleviate symptoms and 
enable the patient to adjust to life with 
an ileostomy. However, patients should 
be advised that successful restoration of 
intestinal continuity is uncommon. In our 
experience, spontaneous healing of the 
fistula is rare and symptoms usually recur 
once continuity is restored. Most patients 
with rectovaginal fistulas have associated 
rectal involvement, making local repair of 
the fistula possible in only a few selected 
patients. Local repair should be 
attempted only when the disease is in 
remission, the rectum is apparently 
healthy and meticulous surgical technique 
is used.18,19 The addition of a loop 
ileostomy to divert stool may improve 
healing and the outcome after surgery.
Conclusions
Our experience with a loop ileostomy 
to manage anorectal Crohn’s disease sug­
gests that this procedure will provide tem­
porary relief of symptoms. Fecal diver­
sion does not appear to alter the 
long-term course of the disease and suc­
cessful restoration of intestinal continuity 
is uncommon.
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Laser Surgery in 
Gynecology and Dermatology
This postgraduate course will be held Feb. 
20-22, 1986, at the Hyatt Lake Tahoe, 
Lake Tahoe, Calif. It will provide a com­
prehensive review of the biophysical basis 
for carbon dioxide laser surgery in gyne­
cology, and for argon, neodymium-YAG 
and carbon dioxide laser surgery in der­
matology. The course is designed for phy­
sicians and nurses and will offer separate 
programs for each specialty. The range 
of applications and surgical techniques 
will be detailed. The course will consist 
of lectures, video demonstrations and 
hands-on training sessions with the sur­
gical lasers under faculty supervision. 
There will be an extensive commercial 
exhibition in conjunction with the course.
For further information on the scien­
tific program and registration contact the 
course directors: Dr. V.C. Wright, 
Department of Obstetrics and Gynecol­
ogy, The University of Western Ontario, 
887 Richmond St., London, Ont. N6A 
3J1, tel. (519) 438-1411; or Dr. Alex 
Ferenczy, Department of Pathology, The
Sir Mortimer B. Davis-Jewish General 
Hospital, 3755 Cote Ste-Catherine, Mon­
treal, PQ H3T 1E2, tel. (514) 342-3111.
Neurovascular Surgery
The 3rd annual meeting of the Neurovas­
cular Society of North America and the 
Society for Neurovascular Surgery will be 
held in Chicago, 111., Apr. 17-19, 1986.
General sessions will strive to identify 
problems affecting the heart, blood ves­
sels and brain, pathologic mechanisms, 
and methods of diagnosis and manage­
ment. Special sessions will address in 
detail such topics as vertebral artery sur­
gery, ultrasonography, headaches, nerve 
repair and anticoagulation. The meeting 
will be open to all diagnostic, medical and 
surgical specialties.
For further information write the 
Executive Director, Neurovascular Soci­
ety of North America/Society for Neu­
rovascular Surgery, PO Box 679, Oak 
Park, IL 60302; or call (312) 482-3950.
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Tube Cecostomy Revisited
A retrospective review of 59 tube 
cecostomies, performed between 1971 
and 1981, was undertaken to evaluate 
current operative indications, outcome 
and associated morbidity. Tube 
cecostomy was performed as a com­
plementary procedure in 81.4%  of 
cases; in the other 18.6%, it represented 
either the only operative intervention or 
the initial stage of a two-stage proce­
dure. Complications included local infec­
tion in 32%  of cases, peri-catheter leak 
in 25% , skin excoriation in 24% and 
pain in 12%. Catheters remained in place 
an average of 14 days, but function was 
adequate in only 40% of cases. Cecal 
drainage persisted from 24 hours to 90 
days after the tube was removed. Two 
additional procedures were required to 
close persistent cecal fistulas. The 
authors conclude that the high morbidity 
associated with this procedure militates 
against its routine use. Decompression 
by cecostomy may be inadequate for 
treating acute colonic obstruction.
Une etude retrospective de 59 caecosto- 
mies tubaires effectuees entre 1971 et 
1981 a ete entreprise dans le but d'eva- 
luer les indications operatoires courantes, 
les resultats et la morbidite relies a cette 
operation. La caecostomie tubaire avait 
ete pratiquee en tant qu'intervention 
secondaire dans 81,4%  des cas; dans 
les autres 18,6%, il s'agissait soit d'une 
operation unique, soit de la premiere 
etape d'une operation en deux temps. 
Parmi les complications, on compte 32%  
d'infections locales, 25% de fuites peri- 
catheters, 24% d'excoriation cutanee et 
de la douleur dans 12% des cas. Le 
catheter est demeur6 en place pendant 
une moyenne de 14 jours mais il n'a
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fonctionne adequatement que dans 40%  
des cas. Un drainage caecal a persiste de 
24 heures a 90 jours aprds le retrait du 
catheter. Deux operations additionnelles 
ont et6 necessaires pour refermer des 
fistules caecales persistantes. Les 
auteurs jugent que le haut taux de mor­
bidite reli£ a cette intervention milite 
contre son emploi systematique. Une 
decompression par caecostomie peut 
s'averee insuffisante dans le traitement 
de I'obstruction aigue du colon.
Pillore of Rouen in 1776 performed the 
first recorded cecostomy to relieve colonic 
obstruction.1 Once widely practised and 
accepted, tube cecostomy is less fre­
quently performed as indications for its 
use have narrowed. Even when its prac­
tice was widespread, the procedure had 
its detractors.
Since the turn of the century, tube 
cecostomy has been advocated mainly as 
a decompression procedure for acute 
colonic obstruction2'5 and as a safety 
valve for colonic resection.4’6,7 It has also 
been suggested for perforation or 
impending perforation of the cecum,8,9 
for cecal volvulus,8 adynamic ileus of the 
colon10 and toxic dilatation in inflamma­
tory bowel disease.11 Because of the con­
troversy concerning tube cecostomy, we 
undertook to evaluate retrospectively the 
current operative indications, operative 
outcome and associated morbidity in rela­
tion to tube cecostomy in order to deter­
mine the place of the procedure in 
modern surgery.
Patients and Methods
We reviewed 59 tube cecostomies per­
formed between 1971 and 1981 at the Sir 
Mortimer B. Davis-Jewish General 
Hospital in Montreal. There were 36 
women and 23 men, ranging in age from 
18 to 91 years (average 68 years).
The decision to perform a tube 
cecostomy was made for either of two 
reasons: to provide a safety vent, as a 
complementary procedure, performed 
with another operation or to provide ther­
apeutic decompression for colonic 
obstruction or dilatation.
A Malecot catheter was most fre­
quently used for the tube. Five procedures 
were performed as appendicostomies dur­
ing elective surgery. In each case, opera­
tion included placing two purse-string 
sutures in the wall of the cecum, secur­
ing the cecum to the peritoneum, and fix­
ing the tube to the skin. Drainage through 
the catheter was by gravity into a collec­
tion bag.
Results
Indications for the operation are listed 
in Table I. In 48 patients (81.4%) the 
cecostomy was performed as a com­
plementary procedure. Therapeutic 
cecostomy was carried out in 11 patients 
(18.6%); these represented the only oper­
ative intervention or the first step of a 
multistage procedure.
Three patients died at 2, 11 and 48 days 
postoperatively. All deaths were related 
to cardiac arrest in poor-risk patients with 
cardiovascular disease.
There was no routine regarding type of 
anesthesia, skin closure or antibiotics 
given.
The tube remained in place an average 
of 14 days. By the end of the third 
postoperative week 87% of the catheters 
had been removed and all were out within 
4 weeks of operation.
Tube drainage was adequate in only 24
Table 1—Indications for Tube Cecostomy
Disease
No. of 
patients
Therapeutic
Carcinoma 7
Diverticulitis 1
Cecal volvulus 2
Adhesions 1
Complementary
Carcinoma 22
Diverticulitis 8
Ischemic colitis 1
Sigmoid volvulus 1
Hirschsprung's disease 1
Colotomy and polypectomy 8
Adhesions 2
Ogilvie's syndrome 2
Colovaginal fistula 2
Crohn's disease 1
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patients; in the other 35, there was either 
scant or no catheter drainage. For 
patients who had a complementary 
cecostomy it was impossible to determine 
if there was beneficial siphoning off of 
intestinal gas. In two patients a therapeu­
tic cecostomy did not relieve abdominal 
distension, but the distal obstruction 
cleared, and when bowel movements 
began the distension resolved. There was 
no record of whether bowel preparation 
for subsequent operations was adequate 
or effective.
Catheter care appeared to be a decision 
of the individual surgeon. Some catheters 
were not irrigated, but others were 
irrigated when necessary or once per shift. 
Mineral oil (30 mL) was most often used 
for irrigation. Catheter function appeared 
unrelated to the type of catheter care, the 
underlying disease or the surgical 
procedure.
Complications
Wound infection was the most frequent 
complication (Table II), occurring in 14 
of 48 complementary procedures and in 
5 of 11 therapeutic procedures. Appen- 
dicostomy was associated with a higher 
infection rate than simple tube cecostomy 
(40% versus 31%).
Persistent cecal fistula (lasting 2 weeks 
or more after catheter removal) occurred 
in five patients. The time between tube
Table II—Complications Associated With 
Tube Cecostomy
Complication
No. of 
patients (%)
Infection 19(32)
Leakage around tube 15(25]
Skin excoriation 14 (24)
Fistula ( >  2 wk) 5(8)
Pain 7(12)
Premature dislodgement 2(3)
removal and cecostomy closure ranged 
from 24 hours to 90 days. Two persistent 
fistulas required reoperation to achieve 
closure.
Peri-catheter leak, in 15 patients, was 
not related to the manner in which the 
cecostomy was fashioned. Skin excoria­
tion, in most instances, was related to 
peri-catheter leakage.
Comment
A protective diversionary cecostomy or 
transverse colostomy is now rarely war­
ranted for left-sided colon procedures 
since these can be safely performed 
without diversion as a recent review12 
from our institution has shown. Not only 
are complementary vents unnecessary but 
they add the possibility of sepsis and 
many other complications.
The relative value of various diverting 
procedures for obstructing lesions of the 
left side of the colon has been debatable. 
Study of the pertinent surgical literature 
does not resolve this issue. The virtues of 
tube cecostomy, as cited by its propo­
nents, are as follows: it is easy to perform 
and can be carried out under local 
anesthesia, the cecum is the portion of 
colon most likely to perforate, it does not 
interfere with subsequent resection of the 
left side of the colon and it may eventu­
ally close spontaneously. In cases of 
extreme obesity of the abdominal wall 
and when gross distension of the bowel 
has “ used up” the leaves of the transverse 
mesocolon, transverse colostomy may be 
impossible. Under these circumstances 
cecostomy may be the only method of 
relieving obstruction.13
The use of cecostomy has frequently 
been criticized and has lost favour with 
many surgeons.1315 Detractors point out 
that it provides less-effective decompres­
sion than does a transverse colostomy and 
does not allow complete diversion. Clark
and Hubay16 reported that of 37 patients 
with acute large-bowel obstruction, two 
distal perforations occurred after prox­
imal decompression by a cecostomy. Bals- 
lev and colleagues17 reported that three 
patients died of perforation because 
cecostomy did not adequately relieve dis­
tension. Aseptic decompression of a dis­
tended cecum can be difficult, and perito­
nitis after a cecostomy has been reported 
as the cause of death.18 Welch and 
Donaldson18 reported that the operative 
death rate after preliminary cecostomy 
was 10 times that after transverse 
colostomy for lesions of the left side of 
the colon. Balslev and associates17 
attributed 22% of the deaths in their ser­
ies to  cecostomy. W angensteen19 
deplored the use of cecostomy and stated: 
“ A second year surgical house officer can 
relieve an obstructed colon by an aseptic 
transverse colostomy with less risk to the 
patient than can an experienced surgeon 
who favors performance of cecostomy.” 
Yet surgeons still cling to its use.3,5'8'16
Tube cecostomy fails to decompress the 
bowel adequately in as many as 50% of 
cases.20,21 Albers and Smith20 and Hunt15 
found tube cecostomy an inadequate 
emergency decompression procedure and 
suggested that transverse colostomy re­
sulted in fewer deaths, more effective 
decompression, less metabolic disruption 
and earlier and better preparation of the 
colon (i.e., irrigation) for definitive sur­
gery. Most importantly, poor tube func­
tion has been shown8,17,22,23 to be respon­
sible for a substantial number of deaths 
(Table HU,5,8,16,17,24,25)
A growing number of surgeons advo­
cate primary resection for an obstructing 
carcinoma lying in the proximal or trans­
verse colon or even the splenic flexure. 
This obviates the need for decompres­
sion.13,23,26,27 If there is a perforation 
associated with a left-sided carcinoma, a 
cecostomy is inadequate.
Table III—Cecostomy Related Morbidity____________________________________
No. of 
perioperative
Series
No. of 
patients Infection
Intraperitoneal
leak
No
function
Premature
dislodgement
Hematoma/
bleeding Fistula
deaths (cecostomy 
related)
Secondary
closure
King and associates, 
1966s 153 5 1 1 22 14(5) 17
Jackson and Baird, 
196724 102 3* 5 1 _ _ 10(4) 5
Westdahl and 
Russell, 19695 93 7 0 1 _ _ _ 20 (0) 41 1
Balslev and 
associates, 197017 76 10 _ 8 2 _ _ 5(5) 20
Clark and Hubay, 
197216 161 6 1 3 _ _ 16 5(1) 6
Stainback and 
associates, 19734 235 2 2 1 _ 1 3 5(2) 0
Hoffmann and 
Jensen, 198425 57 18 0 0 1 1 _ 8(1) 11
Present series 59 19 0 2 1 0 5 3(0) 2
•All died.
116 of 48 with tube cecostomy required secondary closure. Patients with mucosa-to-skin suturing required secondary closure.
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In our study, catheter plugging with 
stool, despite irrigation, was a constant 
problem. Reports addressing the issue of 
tube patency vary widely. Some report 
successful decompression,22,28 but failure 
rates as high as 20%24 and 50%20'21 have 
been reported. It is not surprising that 
such tubes do not function well. Their 
inefficiency can perhaps be explained 
partly by the principles governing the flow 
of fluid through cylindrical tubes. 
Poiseuille’s law relates flow directly to the 
fourth power of the radius and inversely 
to both tube length and viscosity of the 
fluid. Conversely, resistance to flow is 
directly related to fluid viscosity and tube 
length and inversely proportional to the 
fourth power of the tube radius. Malecot 
catheters were used in our study but they 
varied in diameter. In some cases it could 
be argued that a catheter of inadequate 
size was used. However, it must be 
remembered that the effluent is a non- 
homogeneous fluid of low viscosity and 
there is usually a large non-fluid compo­
nent. Poiseuiile’s law is operable only 
under special conditions and should be 
applied to the steady, laminar flow of a 
homogeneous fluid. All of these consider­
ations could be eliminated by suturing 
cecal mucosa to skin primarily, but this 
would require another operation for 
closure.29'31
Morbidity associated with cecostomy, 
exclusive of tube function, has been 
extensively described in the literature 
(Table III). These reports cannot be com­
pared, as some are a series of complemen­
tary cecostomies and others are thera­
peutic cecostomies perform ed for 
obstruction; some are tube cecostomies 
while others are mucosa-to-skin suturing 
and some are combinations of the two. 
Nevertheless, the reports clearly point out 
the serious morbidity associated with 
cecostomy.
Inadequate function of the tube can be 
fatal.17>22'24 Death has been attributed 
directly to the cecostomy in up to 40% 
of patients who died perioperatively.24
In comparing cecostomy and transverse 
colostomy to treat obstruction of the left 
side of the colon by carcinoma, Goligher 
and Smiddy32 declared that cecostomy 
was a much more dangerous operation, 
the respective death rates being 50% 
versus 17%. Moreover, analysis of the 
causes of death after the two operations 
revealed that of 36 deaths after 
cecostomy, 22 were due to septic compli­
cations; none of the 8 deaths after trans­
verse colostomy were attributable to 
infection. This constitutes a grave indict­
ment of the former operation.
In addition to the complications listed 
in Table III, many other problems have 
been reported. These include severe skin 
excoriation,5'25 wound dehiscence requir­
ing resuturing under general anesthe­
sia,25 recurrence of a fistula after closure 
o f the cecostomy,5'25 subcutaneous 
emphysema,4 prolapse of omentum,17 
stitch granulom a,25 evisceration,5 
retraction5 and hernia formation at the 
cecostomy site.8'25
Infection was the commonest compli­
cation in our study. Inflammation and 
skin excoriation often occurred in the 
region of the cecostomy after the tube had 
been in place for a number of days but 
these problems were not considered as 
infection. King and colleagues8 stated 
that almost all their patients suffered 
minor wound infections along the tube 
tract. These problems have also been 
addressed by others (Table III). Rates for 
secondary closure are reported to vary 
from 0% to 20%. It is notable that these 
secondary surgical procedures also carry 
an attendant morbidity and mortality.
Other indications for which cecostomy 
has been advocated include perforated 
cecum,8,9 toxic dilatation associated with 
ulcerative colitis11 and cecal volvulus.8 
Even for cecal volvulus some33 advocate 
a right hemicolectomy rather than 
cecostomy. Patients with pseudo­
obstruction of the colon may have 
tremendous dilatation of the colon and 
require decom pression. A lthough 
cecostomy has been recommended in the 
past, recent reports suggest that 
colonoscopic decompression should be 
the first line of therapy.34'36 Failing this, 
cecostomy may be considered.
From this study we conclude that the 
high morbidity rate related to tube 
cecostomy militates against its routine 
use. Furthermore, decompression of the 
colon by cecostomy is generally inade­
quate for acute obstruction and with our 
present understanding of preoperative 
bowel preparation, complementary 
cecostomy is rarely warranted. A compar­
ison between tube cecostomy and trans­
verse loop colostomy as the initial decom­
pressive procedure for patients with 
obstructing lesions of the left colon is 
difficult since we are unaware of any con­
trolled prospective trials comparing the two.
A review of the contemporary literature 
suggests that reasonable current indica­
tions for tube cecostomy include cecal 
volvulus, pseudo-obstruction (if an 
attempt at colonoscopic decompression 
has failed), cecal perforation in associa­
tion with an obstructed left-sided lesion, 
and to relieve obstruction in morbidly 
obese patients when transverse colostomy 
is technically impossible.
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Nosocomial Gram-Negative Parotitis
Nosocomial parotitis is an uncommon 
postoperative complication, usually 
affecting elderly, debilitated, dehydrated 
patients. The preponderance of gram­
positive pathogens has been emphasized. 
The authors present two cases of gram­
negative parotitis and review the litera­
ture on this condition. Because the 
organisms producing nosocomial infec­
tion in patients receiving intensive care 
are commonly gram-negative bacilli, 
treatment should be based on the find­
ings of Gram's staining of the pus 
obtained from Stensen's duct, altered 
when necessary by the final culture 
results.
La parotidite nosocomiale est une com­
plication postoperatoire peu frequente 
qui touche habituellement les personnes 
agees, fragilisees et deshydratees. On a 
souligne la preponderance des organis- 
mes gram-positifs comme pathogenes.
Les auteurs decrivent deux cas de paroti­
dites a gram-negatifs et passent en revue 
les publications sur le sujet. Comme les 
micro-organismes responsables des infec­
tions nosocomiales chez les patients sou- 
mis a des soins intensifs sont souvent 
des bacilles gram-negatifs, le traitement 
devrait etre oriente en fonctions des 
resultats de la coloration Gram sur le pus 
preleve du canal parotidien, quitte a le 
modifier ensuite, si ngcessaire, selon les 
resultats des cultures finales.
Acute parotitis, an uncommon disorder, 
usually affects the elderly, debilitated, 
dehydrated patient. Historically, the 
predominance of Staphylococcus aureus 
as the infecting organism has been 
emphasized, and the empirical treatment 
has been antistaphylococcal agents, until
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the results of definitive cultures are 
known. Recent reports have noted the 
presence of a widening range of patho­
gens, including gram-negative rods and 
anaerobes. We report two cases of 
nosocomial gram-negative parotitis that 
emphasize the increasing importance of 
these organisms.
Case Reports
Case I
A 46-year-old hypertensive man experienced 
the sudden onset of chest pain. Angiography 
demonstrated an ascending aortic dissection 
(type A). The ascending aorta was replaced 
with a Dacron graft at an emergency opera­
tion. As prophylaxis the patient received 
cephalothin intravenously, followed by 
cephalexin orally after he was extubated. Five 
days postoperatively, while he was still taking 
cephalexin, diarrhea developed. By day 7 he 
had pain, swelling and tenderness over the left 
parotid gland, a fever and leukocytosis. Exami­
nation of the mouth showed dry mucosa and 
creamy pus exuding from Stensen’s duct. The 
cephalexin was stopped and cloxacillin begun
FIG. 1—Case 2 showing marked swelling of 
left parotid gland.
intravenously. Gram’s staining of the purulent 
exudate revealed abundant polymorphonuclear 
leukocytes and gram-negative rods. Final cul­
tures grew Escherichia coli sensitive to ampicil- 
lin and gentamicin. Antibiotic therapy was 
changed to ampicillin. The parotitis resolved, 
but the diarrhea persisted. When Clostridium  
difficile cytotoxin was identified in the stool, 
the ampicillin was withdrawn and replaced by 
gentam icin. The colitis resolved after 
metronidazole was prescribed.
Case 2
A 50-year-old woman with chronic renal 
failure underwent renal transplantation. 
Immunosuppressive therapy consisted of 
cyclosporine and prednisone. Postoperatively 
she became hypotensive and acute tubular 
necrosis developed, which required hemodial­
ysis. A bleeding diathesis developed 4 days 
after operation and she was started on cefoxi­
tin for presumed sepsis. On day 11, swelling 
of the left parotid gland was noted and she had 
a fever and leukocytosis (Fig. 1). Thick creamy 
pus was seen draining from Stensen’s duct and 
Gram’s staining demonstrated abundant poly­
morphonuclear leukocytes but no bacteria. 
Cloxacillin and gentamicin were started 
intravenously. Cultures of the pus grew Pseu­
domonas aeruginosa and E. coli, sensitive to 
gentamicin. Blood cultures grew P. aeruginosa. 
The cloxacillin was stopped and the gentami­
cin was given for 10 days. The parotitis 
resolved.
D iscussion
Inflammation in early parotitis is con­
fined to an accumulation of cells within 
the larger ducts. The parenchyma and 
smaller ducts are spared until the 
epithelium of the larger ducts is des­
troyed, allowing the inflammatory 
process to invade the remainder of the 
gland. Once penetration of the paren­
chyma has occurred, multiple abscesses 
may form and coalesce. If the process is 
allowed to continue, pus may penetrate 
the capsule and invade the surrounding 
tissue, extending into the neck, the exter­
nal auditory canal or the skin of the face.
Acute suppurative parotitis is often a 
nosocomial infection. It may develop a 
few hours or many weeks after surgery. 
Crile and Manning1 first observed that 
poor oral hygiene and lack of oral intake
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predispose to retrograde invasion of the 
parotid duct by virulent oral flora. Krip- 
paehne and associates2 emphasized that 
dehydration, malnutrition, advanced age, 
debilitation and the use of anticholiner­
gic medication were predisposing factors.
Petersdorf and colleagues,3 in their 
review of seven cases of staphylococcal 
parotitis, stressed the importance of S. 
aureus as the primary pathogen. In 
Spratt’s4 comprehensive review of 92 
cases at one institution, all but 2 were due 
to gram-positive organisms. Similarly, 
Krippaehne and colleagues2 found that 
64 of 66 cultures grew staphylococci. 
However, the data for these three series 
were collected during the period when 
gram-positive cocci were the major 
nosocomial pathogens. Since the middle 
1960s there has been an increasing 
proportion o f gram-negative infections 
with a relative decrease in gram-positive 
infections.5 Thus, more recent reports 
have implicated gram-negative rods as the 
infecting bacteria in acute parotitis.6'9 
Although gram-negative bacilli are found 
infrequently in the normal orpharynx, 
colonization occurs in patients treated 
with antibiotics in direct relation to the 
severity of the underlying illness.10,11
Initial treatment of acute parotitis 
should be directed against the 
staphylococci and any other organism 
identified on Gram’s staining of the pus 
from Stensen’s duct. In the very ill this 
treatment should include an aminoglyco­
side. Antibiotic therapy may be altered by 
the final culture results. Meticulous 
cleansing of the teeth and gums and main­
taining moist oral membranes can 
minimize the complication. Finally, if the 
parotitis progresses despite adequate 
antibiotic therapy, surgical drainage is 
indicated.
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Inguinal Neuralgia: a Review of 50 Patients
Inguinal neuralgia, an uncommon condi­
tion, can readily be diagnosed if the 
anatomy of the sensory nerves of the 
lumbar plexus is understood. The authors 
review 50 patients with this condition, 
pointing out the importance of injury to 
these nerves, not only on the anterior 
abdominal wall but also in the 
retroperitoneal space on the posterior 
abdominal wall.
Successful treatment is achieved by 
surgical section of the nerves. First the 
inguinal region is explored; if this does 
not result in cure the authors recom­
mend retroperitoneal section of the 
nerve.
La nevralgie inguinale, une affection rare, 
peut etre diagnostiqude rapidement 
quand on comprend bien I'anatomie des 
nerfs sensitifs du plexus solaire. Les 
auteurs ont etudie les cas de 50 patients 
souffrant de cette maladie. Ils soulignent 
I'importance d’une lesion de ces nerfs, 
non seulement sur la paroi abdominale 
anterieure mais aussi dans I'espace retro­
peritoneal, sur la paroi abdominale postd- 
rieure.
La guerison suit la section chirurgicale 
des nerfs. On doit s'attaquer en premier 
lieu a la region inguinale et s'il n 'y a pas 
de soulagement, les auteurs recomman- 
dent une section rdtroperitoneale du nerf.
Inguinal neuralgia is an uncommon syn­
drome of chronic pain and paresthesia in 
the area served by each of the sensory 
nerves in the inguinal region. Typically 
the ilioinguinal, iliohypogastric or 
genitofemoral nerve is involved. The sen­
sory findings vary because of overlap and
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communication among these nerves. The 
pain may be sharp, aching or burning in 
nature. Sharp pain characteristically 
arises along the inguinal canal and is felt 
in the scrotum or labium, or in the upper 
medial thigh. Rarely it may be referred 
to the sacroiliac joint or the hip area. The 
deep aching pain has a similar distribu­
tion. Sometimes there is a dull, hot, burn­
ing sensation in association with numb­
ness. All types of pain are aggravated by 
hip extension, walking, exercise or pres­
sure over the inguinal region. Often the 
pain is severely debilitating and results in 
drug dependency.
Injury to the inguinal nerves on either 
the anterior abdominal wall or posterior 
abdominal wall in the retroperitoneal 
space is often the cause of inguinal neu­
ralgia. Anterior wall injury may occur 
during herniorrhaphy or appendectomy 
or may be associated with the irritation 
of inguinal hernias. Posterior wall injury 
may follow appendiceal abscesses and 
pelvic surgery.
An awareness of the existence of ingui­
nal neuralgia and an understanding of the 
anatomy of the ilioinguinal and genito­
femoral nerves will lead to its diagnosis 
and treatment.
Anatomy (Fig. 1)
The cutaneous branches of the lumbar 
plexus give rise to the iliohypogastric, 
ilioinguinal and genitofemoral nerves and 
the lateral cutaneous nerve of the thigh.
Iliohypogastric Nerve
This sensory and motor nerve is a 
branch of the T12 or LI nerves. It 
emerges behind the psoas muscle just 
above the ilioinguinal nerve and pierces 
the transversus abdominis above the iliac 
crest. Its anterior branch runs forward 
between the oblique internal and external 
muscles and pierces the aponeurosis of the 
external oblique muscle to supply the skin 
above the pubis. Its posterior branch sup­
plies an area of the buttock just posterior 
to the iliac crest.
Fig. la  Fig. lb
FIG. 1—(a) Lumbar plexus and anatomic relations, (b) Genitofemoral nerve and its rela­
tions. 1. = iliohypogastric nerve. 2. = ilioinguinal nerve. 3. = genitofemoral nerve. 4. =  lateral 
cutaneous nerve of thigh.
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Ilioinguinal Nerve
The ilioinguinal nerve, a branch of the 
lumbar plexus, LI, emerges from behind 
the psoas muscle just below the ilio­
hypogastric nerve. It passes obliquely 
across the quadratus lumborum and ilia- 
cus muscles and perforates the transver- 
salis near the anterior superior iliac spine. 
The nerve then pierces the internal 
oblique muscle and accompanies the sper­
matic cord within the inguinal canal; it 
emerges through the external ring. It pro­
vides sensation to the upper medial aspect 
of the thigh and the scrotum or labium.
Genitofemoral Nerve
This nerve arises from the LI and L2 
nerves. It travels obliquely through and 
over the psoas muscle, emerging in the 
vicinity of L4 in the retroperitoneal space. 
It divides into the genital and femoral 
branches, which then travel separately 
across the base of the broad ligament. 
The genital branch passes through the 
internal inguinal ring, descends in associ­
ation with the spermatic cord or round 
ligament, supplying sensation to the scro­
tal or labial skin and medial upper thigh; 
it also supplies motor fibres to the 
cremasteric muscle. The femoral branches 
travel beside the external iliac artery and 
enter the femoral sheath lateral to the
Table 1—Etiology of Neuralgia (54 Operations)
No. of
Cause operations
Inguinal canal disease 19
Indirect hernia 9
Lipoma of cord 8
Leiomyoma 1
Endometrioma 
Entrapment on anterior
1
abdominal wall 9
Scar 7
Tented 2
Previous pelvic surgery 
Suspected anterior
16
abdominal wall injury 
Suspected retroperitoneal
10
injury 6
Unknown 10
femoral artery, providing sensation to the 
upper anterior thigh.
Lateral Cutaneous Nerve o f  Thigh
This arises from the posterior roots of 
L2 and L3. It leaves the lateral border of 
the psoas muscle, traverses the iliacus 
muscle and emerges at or below the junc­
tion of the anterior superior iliac spine 
and the inguinal ligament. Sensation is 
provided to the lateral aspect of the thigh 
to a point just above the knee.
Meralgia paresthetica, entrapment of 
the lateral femoral cutaneous nerve of the 
thigh, is often the result of a congenitally 
aberrant path of this nerve around the 
anterior superior iliac spine through the 
fasciculi of the inguinal ligament. In con­
trast, inguinal neuralgia is often related 
to hernias or nerve injury secondary to 
previous surgery.
Surgery
Historically, the management of ingui­
nal neuralgia has been either to identify 
the nerve at the site of entrapment or 
injury and to free it or to locate the 
genitofemoral nerve in the retroperito- 
neum overlying the psoas muscle and to 
transect it there. Because of the high 
proportion of inguinal lesions (entrap­
ment, hernias) we advocate exploration 
of every groin. If the pain is not relieved, 
we later explore the retroperitoneum and 
divide the nerve through a separate flank 
incision. Surgery may therefore be done 
in two stages.
A standard groin incision is made 
superior and medial to the inguinal liga­
ment. The external oblique muscle is 
incised at the external inguinal ring. The 
superficial branch of the ilioinguinal 
nerve is identified and followed through­
out its course and is often divided. The 
spermatic cord is mobilized, and a search 
is undertaken for one or two branches of 
the genitofemoral nerve that accompany 
the cord.
In women the round ligament is divided 
at the internal ring. This ensures section 
of the genitofemoral nerve at this level.
In an effort to preserve cord structures 
from injury in men, the exploration and 
division is often incomplete. For this 
reason treatment by exploration of the 
inguinal canal alone in men is often 
unsuccessful. We therefore advocate a 
retroperitoneal approach and section of 
the genitofemoral nerve on the psoas fas­
cia to assure division of the nerves.
Report of Cases
We reviewed 50 cases of inguinal neu­
ralgia. The patients (42 women, 8 men) 
were seen by one surgeon between 1970 
and 1984. The mean age of the patients 
was 41.4 years. Two patients had a 
bilateral procedure and two underwent a 
second operation for recurrent pain, giv­
ing a total of 54 operations. Follow-up 
was effected by clinic examination or 
mailed questionnaire. The mean follow­
up was 3.9 years (range from 4 months 
to 14 years).
The 42 women had 46 operations; 38 
considered they were either cured (36) or 
improved (2) and only 4 felt that the oper­
ation had failed. This represents an over­
all success rate of 90%. Eight men under­
went eight operative explorations. Early 
in our series we limited the exploration 
to the inguinal canal alone. There were 
four failures in this group. Of the other 
four men, three have been cured of their 
disease and the condition of one has been 
improved by retroperitoneal division of 
the genitofemoral nerve. This represents 
an overall success rate in men of 50%.
Lipomas and small hernial sacs less 
than 3 cm in depth appeared to be the 
only causative factors in 17 patients. One 
leiomyoma and one endometrioma were 
found in the inguinal canal of two other 
patients. True entrapment was visualized 
in only 9 of 50 patients. Ten others had 
previously undergone surgery on the 
related lower quadrant, but this did not 
appear to involve the affected nerve.
In all, 16 women had previously under­
gone pelvic surgery that included tubal 
ligation, hysterectomy, cesarian section 
and appendectomy. Ten of the 16 had 
had anterior abdominal wall surgery that
Table II—Lumbar Cutaneous Entrapment Syndrome
Nerve
Feature Iliohypogastric Ilioinguinal Genitofemoral
Lateral cutaneous 
of thigh
Injury site Above inguinal canal Posterior to anterior superior 
iliac spine 
Inguinal canal 
Femoral region
Posterior abdominal wall 
Inguinal region
Junction of inguinal ligament 
and anterior superior iliac 
spine
Pain distribution Above pubis Groin, scrotum, back Groin, scrotum, upper thigh Lateral anterior upper thighPoint of maximum 
tenderness
Point of entrapment or where 
nerve emerges through 
external oblique muscle
Medial to anterior superior 
iliac spine or inguinal canal
Internal inguinal ring Anterior superior iliac spine
Treatment Neurolysis, neurectomy Nerve block, neurolysis, 
neurectomy
Excision of portion of main 
trunk of nerve
Nerve block, excision of 
ligament and nerve
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could not be ruled out as the source of 
their nerve pain. In 6 of the 16 the only 
underlying cause of inguinal pain was 
previous pelvic surgery. We believe 
strongly that injury to the genitofemoral 
nerve could have occurred at the base of 
the broad ligament or behind the cecum 
at the time of their operations. The cause 
of inguinal neuralgia was undetermined 
in 10 patients (Table I).
Discussion
Although lumbar plexus neuralgias 
were identified by E.J. Smith in Osier’s 
Modern Medicine,1 in 1910, it was not 
until 1942 when Magee2 presented his 
paper to the “ Gallie Club” in Toronto 
that these neuropathies were recognized 
as being surgically correctable. Three 
years later Lyon,3 another Canadian, 
supported Magee’s findings by reporting 
three more patients who were successfully 
treated by operation. Both authors 
divided the genitofemoral nerve in the 
retroperitoneum on the psoas fascia 
through a transperitoneal approach.
Since that time little has appeared in the
surgical journals4'7 regarding this con­
dition.
Inguinal neuralgia is a poorly recog­
nized and infrequently diagnosed entity. 
D ifferentiating ilioinguinal from  
genitofemoral neuralgia is often difficult 
(Table II). An understanding of the anat­
omy of these nerves is essential for a cor­
rect diagnosis. Many who suffer from this 
problem are inadequately treated in pain 
clinics or by family physicians.
Many patients in our series had a small 
undiagnosed inguinal hernia. We were 
impressed that many women who had no 
demonstrable inguinal condition had 
previously undergone pelvic surgery, such 
as tubal ligation, hysterectomy or cesar­
ian section. We believe that injury to the 
genitofemoral nerve had occurred at the 
base of the broad ligament as a result of 
pelvic surgery. This syndrome was rarely 
associated with true entrapment. Only a 
small proportion of our patients had 
obvious entrapment within the anterior 
abdominal wall.
Treatment of this condition is mainly 
surgical. We recommend first an explo­
ration of the inguinal canal and resection
of both the genitofemoral and ilioingui­
nal nerves. This is usually successful. If 
pain persists then we recommend retro­
peritoneal section of the genitofemoral 
nerve.
We are indebted to James McD. Corston, 
FRCOG, Department of Gynecology, Victoria 
General Hospital, Halifax, NS, for his ongo­
ing interest and support in this study. We thank 
Belinda Johnson and Heather Butler for 
secretarial help.
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Erosive Silicone Synovitis
Although erosive silicone synovitis is an 
unusual complication of implant 
arthroplasty, its recognition is important. 
The authors describe three patients in 
whom this complication occurred after 
Silastic replacements of the carpal 
scaphoid and trapezium bones. Intercar- 
pal arthrodesis is suggested as a form of 
stress shielding for the implants. Regular, 
long-term follow-up of patients with 
these Silastic implants is recommended.
Bien que la synovite erosive causee par 
le silicone soit une complication rare des 
arthroplasties par implants, il est impor­
tant de savoir la reconnattre. Les auteurs 
decrivent trois cas de cette complication
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apres remplacement par implants de 
Silastic d'os trapezoide, scaphoide ou du 
carpe. On recommande une arthrodese 
intercarpienne afin de proteger les
implants du stress. On suggere egale- 
ment une surveillance reguliere au long 
cours des patients qui ont recu ces 
implants de Silastic.
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In the past 20 years, several hundred 
thousand Silastic joint prostheses have 
been implanted in the upper extremity. 
These have included interphalangeal, 
metacarpophalangeal and wrist joints as 
well as the trapezium, scaphoid and 
lunate, and radial and ulnar heads. Their 
use in the treatment of rheumatoid arthri­
tis, osteoarthritis and osteonecrosis has 
been very successful in relieving pain and 
improving joint function.
Complications o f these joint replace­
ments are fracture or dislocation of the 
prostheses, lymphadenopathy,1'2 infec­
tion (less than 1%)3,4 and detritic syno­
vitis.5-8 During the past 10 years, approx­
imately 15 cases o f foreign-body, giant 
cell reactive synovitis have been report­
ed. They have been associated with 
the trapezium,7 metacarpophalangeal 
jo in t,1’2’5,6 trapezoid,7 lunate,9 radial 
head7’8 and great toe.7 In only three of 
these cases was there a destructive arthritis 
secondary to silicone and all were with 
lunate replacements. To date there have 
been no reports o f  problems with the 
scaphoid prosthesis or of erosions of the 
distal radius. This report deals with three 
cases o f erosive silicone synovitis. The 
first involved a scaphoid replacement. 
The other two patients had undergone 
trapezial replacement.
Case Reports
Case 1
A 35-year-old right-handed engineer who 
had nonunion of his left scaphoid (Fig. 1) 
presented with wrist pain, unresponsive to 
nonoperative measures. He underwent a Silas­
tic scaphoid replacement (Fig. 2). Five months 
later he began to have pain and swelling in the 
region of his radiocarpal joint. Synovitis was 
evident but there was no indication of sepsis. 
Within 9 months of replacement a large sub­
cortical cyst was present in the distal radius 
(Fig. 3) and there was an increase in the syno­
vitis. The pain and swelling continued. The cyst 
was biopsied a year later. The synovial tissue 
was hyperplastic with multinucleated giant 
cells. Silastic particles were recovered from the 
cyst and identified by energy dispersive x-ray 
analysis and oil red O staining (Fig. 4). These 
studies were done at the Armed Forces Insti­
tute of Pathology in Washington, DC.
The prosthesis was not removed nor was the 
cyst bone grafted. The patient’s symptoms con­
tinued (Fig. 5) for another 16 months when he 
underwent wrist arthrodesis. The prosthesis 
was removed and further synovial biopsies were 
obtained. There was considerable wear of the 
prosthesis particularly on its proximal surface. 
Once again foreign-body granulomas and syn­
ovial reaction to a foreign body were seen. 
Polarizing light examination failed to show any 
foreign material that polarized light.
Case 2
A 62-year-old right-handed housewife with 
osteoarthritis in the carpometacarpal joints of 
both thumbs underwent a right trapezial Silas-
FIG. 3—Case 1. Large cyst in distal radius 11 months after scaphoid replacement.
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tic arthroplasty. There was no history of infec­
tion but approximately 1 year after replace­
ment, she experienced swelling and pain in the 
carpometacarpal joint. Follow-up films showed 
wear of the prosthesis on its ulnar side and ero­
sion of the adjacent carpal bones (Fig. 6). The 
prosthesis was removed 3 years postoperatively 
and the resulting excision arthroplasty relieved 
the patient’s pain.
Considerable wear was noted on the volar 
surface of the excised implant and there were 
several loose bodies in the joint. There was 
moderate synovitis on the volar aspect of the 
joint and the stem of the prosthesis was frac­
tured. Bacteriologic cultures were negative.
Specimens obtained from the joint and from
the metacarpal shaft both showed fibrous con­
nective tissue with abundant foreign-body 
material. This did not polarize light and was 
interpreted as consistent with silicone particles.
Case 3
A 58-year-old woman underwent a right 
trapezial Silastic replacement because of pain­
ful osteoarthritis of the carpometacarpal joint. 
Forty months later she was seen because of 
pain and swelling in the region of the car­
pometacarpal joint of her right thumb. There 
was no suggestion of infection but roentgeno­
grams showed cystic changes in the adjacent 
carpal bones (scaphoid and trapezoid) (Fig. 7).
FIG. 5—Case 1. Three years after scaphoid replacement there is deterioration of radial 
cyst, changes in trapezium and thinning of prosthesis.
FIG. 6—Case 2. Trapezial replacement with 
erosive changes in scaphoid and trapezoid.
FIG. 7—Case 3. Trapezial replacement. 
Note cystic changes in scaphoid and lunate as 
well as wear of prosthesis on ulnar side.
To date she has declined further surgery.
This woman also had a left trapezial replace­
ment in January 1980 but to date has had no 
problems associated with it.
Discussion
The exact etiology of the erosive 
changes in these cases is not fully under­
stood. It may represent an idiosyncratic 
response in susceptible individuals. On 
the other hand, it may be the end result 
produced when the Silastic prosthesis 
articulates with degenerated, incongruous 
joint surfaces, giving rise to microscopic 
particles of silicone elastomer. The 
amount of wear seen in the two removed 
prostheses would support the latter the­
ory. Fibrillation of the implants is likely 
due also to the prolonged intermittent 
compression they receive with across-the- 
wrist load. It is our belief that some stress 
shielding is necessary to protect the 
prosthesis; intercarpal arthrodesis is 
recommended (e.g., triscaphium fusion 
with lunate replacements and capitolunate 
with scaphoid replacements).10,11
As experience is gained with any 
implantable prosthesis, so will potential 
complications be identified. Wear of and 
local reactions to prostheses are inevita­
ble as long as man-made materials are 
used. We do not wish this report to be a 
condemnation of implant arthroplasty, 
using Silastic, as immeasurable good has 
resulted from the use of such implants. 
We do believe, however, that it is impor­
tant for patients and surgeons to be aware 
of the potential complications of a 
prosthetic device and that further surgery 
may be necessary should a complication 
occur. It is suggested that Silastic carpal 
bone replacements be reassessed clinically 
and radiologically every year.
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Fracture of a Polyethylene Acetabular Cup: a Case Report
Fracture of a polyethylene acetabular cup 
is rare. Current theories of its cause 
emphasize wear of the component.
The case reported illustrates the 
presence of a loosening membrane in 
association with cup fracture. Histologic 
study of the loosening membrane indi­
cated a foreign-body reaction to poly­
ethylene and acrylic wear particles. The 
authors propose a theory relating micro­
motion of the acetabular component to 
the production of particles of wear with 
a subsequent foreign-body reaction fol­
lowed by further loosening. The erosion 
of bony support leads to the concentra­
tion of stress at the junction of the sup­
ported and unsupported segments. This 
may ultimately result in fracture of the 
cup.
Les fractures des acetabules de 
polyethylene sont rares. Les theories 
actuelles sur leur cause insistent sur 
I'usure de la piece.
Le cas que I'on decrit ici montre la pre­
sence d'une membrane de decollement 
en association avec la fracture de I'ace- 
tabule de polyethylene. L'examen histolo- 
gique de cette membrane de decollement 
suggere une reaction contre un corps 
etranger, en I'occurrence des particules 
d'erosion de polyethylene et d'acrylique. 
Les auteurs suggerent une theorie reliant 
une microdislocation de la prothese ace- 
tabulaire a la production de particules 
d'erosion qui provoquent subsequem- 
ment une reaction tissulaire responsable 
d'un relachement plus important. L’ero- 
sion du support osseux mene a une con-
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centration du stress sur la jonction des 
segments soutenus et non soutenus. A 
la limite, ceci entralne la fracture de la 
prosthese acetabulaire.
F ractu re o f  the  u ltra  high-density poly­
ethylene acetabu lar cup after to ta l hip 
replacem ent is a  rare  clinical occurrence. 
C urren t theo ry  em phasizes th a t wear o f 
the com ponent is the  m ain cause o f its 
fa ilu re .1'2 W e presen t a  case to  illustrate 
the  presence o f  a  loosening m em brane 
and osteolysis as a  consequence o f 
foreign-body reac tion  to  wear particles, 
and we p ropose a  theory  relating aseptic 
loosening to  the cup fracture.
Case Report
A 58-year-old white man underwent a right 
Charnley-Muller total hip replacement in 
March 1973 and a similar procedure on the left 
side in March 1977 for degenerative arthritis 
secondary to alcohol-induced avascular necro­
sis. The intra- and postoperative courses were 
uncomplicated.
In November 1984 the patient was seen with 
severe left hip pain caused by a fall while intox­
icated 1 week earlier. He could not bear weight 
on the affected leg. He admitted that he had 
experienced some left groin discomfort on 
initiating ambulation for several months before 
the fall but he had not attended a clinic for 
review since 1977.
The patient weighed 109 kg and was 1.70 m 
tall. He had an antalgic gait with restricted 
range of motion of the left hip due to pain. 
Roentgenograms of the left hip showed a 
grossly displaced acetabular cup with discon­
tinuity of the metal ring (Fig. 1), confirmed by 
push-pull and abduction-adduction films. 
Lucent lines wider than 2 mm were noted at 
the cement-bone interface surrounding the cup 
in zones I, II and III as well as in the ischium.3 
The femoral component did not appear to be 
loose.
Through a Sm ith-Peterson anterior 
approach to the hip the acetabular cup was 
found to be fractured, with a large free 
posterolateral fragment adjacent to a fracture 
o f the posterior acetabular rim. The 
superomedial portion of the cup was stable and 
firmly cemented. The cement mantle was 
excised, and inspection of the cup revealed 
severe eccentric wear (Fig. 2). The fracture had 
occurred through the thinned wall of the cup. 
An area of osteolysis associated with abundant 
loosening membrane was noted deep to the 
fractured portion of the cup and along the
medial wall of the acetabulum extending dis- 
tally into the ischium. Because of superior and 
posterior acetabular bone loss the acetabulum 
was reconstructed using a Muller reinforcement 
ring and an autogenous bone graft. The 
femoral component was found to be stable.
FIG. 1—Anteroposterior roentgenogram showing acetabular cup loosening and fracture 
with femoral subluxation.
FIG. 2—Fracture of 50 mm outside diameter 32 mm inside diameter acetabular cup. Arrow indicates area of eccentric wear.
48 V O L U M E  29, N O . 1, J A N U A R Y  1986 /  TH E  C A N A D IA N  JO U R N A L  O F  SURGERY
Results
Aspirated joint fluid was examined 
under polarized light microscopy reveal­
ing many birefringent wear particles 
previously identified as polyethylene frag­
ments (Schatzker J, Goodman SB, 
Sumner-Smith G: Unpublished data, 
1983).
Histologic sections of the loosening 
membrane revealed large numbers of 
histiocytes and multinucleated giant cells 
in fibrous tissue. Examination under 
polarized light showed many needle-like
birefringent particles located within the 
cells (Fig. 3). Sections through specimens 
of synovium showed a similar cellular 
reaction around particles of cement and 
polyethylene (Fig. 4).
The findings were interpreted as 
demonstrating evidence of a foreign-body 
reaction to polyethylene and cement 
debris produced as a result of wear.
Discussion
Reports in the literature discussing the 
cause of polyethylene fracture have
emphasized component thinning due to 
wear.1'2 Salvati and colleagues1 reported 
two cases of fractured acetabular cups. 
They noted that poor cementing tech­
nique may allow increased motion of the 
acetabular cup and a greater tendency to 
fracture through the superior grooves. 
Weightman and associates2 reported a 
case in which a polyethylene tibial com­
ponent of ultra high molecular weight 
fractured. They suggested that the lack of 
bony support led to increased bending of 
the component and eventual fracture due 
to tensile failure.
Histologic examination of the cement- 
bone interface in clinically loose total hip 
replacements has demonstrated the exis­
tence of a foreign-body membrane com­
posed of histiocytes and giant cells con­
taining acrylic and polyethylene debris.4-7 
Experimental evidence in dogs has related 
the degree of membrane formation to 
poor cement-bone interlock and micro­
m otion.8
Our observations lend credence to the 
following theory: micromotion of the 
deformable acetabular cup results in 
cement and polyethylene debris secondary 
to shear stresses at the cement-bone inter­
face. The acrylic and polyethylene parti­
cles stimulate a foreign-body membrane. 
This membrane is capable of osteolysis,6 
leading to further abnormal motion of the 
component due to undermining of the 
bony support. This produces more acrylic 
and polyethylene debris, initiating a cycle 
that leads to clinical loosening of the 
prosthesis.
We have noted that a portion of the 
cup can be well cemented and stable while 
the adjacent segment can be loose and 
subject to increased bending and shear­
ing forces. Stress concentration at the 
junction of these segments may predi­
spose to polyethylene cup fracture.
We thank Dr. J. Delaney for his assistance 
in the histologic studies.
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FIG. 3—Polarized light microscopy of loosening membrane with giant cells (light arrow) 
and histiocytes surrounding polyethylene particles of wear (dark arrow) (hematoxylin and eosin, 
original magnification x 400).
FIG. 4—Polarized light microscopy of synovial membrane with histiocytes surrounding 
polyethylene particles of wear (arrows) (hematoxylin and eosin, original magnification x 160).
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Inflammatory Abdominal Aortic Aneurysm
The inflammatory abdominal aortic 
aneurysm has received little attention in 
the literature. To date only four reports 
have addressed the subject specifically. 
Controversy remains as to whether this 
is a variant of the usual atherosclerotic 
aneurysm or a separate entity. The oper­
ative reports of 24 patients with inflam­
matory abdominal aortic aneurysms are 
reviewed; 21 were intact and 3 ruptured. 
Intact aneurysms ranged in diameter 
from 5 to 12 cm and the ruptured ones 
from 5 to 10 cm. Nine patients with 
intact aneurysms had symptoms of 
abdominal or back pain. Of 13 patients 
who underwent excretory pyelography 
before operation, only 3 had evidence of 
obstruction. Nine patients had tube 
grafts placed, 10 had aortoiliac grafts 
and 5 aortofemoral grafts. There was 
one intraoperative duodenal injury and in 
another patient it was necessary to 
divide the left renal vein for proximal 
exposure. No attempt was made to 
expose the ureters at operation. All 
patients were discharged from hospital.
The authors believe that the inflamma­
tory aneurysm is a variant of the 
abdominal aortic arteriosclerotic 
aneurysm. Intraoperative complications 
can be avoided by the recognition of the 
pathological features.
L'an&vrisme inflammatoire de I'aorte 
abdominale occupe peu de place dans la 
presse medicale. A ce jour, seulement 
quatre articles ont touche spgcifiquement 
ce sujet. On discute toujours s'il s’agit
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d'une variante de I'an6vrisme atheroscle- 
rotique habituelle ou d'une entite dis- 
tincte. On etudie ici les resultats opera- 
toires chez 24 patients presentant un 
anevrisme inflammatoire de I'aorte abdo­
minale; 21 6taient intacts et 3 etaient 
ruptures. Le diametre des anevrismes 
intacts variait entre 5 et 12 cm et celui 
des anevrismes ruptures, entre 5 et 10 
cm. Neuf patients porteurs d'anevrismes 
intacts se plaignaient de douleur abdomi­
nale ou lombaire. Des 13 patients qui 
ont subi une pyelographie descendante 
avant I'operation, seulement 3 mon- 
traient des signes d'obstruction. Neuf 
patients ont repu une greffe tubaire, 10 
une greffe aorto-iliaque et 5 une greffe 
aorto-femorale. On a enregistre une 
lesion duodenale operatoire et, chez un 
autre patient, il a ete necessaire de sepa- 
rer la veine renale gauche afin d'exposer 
la partie proximale. Aucun essai 
d'exposer les ureteres fut tentg en cours 
de chirurgie. Tous les patients ont recu 
leur conge de I'hopital.
Les auteurs croient que I'anevrisme 
inflammatoire est une variante de I'ane- 
vrisme arteriosclerotique de I'aorte abdo­
minale. Quand on reconnatt ceci, des 
complications opgratoires peuvent etre 
evitees par reconnaissance des traits 
pathologiques.
In 1972 Walker and associates1 described 
the inflammatory abdominal aortic 
aneurysm and suggested that it was a 
different clinical entity from the 
atherosclerotic variety. Recently, Basker- 
ville and colleagues2 used the term peri- 
aneurysmal fibrosis to describe the lesion. 
Inflammatory abdominal aortic aneur­
ysms constitute 2.5% to 10% of all 
infrarenal abdominal aortic aneur­
ysms.13'5 The diagnosis is often not sus­
pected preoperatively, and intraoperative 
complications have led to increased mor­
bidity and death. The etiology, diagnosis 
and appropriate surgical management, 
particularly in relation to the aneurysm 
repair and associated ureteric obstruction, 
are controversial. Our experience with 
this complicated aneurysm forms the 
basis of this report.
Patient Material
Retrospectively, we reviewed the charts 
of all 255 patients who underwent repair 
of abdominal aortic aneurysms at the 
Health Sciences Centre in Winnipeg 
between 1977 and 1983. In 21 (9%) 
patients (19 men, 2 women) the aneurysm 
was considered inflammatory. Of 197 
intact aneurysms, 18 were inflammatory, 
as were 3 of 58 ruptured aneurysms. 
Patients ranged in age from 52 to 82 years 
(average 67 years).
The diagnosis was made by the gross 
appearance of the lesion and biopsy 
examination of the aneurysm wall. About 
one half of the patients had tissue 
removed at operation and the typical 
microscopic findings of fibrosis and 
chronic inflammation were present. Three 
patients with intact inflam m atory 
aneurysms treated before 1977 are 
included in this report, giving a total of 
24 patients with inflammatory aneurysms.
Clinical and Laboratory Findings
Of the 21 patients with intact inflam­
m atory aneurysms, 9 complained 
preoperatively of abdominal or back 
pain, which is commoner than in nonin­
flammatory aneurysms. The size of the 
aneurysm was assessed preoperatively by 
clinical examination, abdominal roent­
genography or ultrasonography or was 
measured at operation. Aneurysms varied 
in size from 5 cm to 12.5 cm in diameter 
(average 7.5 cm). The smallest aneurysm 
was one that had ruptured. Thirteen of 
21 patients with intact aneurysms under­
went excretory pyelography preopera­
tively. Ureteral obstruction was present 
in three patients. Bilateral ureteric 
involvement, probably secondary to 
prostatic hypertrophy, was present in one. 
In the remainder the pyelograms were 
reported as normal. Only 2 of 10 patients 
with an abnormal serum creatinine value 
preoperatively had ureteric obstruction. 
Fifteen of 21 patients with intact inflam­
matory aneurysms had erythrocyte 
sedimentation rates measured preopera­
tively. The values ranged from normal to
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very high (Table I). Although sympto­
matic patients with extensive perianeurys- 
mal inflammation tended to have the 
highest sedimentation rates, there was no 
reliable correlation.
Pathological Features
The gross pathological appearance at
T a b le  1 - E r y t h r o c y t e  S e d im e n ta t io n  
R a te  in  1 5  P a t ie n t s  W ith  In f la m m a t o r y  
A b d o m in a l A o r t ic  A n e u ry s m
N o . o f
L e v e l, m m /h p a t ie n ts
<  2 0 4
2 0 - 4 0 5
4 1 - 6 0 4
>  6 0 2
Fig. lb
FIG. 1—(a) Inflammatory aneurysm with 
adherent duodenum (arrow). Note white mass 
with overlying vascularity, (b) Aneurysm 
opened. Note thick anterior wall.
FIG. 2—Photomicrograph showing, on left, 
normal aortic wall and on right greatly thick­
ened wall with marked inflammation (original 
magnification x 1).
operation is the most important thing for 
the surgeon to recognize. The characteris­
tic features are the dense, white, fibrotic 
tissue and adherent duodenum (Fig. 1). 
All our patients had gross findings of 
perianeurysmal fibrosis, and adjacent 
structures were involved to varying 
degrees. The fibrosis extended from the
FIG. 3—Incision of aorta to allow adherent 
duodenum to retract.
FIG. 4—Intraluminal control of iliac 
arteries.
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left renal vein to the common iliac bifur­
cations in some instances. Biopsies of the 
aortic wall revealed extensive periadven- 
titial fibrosis and destruction of the inter­
nal elastic lamina and most of the media 
(Fig. 2). There were foci of lymphocytes, 
plasma cells and eosinophils. Lymph fol­
licles and giant cells were sometimes 
present. The histologic appearance can 
resemble that of syphilis.
Operative Management and Results
It is most important for the surgeon to 
be aware of the gross appearance of the 
inflammatory aneurysm so that adjacent 
structures will not be injured inadver­
tently. Most serious complications result 
from injuries to the duodenum or adja­
cent veins during ill-advised dissection of 
these structures.1,3'6 It is essential to 
avoid the adherent duodenum by first 
obtaining proximal control of the aorta. 
Division of the left renal vein may give 
better proximal exposure. It may be 
preferable to gain temporary control of 
the aorta at the level of the diaphragm, 
especially when the aneurysm has rup­
tured, as suggested by Crawford and 
associates.5 With proximal control the 
aneurysm is opened, allowing the duode­
num to retract to the right with the wall 
of the aneurysm (Fig. 3). If the inflam­
matory process involves the iliac arteries, 
no attempt should be made to dissect or 
clamp them. It is preferable to obtain 
intraluminal balloon control of the ves­
sels through the open aneurysm (Fig. 4). 
The iliac arteries are oversewn from inside 
the sac and the limbs of the graft 
anastomosed to the external iliac or com­
mon femoral arteries. Likewise, the prox­
imal anastomosis is made inside the sac. 
The aneurysm wall is then approximated 
over the prosthesis. A knitted Dacron 
graft is used for elective reconstruction 
and a woven g raft for rup tu red  
aneurysms (Table II). By these tech­
niques, it was possible to repair all inflam­
matory aneurysms in this series with 
minimal morbidity and no deaths. One 
duodenal perforation occurred but it was 
repaired successfully, and the patient’s 
recovery was uneventful following graft 
replacement.
Discussion
The etiology of the perianeurysmal 
fibrosis and inflammation, which is 
associated with up to 10% of abdominal 
aortic atherosclerotic aneurysms, remains 
obscure. An attractive hypothesis and one 
we support is that of an autoimmune 
reaction with protein breakdown in the 
aortic wall. Although unproven, the 
histologic features and response to steroid 
therapy as reported by Baskerville and 
associates,2 lend support to this hypothe­
sis. Rose and Dent6 have demonstrated
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that the inflammatory process is present 
in most atherosclerotic abdominal aortic 
aneurysms but varies in extent. The 12% 
incidence associated with extensive fibro­
sis in their series is in keeping with that 
reported by others.‘-3-4 Further studies 
may confirm these pathological findings. 
Although Walker and colleagues1 sug­
gested that this entity differs from the 
standard atherosclerotic aneurysm, the 
majority support the concept that it is an 
exaggerated inflammatory process that 
accompanies atherosclerosis.3-5’6 Undue 
back pain, weight loss and a markedly 
elevated erythrocyte sedimentation rate 
are suggestive of an inflammatory 
aneurysm. Excretory intravenous pyelo­
graphy should be done in all patients who 
undergo abdominal aortic surgery, to 
delineate the anatomy of the kidneys and 
ureters. When involved, the ureter charac­
teristically is displaced medially by the 
fibrosis at the level of the pelvis (Fig. 5). 
However, ureteric displacement or 
obstruction neither confirms nor excludes 
the existence of perianeurysmal fibrosis. 
Aortography is of no benefit in the diag­
nosis of the inflammatory component. 
Ultrasonography7 of the aorta may show 
a thickened wall, but recent reports indi­
cate that enhanced computed tomography 
may be the most reliable method of 
assessment.2-5-7-8 Since this perianeurys­
mal fibrosis may be present in the absence 
of any unusual clinical features, the sur­
geon must be familiar with the gross 
pathological features so that the poten­
tial dangers of standard repair are rec­
ognized at operation and modified 
appropriately. M anagement of an 
obstructed ureter remains controver­
sial.9"11 The urologic literature favours 
ureterolysis9 and Darke and colleagues10 
have suggested simultaneous aneurysm 
repair and ureterolysis as their treatment 
of choice. If normal drainage is demon­
strated preoperatively, no attempt should 
be made to mobilize the ureters since there
FIG. 5—Excretory pyelogram demonstrates 
medial deviation of ureter (arrow) due to 
inflammatory aneurysm.
is no evidence that obstruction occurs 
later. When unilateral ureteral obstruc­
tion is present preoperatively, the surgeon 
will have to decide whether to perform 
ureterolysis. In one patient in this series, 
spontaneous resolution of ureteric 
obstruction occurred 6 months after 
repair of the aneurysm (Fig. 6). Since ure­
terolysis may complicate the aneurysm 
repair, it would seem preferable to await 
spontaneous resolution and perform 
follow-up excretory pyelography. It has 
been demonstrated that with steroid ther­
apy the fibrosis and ureteral obstruction 
may resolve without aneurysm resection. 
Delayed ureterolysis is advisable when 
conservative measures fail.
Fig. 6b
FIG. 6—(a) Preoperative excretory pyelo; 
tive retrograde pyelogram showing medial devial 
pyelogram 3 months after repair of aneurysn 
6 months after operation showing resolution
Summary
Twenty-four patients with inflamma­
tory abdominal aortic aneurysms were 
reviewed; 21 were intact and 3 ruptured. 
The erythrocyte sedimentation rate was 
elevated in a number of patients and three 
had ureteric obstruction. The diagnosis 
was rarely made preoperatively, although 
it was occasionally suspected because of 
pain, elevated sedimentation rate and ure­
teric involvem ent. The operative 
approach must be modified to avoid 
injury to the duodenum. All aneurysms 
were successfully replaced with a prosthe­
sis and there were no operative deaths. 
The management of associated ureteric
Fig. 6d
;ram showing left hydronephrosis, (b) Preopera- 
ion of ureter (arrow) which is patent, (c) Excretory 
i without ureterolysis. (d) Excretory pyelogram 
of hydronephrosis.
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involvement remains controversial but 
our present approach is to repair the 
aneurysm, then follow-up the ureteric 
obstruction and perform ureterolysis later 
if necessary.
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NOTICES
continued from page 35
Surgery at Wimbledon
A  course on various surgical topics will 
be held in London, England, from June 
28 to July 5, 1986. Topics to be discussed 
include what’ s new in liver surgery, gas­
tric inlet obstructions, vascular surgical 
emergencies, inflammatory bowel disease, 
thyroid surgery and progress in the treat­
ment o f burn injury.
For further information contact Dr. 
Paul Ross, 490 Old Dock Rd., Kiawah 
Island, SC 29455; (803) 768-1033.
Otolaryngology
The University o f California School o f 
Medicine at San Francisco will be present­
ing a symposium on otolaryngology to be 
held Feb. 1-9, 1986 in Grindelwald, Swit­
zerland. Designed for otolaryngologists, 
otologists, head and neck surgeons, and 
plastic and reconstructive surgeons, this 
symposium will evaluate recent develop­
ments and future directions in related 
areas.
For more in form ation contact 
Extended Programs in Medical Educa­
tion, The University o f California School 
o f Medicine, Rm. 569-U, San Francisco, 
CA 94143; or call (415) 666-4251.
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Prescribing Information
ZAN TAC ®  INJECTION (ranitidine hydrochloride)
PH AR M AC O LO G IC AL C LA S S IF IC A T IO N
Histamine H2-receptor antagonist
IN D IC AT IO N S  AN D  C L IN IC A L  USE
Zantac injection is indicated for the treatment of duodenal ulcer, 
benign gastric ulcer, post-operative ulcer, reflux esophagitis, 
Zollinger-Ellison syndrome and other conditions w here reduc­
tion o f gastric secretion and acid output is desirable. These 
include the prophylaxis o f gastrointestinal haemorrhage from  
stress ulceration in seriously ill patients, the prophylaxis of 
recurrent haemorrhage in patients with bleeding peptic ulcers 
and before general anaesthesia in patients considered to be at 
risk o f acid aspiration (M endelson’s) syndrome, particularly 
obstetric patients during labour.
For appropriate cases Zantac Tablets are also available. 
CO N TR A IN D IC AT IO N S
There  are no known contraindications to the use o f Zantac 
(Ranitidine).
W A R N IN G S
Gastric ulcer-T rea tm en t with a histamine H2-antagonist may 
mask symptoms associated with carcinoma o f the stomach and 
therefore may delay diagnosis o f the condition. Accordingly, 
where gastric ulcer is suspected the possibility o f malignancy 
should be excluded before therapy with Zantac is instituted. 
PRE CAU TIO NS
Use in pregnancy and nursing mothers- T h e  safety of 
Zantac in the treatment o f conditions where a controlled 
reduction o f gastric secretion is required during pregnancy has 
not been established. Reproduction studies performed in rats 
and rabbits have revealed no evidence o f impaired fertility or 
harm to the fetus due to Zantac. If the administration o f Zantac 
during pregnancy is considered to be necessary, its use requires 
that the potential benefits be weighed against possible hazards 
to the patient and to the fetus. However, therapeutic doses of 
Zantac administered to obstetric patients in labour o r undergo­
ing caesarean section have been without adverse effect on 
labour, delivery, or subsequent neonatal progress.
Ranitidine is secreted in breast milk in lactating mothers 
but the clinical significance o f this has not been fully evaluated. 
Use in impaired renal function-R an it id in e  is excreted via 
the kidney and in the presence o f severe renal impairment, 
plasma levels o f ranitidine are increased and prolonged. 
Accordingly, in the presence o f severe renal impairment, clini­
cians may wish to reduce the oral dose to half o f the usual dose 
taken twice daily, similarly it is recom mended that ranitidine 
injection be administered in doses o f 25 m g to patients with 
renal dysfunction.
Children -  Experience with Zantac in children is lim ited and 
such use has not been fu lly evaluated in clinical studies. It has 
however been used successfully in children aged 8-18 years in 
doses up to 150 mg orally twice daily without adverse effect. 
AD VERSE REACTIONS
No serious adverse effects have been reported to date in 
patients treated with Zantac. There has been no clinically signi­
ficant interference with endocrine, gonadal o r  liver function, 
nor has the drug adversely affected the central nervous system 
even in elderly patients.
The incidence o f adverse events am ong Zantac-treated 
patients (8 .1 % ) was very little greater than that among 
placebo-treated patients (7 .7 % ). Only five  adverse events, 
namely, tiredness (0 .38% ), headache (0 .9 0 % ), dizziness 
(0 .3 2 % ), diarrhea (0 .5 2% ) and skin rashes (0 .5 2% ) had a 
greater incidence in the ranitidine treated group than in the 
control group.
A  small proportion (1 .9 9 % ) o f patients treated with 
ranitidine injection experienced itching o r burning at the injec­
tion site. This reaction was mild and usually subsided within 
10-15 minutes.
Headache was experienced by 2 .54%  o f patients receiving 
ranitidine injection. The majority o f these cases w ere not 
thought to be treatment-related. In some instances the headache 
was thought to be due to over-rapid injection of ranitidine, and 
did not recur on rechallenge with slow intravenous injection. 
Similarly, some patients experienced nausea after rapid injec­
tion o f the drug, but on subsequent occasions with slow-intra­
venous injection, experienced no ill-effects.
OVERDOSAGE
Zantac is v ery  specific in action and accordingly no particular 
problems are expected fo llow ing overdose with the drug. 
Symptomatic and supportive therapy should be given as 
appropriate. If need be, the drug m ay be rem oved from  the 
plasma by haemodialysis.
DOSAGE A N D  A D M IN IS T R A T IO N  
Adults: Zantac injection m ay be g iven  either as a slow  (over 
one minute) intravenous injection o f 50 mg, (*M an y physicians 
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Mediastinitis After Whiplash Injury
The authors describe a rare complication 
of whiplash injury. Diffuse mediastinitis 
resulted from extension of a whiplash- 
induced retropharyngeal abscess into the 
thorax. Early diagnosis of the cervical 
infection was masked by the simultane­
ous presence of infectious mononucleo­
sis. Aggressive surgical management 
including bilateral thoracotomy was 
required to resolve the septic course.
A review of the literature discusses 
the pathogenesis of this complication 
including the route of extension into the 
mediastinum and supports the use of 
aggressive surgical therapy to reduce the 
associated mortality.
Les auteurs decrivent une complication 
rare des lesions traumatiques de la 
colonne vertebrale: une mediastinite dif­
fuse qui a resulte de I'extension dans le 
thorax d'un abces retropharynge conse- 
cutif a un coup de fouet cervical. Le dia­
gnostic precoce d'infection cervicale a 
ete masque par la presence surimposge 
d'une mononucleose infectieuse. Un trai- 
tement chirurgical agressif avec thoraco- 
tomie bilaterale a ete necessaire pour 
venir a bout de la sepsie.
Une revue de la litterature permet 
d'elaborer sur la pathogenese de cette 
complication, dont la voie d’extension 
dans le mediastin. Elle soutient le recours 
6 un traitement chirurgical agressif 
comme moyen de reduire la mortality qui 
y est rattachee.
Acute mediastinitis caused by extension 
of infection from the cervical region is 
extremely rare. It is usually a complica­
tion o f an odontogenic infection or 
esophageal perforation during instrumen­
tation.1'3 We report a case of acute medi­
astinitis that occurred after a whiplash 
injury sustained in a minor motor vehi­
cle accident.
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Case Report
A 19-year-old man sustained a whiplash 
injury in a minor motor vehicle accident. At 
the local hospital’s emergency department he 
complained of minor neck and back pain. 
Neck films were normal and he was discharged. 
Five days later, a sore throat and fever de­
veloped. The patient’s family physician pres­
cribed amoxicillin. Over the next 5 days he 
experienced fatigue, increasing fever, chills, 
jaundice and a tender swollen neck due to lym- 
phadenopathy. The monospot test was posi­
tive and he was admitted to hospital with a 
diagnosis of infectious mononucleosis compli­
cated by hepatitis. After 2 days of intravenous 
fluid and prednisone therapy he was discharged 
but was readmitted 2 days later with a sore 
throat, dysphagia, an elevated temperature 
(39.4°C), weakness, dyspnea, a diffuse 
erythematous rash and increased neck swell­
ing. Repeat neck roentgenograms were normal. 
The leukocyte count was 20.0 x 109/L . Over 
the next 24 hours, pleuritic chest pain and 
diffuse abdominal pain with tenderness deve­
loped. At a laparotomy for presumed ruptured 
spleen no abnormalities were found. Postoper- 
atively he became hypoxemic and had bilateral 
pleural effusions (Fig. 1); 800 mL of purulent 
fluid drained from the left pleural cavity. Stain­
ing of the fluid revealed gram-positive 
diplococci and gram-negative rods. The patient 
was transferred to the university hospital 17 
days after injury.
On admission, he complained of fever, dysp­
nea, chest discomfort and left-sided abdomi­
nal pain. A diffuse erythematous maculopapu- 
lar rash was seen. The blood pressure was 
160/50 mm Hg, heart rate 132 beats/min, 
respiratory rate 32/min and his oral tempera­
ture 38.3°C. The pharynx was mildly 
erythematous with no exudate. There was 
diffuse, tender, cervical lymphadenopathy, 
particularly in the left supraclavicular fossa. 
Chest examination revealed reduced breath 
sounds in the left base with bilateral basilar 
rales. Heart sounds were normal and the find­
ings on abdominal examination were un­
remarkable except for a well-healed incision.
Roentgenograms of the neck revealed air in 
the subcutaneous tissues and slight swelling of 
soft tissues (Fig. 2). The leukocyte count was 
11.3 x 109/L  (53% neutrophils, 18% band 
forms, 18% lymphocytes). No atypical lym­
phocytes were noted. Total serum bilirubin 
level was 34.2 jimol/L with a normal alkaline 
phosphatase level and mildly elevated serum 
aspartate am inotransferase level. An 
echocardiogram showed a small posterior 
pericardial effusion, and the roentgenogram 
after a Gastrografin swallow was normal. A 
left chest tube was inserted and drained puru­
lent material.
A diagnosis of high esophageal perforation 
was made. Cefamandole, clindamycin and 
amikacin sulfate therapy was started. At oper­
ation examination of the pharynx revealed mul­
tiple punctate holes and a small laceration in 
the left posterior hypopharynx just above the 
laryngeal inlet. Purulent material could be 
expressed by pressure on the posterior pharyn­
geal wall. The neck was explored through an 
incision along the anterior border of the left 
sternomastoid muscle. Purulent material was 
found in the retroesophageal space and was 
drained with Penrose drains. A right 
thoracostomy tube was placed to drain the 
right-sided empyema and the pericardial cavity 
was drained through a transxiphoid approach. 
Three substernal mediastinal drains were
FIG. 1—Diffuse widening of mediastinum 
and bilateral pleural effusions.
FIG. 2—Lateral neck roentgenogram shows 
air in subcutaneous tissues (arrow), loss of cer­
vical lordosis and mild soft-tissue swelling. 
These are findings compatible with retro­
pharyngeal abscess.
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inserted through a subxiphoid incision and 
advanced to the base of the neck. Culture of 
the pleural fluid grew Eikenella corrodens, 
Streptococcus intermedius and Peptococcus 
magnus. Cefoxitin replaced cefamandole in the 
antibiotic regimen to cover the E. corrodens.
Postoperatively, the patient remained sep­
tic with fever, tachycardia, an increased cardiac 
output and reduced systemic vascular 
resistance. On postoperative day 6, a swelling 
in the right supraclavicular region was incised 
and drained 30 mL of purulent material that 
cultured S. intermedius and Propionibacterium 
acnes. Repeat computed tomography revealed 
a widened mediastinum, an appearance con­
sistent with the presence of undrained pus (Fig. 
3). Eight days after the first operation, the 
patient underwent a left thoracotomy with 
decortication of the left lung, replacement of 
the substernal drainage system and bilateral 
neck explorations. The mediastinum was 
entered through an incision anterior to the aor­
tic arch and a small amount of purulent 
material was drained. Cultures again grew E. 
corrodens and S. intermedius. The patient 
became afebrile for several days but sepsis 
again developed. Right pleural decortication 
was undertaken and the mediastinum was 
opened both anteriorly and posteriorly and 
drained with chest tubes. There was no large 
collection of pus. The mediastinal fluid grew 
m ethicillin-resistant coagulase-negative 
staphylococci.
The patient remained febrile with leukocy­
tosis but the fever gradually resolved over 3 
weeks. He was treated with vancomycin, clin­
damycin and gentamicin for 2 weeks, then with 
vancomycin alone for ano ther week. 
Amphotericin B (0.5 mg/kg daily) was added 
empirically 6 days after operation for 21 days 
because of his persistent febrile state. His 
recovery was somewhat delayed by nausea, 
abdominal discomfort and food intolerance but 
this resolved and he was discharged home 36 
days postoperatively.
Discussion
It has been reported1,4 that 22% of
mediastinal infections originate in the 
neck. Three major routes of communica­
tion allow spread of infection from the 
cervical region into the mediastinum:5 
the retropharyngeal space, the perivascu­
lar space and the pretracheal space. 
Pearse1 reported that the retropharyn­
geal space was involved in 71 % of cases 
of mediastinitis that occurred after cer­
vical suppuration while spread by way of 
the pretracheal and perivascular spaces 
was found in 8% and 21% of instances 
respectively. Most of the cases in the liter­
ature are due to spread of an odontogenic 
infection or extension of a retropharyn­
geal abscess caused by traumatic perfo­
ration of the oropharynx.
Our patient represents one of the rare 
cases of mediastinitis following cervical 
flexion-hyperextension injury.4,6-10 These 
injuries may cause perforation of the 
pharynx or cervical esophagus by one of 
the following three mechanisms:6'8 
pinching of the posterior wall between 
adjacent vertebral bodies as they snap 
back during the flexion phase; breakdown 
of the posterior pharyngeal tissues con­
tused during hyperextension; and direct 
injury by being impaled on a cervical 
osteophyte or fracture dislocation. Our 
patient likely bruised the posterior 
pharynx and sustained a small mucosal 
laceration during hyperextension. The 
resulting inflammation progressed to a 
retropharyngeal abscess and subsequently 
extended by way of the retroesophageal 
space into the mediastinum. Although it 
is possible that the posterior pharynx was 
injured during endotracheal intubation, 
this is unlikely since our patient’s symp­
toms began before his laparotomy and 
the attending anesthetist noted that intu­
bation was uncomplicated. Although two 
groups4,8 have warned that the onset of
fever and neck swelling after a whiplash 
injury should alert the physician to the 
possibility of this complication, the diag­
nosis in our patient was masked by the 
simultaneous presence of infectious 
mononucleosis. This was diagnosed ini­
tially by monospot test and confirmed by 
viral serology.
The bacteriologic features of the medi­
astinitis and neck abscess were consistent 
with an oropharyngeal source for this 
infection.11 Eikenella corrodens, S. inter­
medius and P. magnus are all components 
of the normal oral flora of man. Eikenella 
corrodens has previously been reported 
only once in mediastinitis,12 probably 
because its frequency in mouth flora is 
low and because it is a fastidious microor­
ganism that may be overlooked with rou­
tine culture methods.13 The E. corrodens 
isolated in our case was resistant to clin­
damycin and aminoglycosides and sensi­
tive to cefoxitin. This is the typical pat­
tern for this microorganism14 and was 
the basis for adding cefoxitin to the 
antibiotic regimen. An aminoglycoside 
was continued through most of the 
patient’s stay in the intensive care unit, 
even though a sensitive facultative gram­
negative bacillus was never isolated. Its 
use was probably unnecessary but it was 
continued because of the prolonged 
manifestations of sepsis.
Mediastinitis after cervical suppuration 
is associated with a high death rate. Stan­
dard therapy consists of antibiotics, sup­
portive hemodynamic and nutritional care 
and surgical drainage. Death almost 
always occurs when the surgeon attempts 
to drain a diffuse mediastinal infection 
originating in the neck by a cervical inci­
sion. Although the posterior mediastinum 
can be exposed through the neck down 
to the level of T4-6, this approach is 
clearly inadequate when diffuse mediasti­
nitis is present. Our case demonstrates 
this point. After a failed attempt to drain 
the mediastinum by neck exploration and 
substernal irrigation tubes, a right thora­
cotomy with anterior and posterior medi­
astinal drainage reversed our patient’s 
persistent septic course. The literature 
also supports this contention. Thirty case 
reports1,4-10,12,15-24 in which mediastinitis 
followed cervical infection were available 
for review. Death occurred in 40% (12) 
of these cases and was due to sepsis in all. 
Eleven of the 12 patients were treated by 
cervical exploration alone without thora­
cotomy. Among the 18 survivors, 9 had 
thoracotomies for drainage, usually after 
a neck exploration failed to improve the 
patient’s status. The other nine survived 
with neck exploration and transcervical 
drainage of the superior mediastinum. 
Interestingly these patients usually had 
well-loculated collections as defined by 
computed tomography, roentgenography 
with contrast or operation. This differen­
tiation between a well-defined “ mediasti-
FIG. 3—Computerized tomogram of upper chest revealing markedly abnormal mediasti­
num and bilateral pleural effusions.
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nal abscess” and a more diffuse “ phleg­
m onous m ediastinitis”  has been 
previously made by Neuhof.2 As a 
general approach to these patients, we 
believe that if a well-defined superior 
mediastinal collection is found by com­
puted tomography or contrast radio­
graphy, transcervical drainage of this col­
lection at the time of neck exploration 
may be attempted. Failure of the patient’s 
sepsis to resolve, or progressive mediasti­
nal involvement demonstrated radiolog- 
ically, indicates the need for thoracotomy 
and open mediastinal drainage. Diffuse 
mediastinal involvement when the patient 
presents initially is an indication for early 
thoracotomy.
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Impact on Surgery of Preoperative Localization 
of Parathyroid Lesions
With Dual Radionuclide Subtraction Scanning
In an effort to localize parathyroid lesions 
preoperatively, scanning with radioactive 
thallium and technetium was performed 
in 20 patients considered clinically to 
have hyperparathyroidism. In the 11 
found at surgery to have single 
parathyroid adenomas, scanning cor­
rectly localized the lesion in 10; in the 
other patient the lesion was in the 
unscanned mediastinum. Preoperative 
scanning was not as rewarding in the 
seven patients with parathyroid hyperpla­
sia. A thyroid lesion was the source of 
an abnormality seen on the parathyroid 
scan in one patient, while neck scanning 
and surgical exploration were negative in 
another. Comparison of the patients who 
had parathyroid adenomas localized in 
the neck with a control group of similar 
patients who did not undergo preopera­
tive scanning showed that the average 
surgical time was reduced by 50% with 
preoperative localization and there was a 
decrease in the number of non­
parathyroid tissue biopsies.
Dans une tentative pour localiser des 
lesions parathyroi’diennes en preopera- 
toire, une scintigraphie au thallium et au 
technetium radioactifs a 6t6 pratiquee 
chez 20 patients prgsentant des signes 
cliniques d'hyperparathyroi'die. Sur 11 
patients chez qui la chirurgie a revele un 
adenome parathyroidien unique, la scinti­
graphie avait correctement localise la 
lesion dans 10 cas; chez le dernier 
patient, la lesion se trouvait dans le 
m£diastin non examine par scintigraphie.
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Dans les sept cas d'hyperplasie parathy- 
roidienne la scintigraphie preop£ratoire 
n'a pas connu des r£sultats aussi satis- 
faisants. Chez un patient, une lesion 
thyroidienne 6tait a I'origine de I'anoma- 
lie observee a la scintigraphie parathyroT- 
dienne alors que dans un autre cas, la 
scintigraphie et I'exploration chirurgicale 
du cou se sont averees negatives. La 
comparaison des patients qui souffraient 
des adenomes parathyroidiens localises 
dans le cou avec un groupe t^moin com­
pose de patients similaires mais qui n'ont 
pas eu de scintigraphie preop£ratoire a 
revele que le temps moyen de chirurgie a 
ete reduit de 50% grace a la localisation 
pr6operatoire. On a constat^ egalement 
une diminution du nombre des biopsies 
de tissu non parathyroidien.
There are usually four parathyroid glands 
in humans, located close to or within the 
thyroid gland. However, the number and 
location can vary. It may be difficult to 
recognize parathyroid from other tissue 
and a normal from an abnormal gland by 
gross inspection during operation. 
Intraoperatively, sampling of tissues for 
histologic proof is frequently required. It 
is not surprising, therefore, that surgery 
for hyperparathyroidism can be very tedi­
ous, sometimes requiring considerable 
cervical dissection and mediastinal explo­
ration.
Preoperative localization of parathy­
roid lesions would greatly simplify the 
surgical management. Recently, a new 
dual radionuclide imaging procedure that 
uses radioactive thallium and technetium 
has been described and reported to be suc­
cessful in localizing parathyroid lesions, 
particularly adenomas.1'3
Intravenously administered radioactive 
thallium is taken up by both the thyroid 
gland and the parathyroid lesion, hence 
differentiation is difficult. The 
parathyroid lesion becomes apparent 
when a sodium pertechnetate Tc 99m 
thyroid image is subtracted by computer
from the combined thyroid and para­
thyroid thallium image.
In this paper, we describe our scanning 
technique and the results obtained in 
patients who underwent surgery for 
hyperparathyroidism. The impact on the 
surgical procedure of the correct preoper­
ative localization of parathyroid ade­
nomas is also discussed.
Methods
The study comprised 20 patients with 
a clinical diagnosis of hyperpara­
thyroidism who were subjected to surgery 
after parathyroid scanning. Preopera­
tively, the condition was considered to be 
primary hyperparathyroidism in 13 
patients and secondary in 7. Only one 
patient did not have hypercalcemia, but 
primary hyperparathyroidism was sus­
pected because of recurrent renal calculi 
and hypercalciuria.
The scanning procedure used in the 
first four cases was similar to that de­
scribed by Young and associates.2 Only 
the neck was scanned in these patients. 
Subsequent patients were imaged by a 
modified technique currently in use. After 
the intravenous administration of 80 
to 100 MBq of sodium pertechnetate 
Tc 99m, 20 minutes are allowed for the 
radionuclide to accumulate in the thyroid 
gland. The patient then lies supine under 
the pin-hole collimator of the scintillation 
camera and 100 to 120 MBq of thallous 
chloride T1 201 is given intravenously. 
Im m ediately afterw ards, alternate 
1-minute thallium and technetium images 
are obtained for the neck to a total of 20 
minutes. Subsequently, images of the 
upper mediastinum are obtained in a simi­
lar manner. All images are recorded dig­
itally by computer using 64 x 64 matrix 
frames. During the procedure, the patient 
must remain perfectly still. For the neck, 
the technetium group of images are 
summed up and likewise the thallium 
images. The total technetium image is 
subtracted from the total thallium image.
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Correction for technetium comptom scat­
ter is unnecessary as the contribution of 
compton to the thallium image with these 
amounts of radioactivity is small. The 
mediastinal images are subsequently 
processed in the same manner. Focal 
residual activity on the subtracted image 
is interpreted as a parathyroid lesion.
For proper subtraction, there should be 
perfect alignment of the thyroid gland on 
the thallium and technetium images, as 
motion creates artefacts. Gross motion 
can be corrected by computer reposition­
ing of the images if necessary. By adopt­
ing the alternate imaging technique, we 
strive to obtain a perfect anatomical 
alignment on the two sets of images.
One patient had negative neck and 
mediastinal scans and a negative surgical 
exploration of the neck. Before mediasti­
nal exploration was attempted, repeat 
mediastinal scanning was performed 
using thallium alone, because a subster- 
nal thyroid gland was not present and 
subtraction of thyroid activity would not 
have been necessary.
The effect of correct localization on the 
surgical procedure was evaluated. The 
operative time and the number of 
intraoperative nonparathyroid tissue 
biopsies performed were obtained 
retrospectively from the clinical records. 
The findings in the patients who had 
preoperative scan localization of 
parathyroid adenomas in the neck were 
compared with those in a control group 
of nine consecutive patients in whom 
similar surgery was performed before 
scanning was available.
Results
Primary Hyperparathyroidism
The correlation between the scans and 
surgical findings in 13 patients who were 
considered preoperatively to have primary 
hyperparathyroidism are summarized in 
Table I. At surgery, single parathyroid 
adenomas were found in the neck in nine 
patients and in the thymus in two. In one 
patient a follicular adenoma of the
thyroid with an occult sclerosing papillary 
adenocarcinoma was discovered, and in 
another no neck lesion was detected.
The scans correctly localized all nine 
single parathyroid adenomas in the neck 
(Fig. 1).
In one patient with a parathyroid ade­
noma located in the thymus, the initial 
scans of the neck and mediastinum were 
negative. Surgical exploration of the neck 
was also negative. A repeat mediastinal 
scan with thallium alone showed a focal 
area of uptake, 5 cm below the supraster­
nal notch, immediately to the right of the 
midline (Fig. 2). The focal uptake had 
almost completely disappeared 25 to 30 
minutes after thallium administration (the 
initial mediastinal scan was started after 
the neck scan was completed but the 
repeat scan was started immediately after 
the intravenous administration of the 
201T1). At operation the parathyroid ade­
noma was resected from the thymus, at 
the site identified on the scan.
In the second patient with a 
parathyroid adenoma located in the thy­
mus, the neck scan was negative and 
mediastinal scanning was not done. At 
surgery, neck exploration in itself was 
negative but the parathyroid adenoma 
was found and resected from the thymus 
through the neck incision.
The neck scan showed a large focal 
abnormality in the lower part of the right 
thyroid lobe of one patient. The lesion 
was cold on the 99mTc thyroid scan, but 
it accumulated thallium. Because of its 
large size and the lack of hypercalcemia, 
a thyroid lesion was suggested, although 
the possibility of a parathyroid adenoma 
could not be ruled out. The patient was 
under investigation for recurrent renal 
calculi and hypercalciuria. At surgery, a 
thyroid adenoma with an occult scleros­
ing papillary adenocarcinoma was 
resected, but no parathyroid lesion was 
found.
Both neck scan and surgical explora­
tion were negative in one patient. The 
mediastinum was neither scanned nor sur­
gically explored. Here, as in the two 
patients with parathyroid adenomas in the
thymus, neck exploration verified the nor­
mal scan results obtained for the neck.
Secondary Hyperparathyroidism
In seven patients who were thought 
preoperatively to have secondary hyper­
parathyroidism, the scan results were not 
as helpful. Parathyroid hyperplasia was 
found at neck surgery and no patient had 
mediastinal exploration.
A scan correctly localized all four 
hyperplastic parathyroid glands in one 
patient (Fig. 3). In another in whom three 
glands and part of the fourth had previ­
ously been resected, the remaining seg­
ment was localized on the scan (in 
retrospect). In a third patient, a scan 
localized two of four hyperplastic glands. 
In another, one of three hyperplastic
FIG. 1—Images obtained in patient with 
parathyroid adenoma in neck. Upper left is 
summed thallium image (TL201), upper right 
is summed technetium image (TC99M) and 
lower left is difference between them. Sub­
tracted image shows parathyroid adenoma 
located in region of left thyroid lobe, medially 
above level of isthmus.
FIG. 2—Summed thallium image of upper 
mediastinum showing area of focal uptake, 
located 5 cm below suprasternal notch and 
immediately to right of midline; at surgery, 
parathyroid adenoma was readily identified in 
thymus in exactly that position.
Table 1-Scan Correlation With Surgical Findings
Surgical results No. Scan results
Single parathyroid adenomas 11
In neck 9 Correct localization in all cases
In thymus 1 Correct localization*
1 Mediastinum not scanned!
Follicular adenoma of thyroid with occult sclerosing
papillary adenocarcinoma 1 False positive
Negative neck exploration 1 Negative neck scan!
‘ Initial neck and mediastinal scans were negative. Subsequent surgical exploration of neck was also 
negative. Repeat mediastinal scan with thallium only was positive.
tNeck scanning was negative. Mediastinum was not scanned. Surgical exploration of neck area was 
negative but parathyroid adenoma was resected from thymus through neck incision.
^Mediastinum was neither scanned nor explored.
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glands was identified but the fourth gland 
was not found in the neck during surgery. 
In a fifth patient, one of three hyperplas­
tic parathyroid glands was localized; the 
fourth was histologically normal. A sixth 
patient had only one of four hyperplas­
tic glands identified and in the last patient 
no glands were localized.
Length o f  Operation
The operative times in the nine patients 
with parathyroid adenomas in the neck, 
localized preoperatively, ranged from 40 
minutes to 120 minutes (mean 61 
minutes). In the control group the oper­
ative time ranged from 70 minutes to 220 
minutes (mean 122 minutes).
The number of nonparathyroid sam­
ples examined by frozen section in each 
of the nine patients with parathyroid ade­
nomas in the neck, localized by scanning, 
did not exceed one. In the control group 
the number ranged from zero to nine per 
patient.
Discussion
The results of parathyroid scanning 
with subtraction radionuclide imaging are 
excellent in patients with primary hyper­
parathyroidism, but not as rewarding, in 
our hands, in those with secondary hyper­
parathyroidism. Our results are in agree­
ment with those reported elsewhere.2 
Normal parathyroid glands are not visual­
ized by the method described.
When a diagnosis of primary hyper­
parathyroidism is made clinically, it is 
now possible to localize the parathyroid 
adenomas before surgery. In our patients 
whose parathyroid neck adenomas were 
localized preoperatively, the average time 
of surgical exploration of the neck was 
half that in a control group of patients 
whose neck adenomas were not localized.
During exploration, the surgeon 
usually biopsies tissue suspected of being 
parathyroid for examination by frozen 
section. The process is repeated until posi­
tive identification is achieved — quite a 
difficult task by gross inspection of the 
tissues during surgery. In our patients 
with parathyroid adenomas in the neck 
and preoperative localization, the ade­
nomas were identified immediately at sur­
gery. Nonparathyroid tissue was biopsied 
in some cases in an attempt to locate other 
parathyroid glands that were not involved 
and hence not localized on the scan. The 
present approach is to explore only the 
side on which the adenoma has been 
located preoperatively and not to biopsy 
normal glands. With preoperative locali­
zation, the task of the surgeon and 
pathologist is greatly simplified.
When primary hyperparathyroidism is 
diagnosed, negative neck scanning with 
a reliable imaging technique should be 
considered important. Neck exploration 
was negative in three of our patients with 
negative neck scans, although in one a 
parathyroid adenoma was found and 
resected from the thymus through the 
neck incision.
After neck scanning is completed, 
mediastinal scanning is usually performed 
at the same sitting. When the parathyroid 
adenoma is in the mediastinum, a false­
negative scan could result because of 
delayed imaging if the washout of thal­
lium from the lesion is fast. This fast 
washout occurred in one of our patients. 
Therefore, when routine neck and medi­
astinal imaging are negative, our present 
approach is to repeat the mediastinal 
scan, starting immediately after thallium 
administration. When a substernal 
thyroid is not present, the administration 
of sodium pertechnetate Tc 99m can be 
omitted, since subtraction of the thyroid 
from the image would not be necessary.
Cold thyroid nodules and vascular 
lesions can give false results because they 
can accumulate thallium but not tech­
netium. Careful palpation of the thyroid 
gland and restriction of the scanning 
procedure to patients in whom a diagno­
sis of hyperparathyroidism is well estab­
lished clinically would limit the incidence 
of false-positive results.
Why parathyroid lesions take up radio­
active thallium is not clear. The thallous 
ion is an analogue of the potassium ion, 
and, like potassium, is extracted by cells 
upon perfusion. The high cellularity and 
vascularity present in parathyroid ade­
nomas may be contributing factors.2 
These factors are nonspecific and could 
lead to uptake in nonparathyroid lesions. 
The failure to demonstrate some hyper­
plastic parathyroid glands is not under­
stood.
Conclusions
The dual radionuclide technique with 
subtraction imaging is a reliable method 
of detecting parathyroid adenomas. The 
preoperative localization of parathyroid 
adenomas is beneficial in shortening the 
operative time and in reducing dissection 
and the number of frozen sections 
required.
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FIG. 3—Upper row shows summed thallium and technetium images. Lower row shows 
subtracted images with and without outline of thyroid gland. Four hyperplastic parathyroid 
glands are demonstrated on subtracted images as areas of increased thallium uptake.
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A
Failure of Gastroplasty Pouch and Stoma Size 
to Correlate With Postoperative Weight Loss
At the University of Alberta hospitals 
patients who underwent gastroplasty — 
horizontal, vertical with multistranded 
nylon banding of the stomas and vertical 
banded with Teflon reinforced stomas — 
have been followed up for over 2 years. 
Pouch volume ranged from 25 to 30 mL. 
Pouch volume and stoma size were 
measured radiologically 2 years after 
operation and correlated with the percen­
tage excess weight loss. Any patient fail­
ing to lose at least 40% of the excess 
weight was considered a failure.
There was no consistent correlation 
between pouch or stoma size and per­
centage excess weight loss for any of 
the three procedures studied. The failure 
rate for patients included in the study 
group was 33.3%  for horizontal, 32.4%  
for vertical and 32.8%  for vertical 
banded gastroplasty.
The probable reason for the lack of 
correlation is that some patients change 
their diets so as to subvert the restric­
tion imposed by the gastroplasty.
Les patients des hopitaux affilies a I'Uni- 
versite d'Alberta qui ont subi une gastro- 
plastie (horizontale, verticale avec ban­
dage du stoma 6 I'aide de multifilaments 
de nylon, ou verticale avec bandage du 
stoma h I'aide de Teflon) on fait I'objet 
d'examens de surveillance sur une 
periode de 2 ans. Le volume du sac 
variait de 25 h 30 mL. Le volume du sac 
et la taille du stoma ont ete mesures & la 
radiographie 2 ans aprds I'operation et 
6taient proportionnels au pourcentage de 
perte de poids excedentaire. Tous les 
patients qui n'ont pas reussi a perdre au 
moins 40%  d'excgs de poids ont ete 
considers comme un echec.
On n'a constate aucune correlation
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constante entre la taille du sac ou du 
stoma et le pourcentage de perte de 
poids excedentaire pour aucune des trois 
interventions etudiees. Les taux d'echecs 
ont 6te de 33.3%  pour les patients trai­
l s  par gastroplastie horizontale, 32.4%  
dans les cas de gastroplastie verticale et 
32.8%  pour les gastroplasties verticales 
avec bandage.
La raison probable du manque de cor­
relation est que certains patients changent 
leur regime, renversant les restrictions 
telles qu'imposees par la gastroplastie.
Gastroplasty, a method of inducing 
weight loss by limiting ingestion of food, 
is said to achieve its effect through the 
creation of a small pouch at the cardia of 
the stomach, emptying through a restrict­
ing stoma into the distal stomach. In our 
hands the operation, whether horizontal, 
vertical or vertical banded, has been suc­
cessful initially. However, during the 
second postoperative year failures have 
become more frequent and a number of 
patients have regained a substantial 
amount of the lost weight. Surgeons who 
have measured pouch and stoma sizes in 
the postoperative period have noted an 
increase in both, especially after horizon­
tal gastroplasty and vertical gastroplasty, 
although the increase was less marked in 
the latter. Failure to lose weight has often 
been attributed to these changes. The ten­
dency, therefore, has been to reduce gas­
troplasty pouch and stoma size, the pouch 
being constructed on the minimally dis­
tensible lesser curvature and the stoma 
reinforced and lengthened.
It has been my observation that in 
horizontal gastroplasty pouches with 
nylon-reinforced stomas ranging in 
volume from 25 to 60 mL and followed 
up for 3 to 6 years, the initial pouch size 
did not correlate with initial weight loss 
or subsequent failure ra te .1 Some 
patients with larger stomas and pouches 
achieved satisfactory weight loss that was 
maintained, but others with a small pouch 
and stoma, although achieving initial 
weight loss, subsequently regained 
weight. The question is, What is the role 
of pouch and stoma size in the results 
achieved after restrictive operations for 
weight loss?
Patients and Methods
Both women and men were included in 
this survey, in a ratio of 8:1.
There were three separate groups: 54 
patients who underwent horizontal gas­
troplasty, 61 patients who had a vertical 
gastroplasty and 34 patients who had ver­
tical banded gastroplasty. In the first two 
groups, stomas were reinforced with mul­
tiple strands of no. 1 nylon and in the 
banded group with 6-mm poly- 
tetrafluoroethylene (PTFE). The opera­
tive techniques for these procedures have 
already been described.2,3 Pouch 
volumes in all cases were between 25 and 
30 mL.
All patients were followed up routinely. 
Weight loss was recorded as a percentage 
of excess weight lost. Films of the upper 
gastrointestinal system were obtained 60 
days after operation and annually there­
after. This procedure was performed by
Table 1—Patients Who Failed to Achieve Initial Loss 
of 40% Excess Weight
Gastroplasty No. of Weight loss,% % of total
procedure patients Mean Range patients
Horizontal 5 31.6 18-39 8.9
Vertical 5 28 22-39 8.0
Vertical banded 5 27 21-33 8.8
+■
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4
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a single radiologist, expert in the tech- of distending the pouch with gas granules
niques of demonstrating the stoma and to determine its maximum size. Pouch
X  EXCESS WEIGHT LOSS
FIG. 2—Horizontal gastroplasty. Successes and failures related to stomal diameter.
T a b le  II--P o u c h  an d  S to m a  S iz e s
G a s t r o p la s t y
p ro ce d u re
S u c c e s s , cm F a ilu re , cm
M e an R a n g e M e a n R ang e
P o u ch e s , c m 2 H o r iz o n ta l 3 3 .0 8 5 - 7 6 3 0 .2 1 1 0 - 9 0
V e r t ic a l 3 4 .9 4 8 - 8 1 2 2 .0 8 8 - 3 6
V e r t ic a l b anded 3 2 .6 3 1 0 - 5 8 2 1 .8 0 1 2 - 4 2
S to m a s , m m H o r iz o n ta l 7 .0 8 3 - 1 6 7 .5 7 4 - 2 0
V e r t ic a l 6 .8 1 3 - 1 2 6 .3 1 4 - 1 0
V e r t ic a l banded 5 .81 3 - 1 0 7 .0 0 3 - 1 2
size, as seen radiologically, is reported in 
centimetres squared and stomal diameter 
in millimetres. The number of patients in 
each group who had sequential roent­
genography was less than the total: 
horizontal gastroplasty 38, vertical gas­
troplasty 45, vertical banded gastroplasty 
21. Pouches that developed multiple 
stomas were not included in the main 
body of data but are presented 
individually.
In this study, the percentage of excess 
weight lost was related to pouch and 
stoma sizes 2 years after operation. The 
results have been arbitrarily divided into 
two groups, success and failure. A patient 
was considered a failure if the excess 
weight loss achieved or maintained was 
less than 40%. This criterion was selected 
because all patients requesting further 
surgery to improve weight loss had excess 
losses near or less than 40%.
Our results were presented as a series 
of bar graphs with pouch and stoma sizes 
on the Y axis and percentage excess 
weight loss on the X axis. A space at 40% 
excess weight loss divides the successes 
from the failures.
Results
All patients lost weight, the maximum 
loss being achieved within 12 to 18 
months. However, 8% of each group 
failed to lose at least 40% excess weight 
(Table I). Subsequently, all patients 
regained weight, some a minimal amount, 
and a small number approached preoper­
ative weights. Figures 1 and 2 show that 
for horizontal gastroplasty there is little 
difference in pouch and stoma sizes 
between the successes and failures. This 
is also true for vertical (Figs. 3 and 4) and 
vertical banded (Figs. 5 and 6) gas­
troplasties.
It is obvious from the figures that some 
patients with relatively large stomas and 
pouches achieved and maintained a satis­
factory weight loss, while others with a 
small stoma and pouch failed.
Table II compares mean sizes and 
ranges for each procedure. These data 
confirm the impressions obtained from 
the graphs. Mean pouch size is, if any­
thing, larger in the successes than the 
failures for all three groups. Mean stoma 
sizes are almost identical within each 
group, the horizontal gastroplasties hav­
ing the largest diameter and the vertical 
banded the smallest. The one larger 
diameter stoma (12 mm) in the latter 
small group of failures skews the mean, 
giving an artificially high value.
The failure of pouch and stoma size to 
correlate with weight loss was further 
emphasized when a few patients (Table 
III) acquired a second stoma due to 
staple-line failure. Of this group, six are 
still deemed successes and five failures.
The failure rates of patients followed
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up roentgenographically and in the total 
groups are shown in Table IV. Percent 
failure rates are almost identical.
Patients in the failed group often return 
seeking further treatment for persistent 
obesity. In group 1,11 have undergone 
gastric bypass and 2 intestinal bypass, and 
1 had a vertical banded gastroplasty that 
failed and was subsequently converted to 
a gastric bypass (25% converted). Follow­
ing vertical gastroplasty, five patients had 
conversion to gastric bypasses and two to 
intestinal bypasses (11% converted). 
Three patients had vertical banded gas­
troplasties that failed and were converted 
to gastric bypasses (8% converted).
D iscussion
If one accepts the premise that gastric 
restrictive procedures induce weight loss 
by limiting intake of food, then the weight 
loss, other things being equal, should be 
directly related to the degree of restric­
tion induced. Therefore, smaller, less- 
distensible pouches and small, well- 
supported stomas would appear to be the 
criteria necessary to produce a uniform 
and lasting weight loss. In a previous 
paper1 I showed that reducing pouch 
volumes from 60 mL to 20 to 25 mL 
helped to reduce failure rates. Neverthe­
less, in this series of small-pouch horizon­
tal gastroplasties, the failure rate was 
33.3%. Seventy-seven percent of failures 
have been converted to other types of 
weight loss operations that have success­
fully induced further weight loss.
In the vertical gastroplasty group, 
32.4% of gastroplasties failed and 35% 
of these have already been converted to 
other weight loss operations. The verti­
cal banded gastroplasty group has a 
32.4% failure rate and 27% of the gas­
troplasties have been converted to gastric 
bypass. It seems appropriate to ask, 
“ What failure rate is acceptable?” A 32% 
rate for horizontal, vertical and vertical 
banded gastroplasties is high when com­
pared with long-established intestinal 
bypass (1%).3 Furthermore, with each 
year of follow-up the number of failures 
increases.
The following technical detail is worth 
noting. It had been anticipated that ver­
tical gastroplasty, with a longer stoma 
channel associated with the PTFE band, 
might result in greater and more 
prolonged weight loss vis-a-vis the stoma 
banded with nylon suture. There appears 
to be little difference in results to date.
Why then are there conflicting results 
and a lack of correlation between weight 
loss and the imposed degree of restric­
tion? The experience of this clinic indi­
cates that patients ultimately learn to sub­
vert the restriction on solid foods by 
ingesting semi-solid or high caloric 
liquids. Furthermore, chewed solid food
FIG. 3—Vertical gastroplasty. Successes and failures related to pouch size.
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Table Ill-Patients With Two Stomas
Gastroplasty
procedure
Success Failure
No. of 
patients
% final excess 
weight loss
Days
postop
No. of 
patients
% final excess 
weight loss
Days
postop
Horizontal 3 72 1035 3 23 1062*
43 1415 22 1055*
72 1394 24 1349*
Vertical 1 44 1107* 1 35 786*
Vertical banded 2 51 660 1 '9 589*
52 1021
'Converted to gastric bypass.
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may be flushed through the stoma by con­
comitant ingestion o f fluids. Once this 
habit is established, few patients can be 
persuaded to return to the more rational 
eating habits that result in reversal of 
weight gain or further weight loss.
The high early failure rate and the 
number of patients requesting further sur­
gery prompted me, some years ago, to 
give up horizontal, vertical and vertical 
banded gastroplasties as weight loss 
procedures.
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FIG. 5—Vertical banded gastroplasty. Successes and failures related to pouch size.
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FIG. 6—Vertical banded gastroplasty. Successes and failures related to stomal diameter.
Table IV-Number of Failures in Patients Who Underwent 
Roentgenography Compared With Total Group
Roentgenography Total group
Gastroplasty
procedure
No. of 
patients
Failure, 
no. (%)
No. of 
patients
Failure, 
no. (%)
Horizontal 38 14(37) 54 18(33)
Vertical 45 13(29) 61 20 (33)
Vertical banded 21 5(24) 34 11 (32)
All patients followed up had upper gastrointestinal series. However, owing to the vagaries of clinical 
research, only part had a study at 2 years. The table indicates that the failure rate was essentially 
consistent across each group and that the patients who underwent roentgenography were not selected 
to favour success or failure.
3. Idem: Comparison of weight losses following horizontal, 
vertical and vertical banded gastroplasty of equal pouch 
and stoma size: comparison with results of intestinal bypass 
surgery. Clin Nutr (in press)
ERRATUM
Malliner Laboratories Inc. announces that 
advertising brochures distributed be­
tween the dates of September 16, 1981 
and July 9, 1985 contain the fo llow ing 
printing errors:
1 Surgicel should be referenced as 
the property of Johnson & Johnson 
Inc.
2 Surgicel should be referred to as 
O xidized Regenerated Cellulose  
and not Oxidized Cellulose.
3 The reference to the scientific litera­
ture should be updated to read:
"  + Adapted from the fo llow ing arti­
cles and other research performed at 
the University of Arizona Health 
Sciences Center, Department o f Sur­
gical Biology:
Silverstein, M.E., Keown, K., 
Owen, J.A ., and Chvapil, M., 
Collagen Fibers as a Fleece 
Hemostatic Agent, The Journal of 
Trauma, Vol. 20, No. 8, (1980). 
Silverstein, M.E., and Chvapil, M., 
Experimental and Clinical Ex­
periences w ith Collagen Fleece as 
a Hemostatic Agent, The Journal 
of Trauma, Vol. 21, No. 5, 
(1981).
Chvapil, M., Owen, J.A . and 
DeYoung, D.W., A Standardized 
Animal Model for Evaluation of 
Hemostatic Effectiveness of Var­
ious Materials, The Journal of 
T raum a, V o l. 23 , No. 12, 
(19 83 )."
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S.M . Str a sb er g , m d , frcsc*
So You Wanted to Do Surgery 
and They Keep Talking About Research: 
a Discussion for the Surgical Resident and Intern
Surgical residents and interns frequently 
misunderstand the relation between sur­
gery and research, and the contribution 
of surgical research to clinical practice. 
The problem is that the effects of 
research must be viewed in the long 
term. Once the resident can do this, the 
importance of research to surgery is evi­
dent and surgical research can be seen 
for what it is, the growing surface of 
surgery. Training to do surgical research 
has many parallels with clinical training.
A core-training period in investigation 
provides the resident with the right men­
tal approaches to investigation so that 
training in a specific area of research 
may be done later. Surgical scientists 
must be excellent clinicians as well as 
scientists and so long training periods 
are required. Four years of clinical prac­
tice training and 3 of research training 
are probably ideal. Shorter periods of 
research training may be valuable for 
many surgical residents, particularly 
those who have had little research 
experience. Training should be tailored to 
the trainee's desired role in surgery.
Les residents et internes en chirurgie se 
meprennent souvent sur le rapport qui 
existe entre la pratique de la chirurgie et 
la recherche en ce domaine, ainsi que 
sur la contribution de la recherche 6 la 
pratique Clinique chirurgicale. Le pro- 
bleme resulte de ce que les effets de la 
recherche doivent etre envisages £ long 
terme. Une fois que le resident a appris a 
penser de cette facon, I'importance de la 
recherche pour la chirurgie devient pour 
lui evidente et la recherche chirurgicale
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se revfele alors pour ce qu'elle est: l'6le- 
ment progressif de la chirurgie. La forma­
tion en recherche chirurgicale offre plu- 
sieurs similitudes avec la formation 
Clinique. Une p6riode de formation en 
recherche procure au resident I'ouverture 
d'esprit qu'il faut pour la recherche et le 
prepare a entreprendre ulterieurement 
une formation dans un secteur sp6cifique 
de la recherche. Le chirurgien scientiste 
se doit d'exceller en clinique comme en 
science, de sorte que de longues p6rio- 
des de formation sont necessaires. Qua- 
tre annees de pratique clinique et 3 
annees de formation en recherche pr6- 
sentent probablement lAquilibre ideal.
Une periode de formation plus courte en 
chirurgie peut etre utile pour plusieurs 
residents en chirurgie, particulierement 
pour ceux qui possedent peu d'exp§- 
rience en recherche. La formation devrait 
etre modelee au role que le futur chirur­
gien entend jouer dans sa speciality.
You are a clerk, intern or surgical resi­
dent. You are in surgical training, are 
about to enter it or are giving it serious 
consideration. You like surgical 
problems, you like the direct approach of 
surgery and you certainly like operating 
or know that you will.
Your plans seem quite straightforward, 
although you are uncertain of what will 
happen at the end of your training. The 
word research comes up and then keeps 
coming up. On the residency application 
form some schools ask you if you are 
interested in research. In interviews, they 
ask “ What are your long-term plans in 
surgery?” Your friends say that what they 
are looking for is a “ research” answer. 
The word is that if you want to get into 
training, you must say you are interested 
in research. Already there are some pro­
grams in which you have to do a year of 
research. There’s talk that residents who 
do research during their training have a 
better chance of getting a job after.
Why is there all this talk about research 
when all you want to do is surgery? It’s 
annoying and confusing. If you have or
have had some of these thoughts, read on. 
I shall try to give you some background 
and answer some of the questions about 
research that interns and residents often 
raise.
What’s Research — What’s Surgery?
Research is a word that everyone thinks 
they should know. So it’s often used by 
those who don’t know what it means at 
all. Moreover, the time scale of research 
and its place in surgery is not understood. 
People talk of surgery and research as if 
they are two separate disciplines. To begin 
to clear the confusion, we must under­
stand the meaning and relation of these 
terms.
Surgery is a discipline with several 
facets. One is patient care. Another is the 
training of doctors to be surgeons. The 
final part of our discipline is the one that 
asks and answers questions about how 
good our patient care is, how good our 
teaching is, and how the two may be 
improved. That part of surgery, the ask­
ing and answering part, is research — sur­
gical research. It is not a separate dis­
cipline, but an integrated, interwoven, 
essential part of surgery. It is the grow­
ing plate, the remodeller, the changer.
There are several reasons why this is 
not obvious. Many surgeons are involved 
only in the patient-care aspect of surgery. 
It is easy to slip into the error of gener­
alizing about the person who is your role 
model to the discipline. That is somewhat 
like the story of the blindfolded man feel­
ing the elephant. The entire structure was 
never perceived but was conceived vari­
ously depending on the part felt.
Failure to appreciate the existence of 
different time scales also inhibits under­
standing of the role of surgical research 
in the discipline of surgery. We tend to 
think in short time scales. The longest 
time scale experienced by a young person 
is the residency training period of 4 to 7 
years. But the time scale of research is 
often decades. For example, 1928 was a 
notable year in the history of gallbladder
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surgery since it was then that oral 
cholecystography was described and gall­
stones could at last be diagnosed with cer­
tainty on a routine basis. But the death 
rate in that year for cholecystectomy was 
60 patients per 1000 operations; today, it 
is only 1 to 2 patients per 1000 operations. 
The change was the result of asking and 
answering questions about clinical prac­
tice (i.e., research). This is just one exam­
ple. To fully appreciate the role and time 
scale of research within surgery, take an 
hour off, go to the library and examine 
standard surgical texts of the 1920s and 
the 1950s and compare them to a modern 
text. It’s eye-opening. There were no use­
ful implantable prostheses, there was no 
transplantation and no nutritional sup­
port, only rudimentary evaluation and 
treatment of shock and cardiopulmonary 
failure, no or limited antibiotics...and 
on...and on. The list is long: the change 
is surgical research. Oh, by the way, oral 
cholecystography itself was developed by 
a surgeon, Evarts Graham. There was a 
real problem in the diagnosis of cholelithi­
asis before 1928. Many people had 
cholecystectomy for biliary colic-like 
pain, but at operation were found to have 
no stones. In most cases, patients were 
not improved by such operations. Instead 
of accepting the state of the art, Graham 
asked and answered the question of how 
surgical practice might be improved. The 
point is that to understand the effect of 
research in surgery, you must consider the 
time scale of research. It is relatively long, 
but its effects are far-reaching and long- 
lasting.
Definition and Classification 
of Surgical Research
Research means to look deeply into a 
question (not to look “ again” ). It means 
to answer a question using a group of 
rules collectively referred to as the scien­
tific method. There are many ways of 
knowing. The scientific method is a way 
of knowing about the physical world; its 
advantage is that it results in conclusions 
that can be accepted universally provided 
its rules have been adhered to. If opera­
tion A gives superior results to operation 
B in Winnipeg, then, as long as the 
method has been properly applied, this 
will be true in Halifax, Toronto, Medi­
cine Hat or Dawson or anywhere else. It 
will be found to be so if it is tested again. 
The advantages to patients of this way of 
knowing over opinion or dogma are obvi­
ous. Core training in research involves 
learning this scientific method. Learning 
the method is really training in thinking 
or, if you like, mind training. Scientists 
refer to this type of thinking as critical 
thinking, as opposed to uncritical or 
biased thinking.
What follows is my own classification. 
It is just one possible classification; it is
structured to eliminate certain confusing 
words. Surgical research is one type of 
clinical research. Surgeons doing research 
are surgical researchers, surgical investi­
gators or surgical scientists. Clinical 
research, and therefore surgical research, 
differs from basic research. Clinical 
research always has at its root interest in 
the improvement of patient care. Basic 
medical research has at its root the study 
of biologic phenomena. A surgical inves­
tigator interested in improving the treat­
ment of shock might be studying stabili­
zation of cell membranes by drugs. A 
basic scientist interested in the phenome­
non of cell membranes might be conduct­
ing the same experiment as the surgical 
investigator. But one is doing surgical 
investigation, the other basic investiga­
tion. The surgeon will, if his work is suc­
cessful, take his findings from the labora­
tory bench to the bedside treatment of 
patients in shock. This is his purpose for 
looking into the problem in the first place. 
The basic scientist will turn his knowledge 
into a better understanding of how the cell 
functions. Clinicians do not do basic 
science, nor are they basic scientists 
because their motivations are different. 
However, clinical research is very depen­
dent on basic science, which is often the 
source of new ideas for understanding or 
attacking clinical problems.
Types o f  Surgical Research
There are three kinds of clinical or sur­
gical research: clinical epidemiology, tech­
nologic reset,..!. <md scientific research.
Clinical epidemiology asks questions 
about the natural history of disease or 
about how effective our clinical methods 
are. Clinical methods include diagnostic 
and therapeutic techniques and also 
methods of teaching doctors and patients. 
We evaluate clinical methods by “ clini­
cal trials” in which the new diagnostic or 
therapeutic methods are tested against 
standard methods. Clinical trial methods 
are a form of the scientific method 
referred to earlier; special training is 
required to learn this type of critical 
thinking. Clinical epidemiology also exa­
mines the natural history of disease. 
Recently, it was recognized that many 
patients who have had gallstone pancrea­
titis will suffer a second attack within a 
short time. This attack is often severe, 
sometimes fatal. This important finding 
has started to change surgical practice. 
Most surgeons now agree that early sur­
gical treatment for gallstones after an 
attack of pancreatitis is advisable. No one 
surgical practitioner is likely to make such 
an observation. Such observations are 
made by asking and answering questions 
— surgical epidemiology questions.
The second type of surgical research is 
technologic research. This may be 
thought of as methods and materials
development. Much surgical research is 
of this type. Development and testing of 
implantable materials and of new oper­
ative techniques (e.g., new techniques 
employing staplers) is technologic 
research. Surgical researchers are fre­
quently involved in developing special 
instruments, often working with biomed­
ical engineers. Such instruments may be 
used to measure flows, test tissue 
strengths or to measure structural 
strength or activity of organs or tissues. 
Surgeons often develop new instruments 
for use in the operating room. These are 
just a few examples of technologic inves­
tigation. This type of investigation is 
often done in laboratories; while human 
subjects are frequently used in techno­
logic research, it is often necessary to use 
animals. For instance, when an instru­
ment such as a stapler is first used, it is 
tried out in a model of a human (i.e., an 
animal model). If you are a bit confused 
now about the two types of research dis­
cussed so far, just remember that tech­
nologic research is development of 
methods and materials. The clinical use­
fulness of such techniques is tested in that 
part of clinical epidemiology referred to 
as clinical trials.
The third kind of research is called 
scientific research, which asks questions 
about the mechanism of disease or the 
normal physiology or biochemistry 
underlying that disease. If you ask “ Why 
does retransfusion after prolonged 
hypotension due to hemorrhage not result 
in patient survival?” , you are asking a 
scientific question. To answer that ques­
tion, you may need to question how cells 
operate normally and how they respond 
to certain types of injury. Surgeons have 
made many important contributions of 
this type of research and these have 
resulted in major clinical developments in 
the treatment of shock, burns, gastroin­
testinal, cardiovascular and neurologic 
diseases, just to name a few. Scientific 
research is powerful because understand­
ing the mechanism of disease often leads 
to new treatment strategies. This type of 
research is performed using either humans 
or animal models. Surgeons also contrib­
ute to scientific research that does not 
seem to relate directly to surgical 
problems because their surgical training 
makes them excellent at modelling. A 
good example of this is Banting’s discov­
ery of insulin.
Clinical epidemiology, technologic 
research and scientific research may ask 
different types of questions, but they are 
interdependent. The products of scientific 
and technologic research must be tested 
by clinical trials to determine their value. 
Studying the natural history of disease 
often leads to questions about mechan­
isms of disease (i.e., scientific research). 
Technologic research often is the spring-
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board for advances in scientific research. 
Study of the natural history of disease or 
scientific research advances may require 
new technologies. This flow back and 
forth between different types of research 
efforts is what investigators mean when 
they talk of “bedside to bench to bed­
side” (i.e., from the patient problem to 
the laboratory bench and then back to the 
patient for tests of efficacy). The relation 
between the various types of research is 
shown in Fig. 1. The different types of 
research have several features in common: 
they all use the scientific method, so to 
do any of them, one has to learn critical 
thinking; also, clinical research of all 
three types is related to, based on and 
stimulates basic research.
Research Studies and 
Descriptive Studies
Not everything published in the litera­
ture is research. Some studies review the 
research literature and draw a field 
together. These reviews are often very 
valuable. Some studies are termed 
descriptive. Case reports, of interesting, 
rare individual cases or a series of one 
class (e.g., all the gastric ulcers seen in one 
institution over 20 years) are descriptive 
studies. Description may be one phase of 
a research study. For instance, it may be 
necessary to develop a data base and 
begin to gather data before asking ques­
tions. Descriptive studies may be valua­
ble, particularly when rare or unusual 
cases are described or when a surgical 
field is developing rapidly. But descrip­
tions of clinical case material alone do not 
constitute research. Descriptive studies 
can be, and unfortunately frequently are, 
repetitious, adding little to what is avail­
able in standard texts. A balance between 
research studies and descriptive studies is 
required. In my opinion, there is an 
imbalance in the surgical literature. Do 
not confuse research and descriptive 
studies just because they are both pub­
lished. If it’s good research, it will ask and 
answer a question convincingly. In 
descriptive studies, the questions often 
come at the end of the study and can 
rarely be answered decisively by the study.
Training the Surgical Scientist
In this section, I shall describe what I 
consider is the proper training of a surgi­
cal scientist. This type of training may not 
be for you; in fact, probably only a 
minority of surgical trainees should do the 
type of training I am about to describe. 
But, it provides a springboard for other 
types of surgical training in research. 
There are several principles that I consider 
very important and the training is based 
upon these.
• Do what you want to do! Do what 
you think you will enjoy. Do what you
find exciting. Most good researchers have 
an intense desire to investigate and love 
doing it. How will you know if you will 
like research? Do you have the qualities 
of inquisitiveness, thoroughness and per­
sistence? Is the unknown a challenge to 
you or do you shrink from it? Can you 
sense the excitement of discovery or do 
you find it difficult to imagine? Such 
questions may help, but in the end, you 
must really do research to know whether 
it’s for you. Once you know, do it 
because you like it and not as an obliga­
tion or as part of getting a job; that can 
be a disaster. You will be unhappy and 
so will the people who brought you on.
On the other hand, if you do like it, 
there are great personal rewards and satis­
factions in investigation. Your abilities to 
design and conduct studies will improve 
with experience and you will see your 
effectiveness as a surgical investigator 
increase. You will develop national and 
international associates, engage in 
cooperative ventures and you will have 
your own students. These are great pleas­
ures in addition to the satisfactions of 
clinical practice.
• Get trained to the level of excellence 
in surgical patient care. Above and before 
all else, you must be an excellent clinical 
surgeon both inside and outside the oper­
ating room. You must have the respect 
of your peers and residents as a clinician. 
Consider restricting your clinical practice 
to one area within your specialty and base 
that restriction upon your research
interest. In that way, you will be a clini­
cal authority, as well as a research 
authority.
• Take as much time in training as you 
need to get the skills that you require for 
your work in clinical practice and 
research. Once you start in practice, it will 
be difficult to get further training. If you 
are inadequately trained as a clinician or 
a scientist, you will probably fail.
A Training-Program Model
The training of the surgical scientist 
requires parallel training in clinical prac­
tice and research. These are like the two 
legs of a runner; both must be well deve­
loped. Each requires a period of core 
training and then a period of speciali­
zation.
In clinical surgery, a period of core 
training is provided for learning the prin­
ciples of clinical surgery. This is gener­
ally a 2-year period. In surgical research, 
core training is also required to learn the 
scientific method, to learn critical think­
ing. The training in research must be 
“ hands on” like the clinical training, 
except perhaps in both areas it is really 
“ minds and hands on” . In research, this 
is the period for learning the skeleton of 
research, how to ask and answer ques­
tions, what ways there are to attack a 
question, to design a study, what are good 
and bad questions, what are appropriate 
controls and what constitutes bias. You 
learn persistence, how to deal with failure
FIG. 1—Interdependence of three types of clinical research and research in basic sciences.
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and disappointment, how to be dispas­
sionate, determined and sure, how to take 
criticism and use it, how to take pride in 
the work of others and how to know if 
your work is conclusive. You learn criti­
cal thinking and critical thinking can be 
taught.
In my opinion, the best core training 
in research is done in an MSc program, 
particularly if you will be exposed to other 
students and their studies during this 
training. Your study and theirs are models 
for understanding and getting a grip on 
science. The course work allows you to 
learn or brush up on statistics and appli­
cations of computers, and the thesis 
preparation and examination are also 
valuable mind training.
If possible you should do your core 
training in the subject area that you will 
ultimately be interested in. However, core 
research training is best done early, 
usually after 1 year of clinical core train­
ing and it is often not possible for a stu­
dent to be sure of an ultimate subject 
area. In my opinion, this is not of great 
importance. What is important is that the 
research is done in surroundings and cir­
cumstances in which good core training 
can be obtained. What do you look for? 
The laboratory or clinical epidemiology 
unit should be active, publishing, hold­
ing grants; the supervisor should be avail­
able, often present. The supervisor should 
preferably be a member of the graduate 
school and have turned out graduate stu­
dents. Talk to his present and past stu­
dents. What has happened to his former 
students?
On the clinical side, 2 years are also 
required for core training, and another 2 
years are usually required to get the kind 
of clinical expertise I have referred to 
earlier. Some can do all the clinical train­
ing in 3 years. But remember, don’t skimp
here or in the research training. The last 
year of clinical training should be of a 
superspecialist type and be closely linked 
to your special research training.
Special research training usually 
requires only 1 year, if you have already 
acquired an MSc. At this time, you will 
look for a laboratory that is working in 
the area of your special interest. The very 
specialized techniques and literature will 
be learned. This is when you get to know 
your “ field” .
I have given a rather specific plan, but 
the important features are core training 
in both clinical and investigative surgery 
and special training in both areas. The 
timing is less important than the time 
spent and the quality of the training. In 
general, at least 4 clinical and 3 research 
years are required to optimize the chance 
for success. For some, the correct 
approach will be to do all the clinical 
training first and for others, all the 
research training first. The latter 
approaches best suit those who know 
what their ultimate subject area will be 
and this type of training may be appropri­
ate for a PhD. But for the majority I 
would favour an introduction to surgery, 
followed by core research training fol­
lowed by surgical training to fellowship 
level and then 2 years of special clinical 
and research training. I have outlined 
some of my reasons for this in Table I.
Who should do surgical scientist train­
ing? As I said, only a minority of surgi­
cal trainees want to get this type of train­
ing. Some will know that they want to be 
surgical scientists before they enter sur­
gery, and structured surgical scientist pro­
grams are available for them at some 
schools. Others will get this kind of train­
ing by a less direct route. They will start 
one of the alternative training programs 
described below and get “ turned on” by
their exposure to research. Then they will 
design the rest of their training appropri­
ately. By the way, some of the people who 
think they want to become surgical scien­
tists will change their minds along the way 
also. There’s no shame in this and pro­
grams should be flexible and understand­
ing when this occurs, provided arrange­
ments were made in good faith initially.
Other Research Training Plans
Many prospective surgical residents 
don’t know if they will find research 
interesting. In many cases, they don’t 
really know what research is. It is 
appropriate for many surgical residents 
who are in that position to do 1 year of 
research training early in their residency. 
Because they are going to be practitioners, 
the best type of research training in many 
cases would be in clinical epidemiology. 
Unfortunately, right now there are few 
good positions of this type. But, as I said 
earlier, research training is mind training, 
and as long as you get into a good 
research setting you will develop an 
understanding of how research is done. 
You will find out if asking questions and 
then conclusively answering them turns 
you on and whether you have the neces­
sary qualities. Don’t be afraid to find out 
if you have these qualities. Remember 
that critical thinking can be taught and 
that persistence is a very important attrib­
ute in investigation. Imagination grows 
with practice. Some of what appears to 
be imagination is experience. Some of 
what appears to be brilliance is thorough 
reading and classification and hard study. 
Don’t sell yourself short until you try.
It doesn’t really matter whether you 
determine your qualities and suitability 
for research by doing clinical epidemiol­
ogy or working in a laboratory doing 
technologic or scientific research, as long 
as the research methods are good. But I 
suggest that during this year you take one 
of the clinical epidemiologic courses that 
are now available in some schools. This 
will prepare you to participate in clinical 
epidemiologic studies, although without 
further training it would be difficult to 
design and run them.
Surgeons who have a major interest in 
teaching should also be familiar with 
research methodology. As I said earlier, 
research methods are used to test the 
effectiveness of our teaching methods as 
well as our diagnostic and treatment 
methods, and research methodology is 
used to determine whether new teaching 
techniques are efficacious. One really can­
not be a teaching specialist without some 
understanding of these methods.
Some specialties or surgical training 
courses require at least 1 research year. 
Their reasoning is based on two premises. 
First, some investigators would be lost
T a b le  1— O n e W a y  to  T r a in  a s a  S u rg ic a l S c ie n t is t
Y e a r C lin ic a l s tu d y R e s e a r c h  s tu d y
R1 In tr o d u c t io n  t o  s u rg e ry . In  a d d it io n  to  c o re  
c lin ic a l t r a in in g ,  th is  y e a r  p ro v id e s  a n  
id e a  o f  s c o p e  o f  s u rg e ry  a n d  k n o w le d g e  
o f  s u rg ic a l il ln e s s  w h ic h  h e lp s  in  
r e s e a rc h . I t  a ls o  a d d s  m a tu r i ty  a n d  
r e s p o n s ib i lity  h e lp fu l in  re s e a rc h .
R 2 ,3 S tu d ie s  to  M S c  le v e l.  C o re  re s e a rc h  t r a in in g .  
S e le c t  s u b je c t  a r e a  i f  p o s s ib le  b u t  c o n ­
c e n t r a t e  o n  le a rn in g  h o w  t o  do r e s e a r c h  
a n d  t o  th in k  c r i t ic a l ly .  R e s e a rc h  t r a in in g  
h e re  h e lp s  c l in ic a l t r a in in g  a n d  s t im u la te s  
a q u e s t io n -a s k in g  m o d e  t h a t  w il l  id e n t i f y  
p ro b le m s , h e lp in g  t o  s e le c t  a r e a  o f  
in t e r e s t .
R 4 C o m p le te  c o re  t r a in in g
R 5 C h ie f  re s id e n c y  -  s t a r t  t o  c o n c e n tr a te  on  
s p e c ia l a re a  o f  in te r e s t .  G e t  fe l lo w s h ip .
R 6 S p e c ia l re s e a r c h  t r a in in g . C h o o s e  a r e a  o f  
s p e c if ic  in t e r e s t .  W r i t e  g ra n ts  i f  t h is  is 
f in a l  y e a r  b e fo r e  s ta r t in g  p r a c t ic e .
R 7 C o n tin u e  s p e c ia l c lin ic a l t ra in in g , R 6  a n d  R 7  
m a y  b e  r e v e r s e d .
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and a wrong career path chosen if they 
were not exposed to investigation. 
Second, the mind training is thought to 
be essential for the specialist so that he 
may evaluate the literature and incor­
porate changes in his specialty during his 
career. There is merit in these arguments 
particularly if qualified supervisors are 
available. While there are some obvious 
negatives to this approach, every surgi­
cal resident should understand the role of 
surgical research in surgery whether or 
not some research training is done. The 
surgical resident must have some idea of 
how to evaluate changes in his specialty. 
Unproven ideas should be rejected but 
adequately proven ones incorporated in 
practice. Furthermore, as a surgical resi­
dent, you should have sufficient under­
standing of the value of clinical trials to 
convince you to participate in them as a 
practising surgeon. Otherwise your 
specialty will stagnate. Right now these 
fundamental skills are not adequately 
taught, and this is an area in which many 
programs can improve.
In summary, you may be in one of 
three positions with respect to research 
training. First, you may be fairly sure that 
you wish to pursue a career as a surgeon 
scientist. If so, the first type of training 
that I have described is what you should 
be seeking. Second, you may not know 
whether you like investigation or you may 
feel that you cannot get an idea of what 
research is like without doing some. You 
may want to learn about research metho­
dology and critical thinking to help your
approach to patients or to the literature. 
If you fall into any of these groups, then 
1 year of research, perhaps with an 
emphasis on clinical epidemiology, is indi­
cated. Finally, you may be quite sure that 
research is an aspect of surgery that does 
not interest you. No formal training is 
then necessary, but some appreciation of 
the role of research and how to evaluate 
new methods will help you later. 
Whatever you finally choose to do in sur­
gery, remember that there are no better 
or worse areas. The merit of your work 
will be judged on how well you do it and 
not on its subject. Those who feel that 
they are somehow superior because they 
do research or because they are involved 
exclusively in patient care frequently fail 
to impress their peers.
S. Kyzer, md; I. Bayer, md; Ch . Chaimoff, md
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Spontaneous Rupture of the Common Bile Duct
Spontaneous rupture of the common bile 
duct in adults is very rare. The authors 
report only the 14th case in the Western 
literature. A 25-year-old woman had 
signs of peritonitis suggestive of a perfo­
rated appendix, but at operation the 
appendix appeared normal and a large 
amount of bile was found in the 
peritoneal cavity. A 2-mm tear was 
found on the anterior wall of the com­
mon bile duct. The patient recovered 
without complications after T-tube 
drainage and cholecystectomy. In this 
patient none of the factors thought to 
cause spontaneous rupture of the com­
mon bile duct were present, so the 
authors conclude that the case may be 
classified as idiopathic spontaneous rup­
ture of the common bile duct.
Chez I'adulte, la rupture spontanee du 
choledoque est tres rare. Les auteurs 
dycrivent ce qui constitue le 14e cas sig­
nals seulement dans la presse medicale 
occidentale. Une femme de 25 ans a 
presente les signes d'une peritonite sug-
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gerant la possibility d'une perforation de 
I'appendice. A I'operation, I'appendice 
paraissait toutefois normal et une grande 
quantity de bile fut retrouvee dans la 
cavite peritoneale. Une dychirure de 2 
mm a ete retrouvee dans la paroi 
anterieure du choledoque. La guerison a 
suivi une choiycystectomie et un 
drainage a I'aide d'un tube en T. On n'a 
retrouve chez cette patiente aucun des 
facteurs que Ton croit capable de causer 
une rupture spontanee du choledoque.
Les auteurs concluent done que ce cas 
peut etre ciassifie comme etant une rup­
ture spontanee idiopathique du chole- 
doque.
Compared with spontaneous rupture of 
the common bile duct in infants,1 this 
condition in adults is exceedingly rare. 
Spira2 in 1976 summarized 11 cases, 
including one of his own. Lipinski and 
colleagues3 reported another two cases, 
but no others have been reported in the 
Western literature. In this paper we report 
one more case.
Case Report
A 25-year-old, otherwise healthy, unmarried 
woman of Arabic origin was admitted to the 
emergency room because of severe abdominal 
pains that had begun 48 hours earlier. The pain 
was diffuse but of highest intensity in the right 
lower quadrant. She could not remember 
suffering any blunt abdominal trauma. Her 
temperature was 38°C and her pulse rate was
96 beats/min. On physical examination of the 
abdomen, there was generalized tenderness 
with signs of peritonitis, maximally located in 
the right lower quadrant. The liver and spleen 
were not palpable and no abdominal masses 
were found.
Her hemoglobin level was 130 g/L, leuko­
cyte count 21.3 x  109/L , serum urea nitrogen 
level 14.3 mmol/L urea, creatinine 62 gmol/L, 
bilirubin 18.8 fimol/L, diastase 153 U/L, alka­
line phosphatase 140 U/L and y-glutamyl 
transferase 74 U/L.
A plain film revealed no signs of intra­
abdominal free air or intestinal obstruction.
Because the suggestive diagnosis was perfo­
rated appendix, the peritoneal cavity was 
opened through a McBurney incision. A huge 
amount of bile was present but the appendix 
was intact. A perforated duodenal ulcer was 
suspected so the appendix was untouched, the 
McBurney incision sutured and the peritoneal 
cavity reopened through an upper midline inci­
sion. The lesser and greater sacs were filled with 
bile and the duodenum was found intact. A 
perforation (diameter 2 mm) of the anterior 
wall of the common bile duct was detected, 
covered by fibrin. The perforation was located 
3 cm distal to the bifurcation of the right and 
left hepatic ducts (Fig. 1). The common bile 
duct was of normal size and no stones were evi­
dent there or in the gallbladder. There were no 
signs of obstruction in the papilla of Vater. A 
T tube was inserted into the common bile duct 
through the perforation and a cholecystectomy 
was performed. A T-tube cholangiogram 
demonstrated narrow hepatic ducts and com­
mon bile duct without filling defects and with 
free passage to the duodenum. The peritoneal 
cavity was washed with normal saline, a drain 
placed down to the common bile duct and the 
abdomen closed.
f
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The postoperative course was smooth. The 
T tube was closed without complication on 
postoperative day 5. A T-tube cholangiogram 
performed 14 days later was normal (Fig. 2).
Discussion
Although spontaneous rupture of the 
common bile duct was first described in 
1882 by Freeland,4 only 13 cases have so
FIG. 1—Perforation is seen in middle of 
common bile duct (CBD). Perforation was ini­
tially 2 mm in diameter, but due to dissection 
it became wider and here is about 4 mm. GB 
= gallbladder, D — duodenum.
far been described in the Western litera­
ture. According to Shepherd,5 rupture of 
the bile duct is classified as follows: (a) 
traumatic rupture of the duct due to 
penetrating or nonpenetrating injury, (b) 
pathologic rupture following cholecystec­
tomy or duct surgery and perforative cal­
culous cholangitis, and (c) spontaneous 
or unexplained rupture of the duct. Our 
case belongs to the last category.
As described by Spira,2 most cases 
reported in the literature were associated 
with cholelithiasis, although its role in this 
condition is uncertain. Probably a com­
bination of factors contribute to the 
development of spontaneous rupture of 
the common bile duct, such as erosion 
of a common-bile-duct stone,6'8 chole­
dochal cyst or diverticulum,911 increased 
intraductal pressure secondary to obstruc­
tion at the sphincter of Oddi,1 intra­
mural infection,12,13 and necrosis of the 
wall of the common bile duct second­
ary to thrombosis of the intramural 
vessels.14
In our case no calculi were found in the 
gallbladder or in the common bile duct 
and none of the factors described could 
be demonstrated. Due to the narrow duct, 
no biopsy was performed from the edge 
of the perforation because such a maneu­
ver may contribute to the future develop­
ment of common-bile-duct stenosis. 
Macroscopically, neither acute nor 
chronic inflammation of the common bile 
duct was evident.
For us the explanation of common-bile- 
duct rupture in our case is an enigma and 
in our opinion the case may be classified 
as idiopathic spontaneous rupture of the 
common bile duct.
FIG. 2—Postoperative T-tube cholangiograms demonstrating normal choledochus with no 
sign of leakage. Free passage to duodenum is clearly demonstrated. Slight enlargement of 
choledochus is due to injection of contrast material.
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NOTICES
continued from page 53
Shock
The 9th annual conference of the Shock 
Society will be held at the Camelback Inn 
in Scottsdale, Ariz., June 8-11, 1986. The 
scientific program chairman will be Dr. 
Gerald S. Moss of Chicago.
The scientific sessions will consist of a 
workshop, symposia, papers, poster 
presentations, special dinner speakers and 
a keynote address. Topics to be covered 
include metabolism in shock-like states, 
oxygen radicals, critical issues in shock 
research and circulatory shock studies 
from 1940 to 1950.
For more information contact Dr. 
Sherwood M. Reichard, Executive Direc­
tor, Shock Society, Medical College of 
Georgia, Augusta, GA 30912.
Transurethral Ureteroscopy
A seminar and workshop on transurethral 
ureteroscopy will be held Apr. 5 and 6, 
1986, at the University of California San 
Diego School of Medicine and at The San 
Diego Hilton Beach and Tennis Resort. 
Accreditation will be 13.5 hours of AMA 
credit. The fee for physicians will be $350 
and for interns and residents, $250. Dr. 
Jeffry L. Huffman will be the course 
director.
For further information write to the 
Office of Continuing Medical Education, 
Rm. M-017, University of California San 
Diego School of Medicine, La Jolla, CA 
92093; or call (619) 452-3940.
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BOOK REVIEWS
CONTROVERSIES IN TRAUMA MANA­
GEMENT. Edited by Robert H. Dailey 
and Michael Callaham. Clinics in Emer­
gency Medicine. Vol. 6. 257 pp. Illust. 
Churchill Livingstone, Edinburgh; Aca­
demic Press Canada, Don Mills, Ont., 
1985. Price not stated. ISBN 0-443-08192-1.
This text, part of an ongoing series of “ Clinics 
in Emergency Medicine” , is well worth own­
ing. It addresses 10 issues relating to trauma 
— all are relevant. The volume’s format, 
presenting two sides of the issue and conclud­
ing with an editorial comment, works well. 
There is no shortage of meaty controversies, 
as illustrated by such titles as “ load and go” , 
“ emergency department thoracotomy” and 
“ organized trauma regions and the American 
College of Surgeons categorization of centers” .
The illustrations are adequate only but 
suffice given the nature of the book. The writ­
ing from the 27 contributors is generally of 
good quality and quite readable.
I would recommend this book to emergency 
physicians, in particular, and to any doctor 
involved in the care of seriously injured 
patients, in general.
Robert Y. McMurtry, md, frcsc
Director, Regional Trauma Unit, 
Sunnybrook Medical Centre,
2075 Bayview Ave.,
Toronto, Ont.
M4N 3M5
HORMONE-PRODUCING TUMORS OF 
THE GASTROINTESTINAL TRACT. 
Edited by Sidney Cohen and Roger D. 
Soloway. Contemporary Issues in Gastro­
enterology. Vol. 5. 164 pp. Illust. 
Churchill Livingstone, Edinburgh; Aca­
demic Press Canada, Don Mills, Ont., 
1985, $51.25. ISBN 0-443-08370-3.
This multiauthored book is cohesive and well 
written. It is well presented, accurate and, but 
for several spelling mistakes, well edited. The 
text brings together all that the practising gas­
troenterologist or general surgeon might want 
to know about these rare tumours of the gut 
— and more.
The opening chapter is a readable review of 
the gastrointestinal regulatory peptides, the 
APUD system and tumours arising from 
peptide-producing cells of the intestine. Several 
excellent photomicrographs and photoelectron- 
micrographs reflect the pathologic interests of 
the Hammersmith authors.
There follow individual chapters on the 
Zollinger-EUison syndrome (also the subject of 
many other excellent reviews), glucagonomas 
(containing 138 references), somatostatinomas
(20 reported cases), VIPomas (comprehensive 
review of watery diarrhea with hypokalemia 
and achlorhydria), and pancreatic polypeptide 
and mixed peptide-producing tumours (new 
frontiers provided by the recognition of more 
peptides).
The final two chapters review the chemother­
apy and surgery applied to these tumours. The 
last chapter includes a useful approach to car­
cinoids.
Although I was able to read this succinct, 
yet comprehensive review in less than 3 hours, 
I wonder who will buy it. The practising phy­
sician will find its content too remote from his 
everyday experience, and the text is well beyond 
the grasp of undergraduates who may never see 
a case in a lifetime of non-specialist practice. 
Probably the researcher will already have 
access to the information contained in this 
book. Some clinical teachers and postgradu­
ate students might find this a useful reference 
book for rounds and presentations, but the 
information is already available in the form of 
good reviews in several medical journals. Also, 
many competing publishing houses produce 
series of symposia of this type that seem to out­
strip their need. None of this should detract 
from the high quality of the book or the scho­
larly achievement of its authors and editors. 
If you need a ready source of information 
about the rare endocrine tumours of the gas­
trointestinal tract, this one will do nicely.
W.G. Thompson, md, frcpc
Professor of Medicine,
Assistant Dean for Clinical Affairs,
Division of Gastroenterology,
Ottawa Civic Hospital,
University o f Ottawa,
1053 Carling Ave.,
Ottawa, Ont.
K1Y 4E9
MAXILLOFACIAL INJURIES. 2 vol. set. 
N.L. Rowe and J.LI. Williams. 1030 pp. 
Illust. Churchill Livingstone, Edinburgh; 
Academic Press Canada, Don Mills, Ont., 
1985. $273. ISBN 0-443-01509-0 (2 vol. set).
To review these two volumes was to me not 
a chore but an exercise of educational enrich­
ment. The text is easy to read and the evolu­
tion of the subject matter is extremely well 
organized and presented. Each chapter aroused 
my curiosity as to what would be covered 
sequentially. Complex problems of manage­
ment are discussed comprehensively and sup­
ported by many illustrations and excellent line 
drawings. These diagrams effectively clarify the 
text.
For health professionals involved in the 
management of maxillofacial injuries, these
two volumes are indispensable. They present 
the current state of the art in the management 
of such problems. Both volumes should be 
available as a reference in the health profes­
sional’s library, or in the library of the Health 
Care Centre.
This set is a major contribution in what is 
a complex field.
J.D. Baxter, md, frcsc
Professor and Chairman,
Department of Otolaryngology,
McGill University,
Royal Victoria Hospital,
687 Pine Ave. W,
Montreal, PQ 
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O’CONNOR’S TEXTBOOK OF ARTHRO­
SCOPIC SURGERY. Edited by Heshmat 
Shahriaree. 337 pp. Illust. J.B. Lippincott 
Company, Philadelphia, 1984. $95. (US). 
ISBN 0-397-52117-0.
This volume is based on a previous textbook 
by Richard L. O ’Connor entitled 
“Arthroscopy” . Many have contributed chap­
ters from their specific fields of expertise. The 
book is well illustrated, with excellent captions.
The chapter on arthroscopic instrumentation 
is superficial and could be improved. Gas 
arthroscopy, not common in North America, 
is well described and its use in 800 cases is 
noted. The chapter on the menisci details the 
anatomy and pathologic changes well.
The history of partial meniscectomy is well 
outlined and precise and represents the 
dynamic personality of the late Dr. O’Connor. 
The chapter on meniscal lesions and their treat­
ment is among the best. It is detailed, with a 
good discussion of the management of 
associated pitfalls. I find it unfortunate that 
conservative management followed by a par­
tial meniscectomy is still accepted as treatment 
for hypermobile medial meniscus.
The chapter on acute knee arthroscopy by 
Jan Gillquist is well written, emphasizing the 
anterior approach. I believe that the chapter 
on arthroscopy and the management of frac­
tures of the tibial plateau will be confusing to 
the inexperienced reader.
All aspects of the synovial plica of the knee 
are well described. James Guhl’s chapter on 
osteochondritis dissecans is of the highest 
calibre.
The subject of intra-articular adhesions and 
fibrous ankylosis of the knee is well stated, 
emphasizing the author’s appreciation of the 
pathological characteristics in the suprapatel­
lar pouch. The chapters on cystic conditions 
of the knee, extra-articular sources of knee pain 
and synovial disease can easily be eliminated 
without any loss to the total text.
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This book is recommended to the person 
interested in arthroscopic surgery. It is com­
plete and well illustrated.
Leon H ell er , m d , fr c sc , facs
Department of Orthopedic Surgery,
Sir Mortimer B. Davis- 
Jewish General Hospital,
3755 C6te Ste-Catherine,
Montreal, PQ 
H3T 1E2
VASCULAR AND DOPPLER ULTRA­
SOUND. Edited by C. Carl Jaffe. 311 pp. 
Illust. Churchill Livingstone, Edinburgh; 
Academic Press Canada, Don Mills, Ont., 
1984. $40.50. ISBN 0-443-08295-2.
This book is volume 13 in a 17-part series enti­
tled “ Clinics in Diagnostic Ultrasound” . It 
contains eight chapters each by a different con­
tributor.
The first two chapters entitled “ Doppler 
applications and limits of the method” and 
“ Doppler instrumentation for the evaluation 
of arterial and venous disease” serve as com­
prehensive introductions to Doppler technol­
ogy. Topics covered include the principles of 
physics related to Doppler instruments, non- 
directional versus directional systems, 
continuous-wave versus pulsed Doppler, a dis­
cussion of the various electronic methods used 
to process the Doppler signal and the problem 
of statistical variability of the signals produced.
Zierler and Strandness review the clinical use 
of the Doppler velocity meter in the diagnosis 
and management of peripheral arterial and 
venous disease.
The role of duplex scanners (combined B- 
mode imaging and pulsed Doppler analysis) in 
the evaluation of carotid disease is detailed 
thoroughly by Driesbach.
Smith and Lawson review applications of
Doppler ultrasound in the abdomen. These 
include intraoperative assessment of renal and 
intestinal ischemia using sterile probes and 
transcutaneous evaluation of renal transplants, 
the renal vasculature, and the portal circula­
tion in portal hypertension. In addition, its use 
as an adjunct in better defining various struc­
tures using real-time sonography is outlined.
Gill reports on the use of a complex 
experimental combination of B-scanning and 
pulsed Doppler flowmetry to measure the fetal 
circulation noninvasively in utero. The tech­
nique has been devised to diagnose intrauter­
ine growth retardation and other causes of 
perinatal morbidity and mortality.
The combination of Doppler ultrasound and 
2-D echocardiography to produce exciting 
hemodynamic-anatomic correlations in the 
noninvasive diagnosis of cardiac disease is dis­
cussed in detail.
The final chapter reviews the use of Dop­
pler techniques in quantitating arterial occlu­
sive disease and detecting venous obstruction. 
This section is somewhat redundant in that it 
covers much of the material contained in 
chapter 3.
Overall this monograph constitutes an excel­
lent basic review of the multiple uses of Dop­
pler ultrasound in medicine. Its strength lies 
in the chapters on the basic physics of the tech­
niques and in highlighting both the usefulness 
and the current limitations of this evolving 
methodology. Although written primarily for 
radiologists, it should serve well as a basic 
review of Doppler for students, residents and 
technicians as well as practitioners newly enter­
ing the field.
J am es F . Sym es, m d , frcsc
Division of Cardiovascular
and Thoracic Surgery,
Royal Victoria Hospital,
687 Pine Ave. W,
Montreal, PQ 
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◄  PRESCRIBING INFORMATION ►
ANUSOL*-HC
ointment/suppositories 
hemorrhoidal preparations
INDICATIONS: For the relief of the pain and dis­
comfort following anorectal surgery of all types 
and that which is associated with the acute phase 
of common anorectal disorders. These include 
hemorrhoids, internal and external (including 
those accompanying pregancy) whether or not 
complicated by thrombosis and prolapse; pruritis 
ani; proctitis, cryptitis, fissures and incomplete 
fistulas; and other congestive allergic or inflam­
matory conditions.
CONTRAINDICATIONS: Should not be used in 
patients with a sensitivity to any of the compo­
nents. Not to be used in the presence of existing 
tuberculous, fungal and viral lesions of the skin. 
PRECAUTIONS: Until an adequate proctologic 
examination is complete and a diagnosis made, 
any preparation containing hydrocortisone 
should not be used. In addition, specific measures 
against infection, allergy and other causal factors 
must not be neglected. Prolonged use could pro­
duce systemic corticosteroid effects, although 
none have been noted to date. As with all medica­
tion that is applied locally, if idiosyncratic reactions 
occur, medication should be discontinued. The 
safe use of topical corticosteroids during preg­
nancy has not been fully established. Therefore, 
during pregnancy, they should not be used unne­
cessarily on extended areas, in large amounts, or 
for prolonged periods of time.
ADVERSE EFFECTS: Occasionally patients may 
experience burning upon application, especially 
if the anoderm is not intact. Local sensitivity reac­
tions have been rare.
OVERDOSE: The chances of overdosage are very 
rare, and no toxic reactions or side-effects have 
been reported. In case of accidental ingestion, 
perform gastric lavage followed by a purgative 
dose of magnesium sulfate.
DOSAGE: OINTMENTS: Administer in the morn­
ing and again at bedtime, and after each bowel 
movement. Continue this treatment until the acute 
phase of pain and discomfort passes and the 
inflammation subsides.
SUPPOSITORIES: Insert 1 suppository in the morn­
ing and 1 suppository at bedtime and after each 
bowel movement. Continue this treatment until 
the acute phase of pain and discomfort passes 
and the inflammation subsides.
SUPPLIED: Ointment: Available in 15 g and 30 g 
tubes with a plastic applicator. Suppositories: 
Available in boxes of 12 and 24 suppositories.
INGREDIENTS: Suppositories Ointment
Zinc Sulfate
Monohydratef 10 mg 0.5%
Hydrocortisone
Acetate 10 mg 0.5%
TUCKS*
A soothing, cooling, medicated wet dressing and 
cleansing pad for hemorrhoids, feminine hygiene 
and personal itching problems.
DIRECTIONS: Gently wipe and cleanse affected 
area. For additional relief, apply Tucks for 15-30 
minutes, 3 to 4 times daily.
Soft pads medicated with Hamamelis water 50%, 
glycerin 10%, distilled water, q.s.
ANUSOL*-HC
*Reg. TM. of Warner-Lambert Canada Inc. 
Parke-Davis Canada Inc. auth. user 
TUCKS*
*Reg. TM. of Parke, Davis & Company,
Parke, Davis & Company, Ltd. Registered user
PARKE-DAVIS —  IPAAB I
Parke-Davis Canada Inc, Scarborough, Ontario I ,M * C 1 | CCPP |
SESAP IV Critique
ITEM 130
In the absence of obstruction, a clean cystotomy will heal satisfactorily and 
does not require prolonged drainage or decompression. The suture line need 
only be protected against early postoperative retention and the resultant over­
distention.
77
Reference
130/1. Kaufman JJ: Current Urological Therapy. Philadelphia, WB Saunders 
Co, 1980, pp 225-226
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CLASSIFIED ADVERTISING
As a further service to its readers the Canadian Journal o f  Surgery is pleased to accept suitable classified 
advertisements. The deadline is 1 month before issue date. Regular classified rates (for each insertion): $38.00 
for the first 40 words or less, additional words 45C each (additional $15.00 for frame). Special Display under 
75 words, 214" X 2" $95.00. $5.00 charge (first insertion only) for CJS box numbers. Display rates 
available on request.
Copy should be mailed to the Canadian Journal o f  Surgery, PO Box 8650, Ottawa, Ontario K1G 0G8.
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PAAB
CCPP
This logo appearing on pharmaceutical advertisements in 
professional journals means that the advertisements have 
been reviewed— and cleared for publishing— by the Phar­
maceutical Advertising Advisory Board/Conseii Consuttatif 
de Publicity Pharmaceutique.
This unique screening system for pharmaceutical advertis­
ing is the first of its kind in North America. The Board of 
Directors is composed of individuals representing the fol­
lowing organizations: • Association des fabricants du 
Quebec de Produits Pharmaceutiques • Association des 
m^decins de langue franpaise du Canada • Association of 
Medical Media • Canadian Advertising Advisory Board • 
Canadian Drug Manufacturers • Canadian Medical Associa­
tion • Canadian Pharmaceutical Association • Consumers' 
Association of Canada • Pharmaceutical Manufacturers 
Association of Canada.
The Health Protection Branch of Health and Welfare Canada 
acts as advisor and resource body to the board.
The program ensures the accuracy of pharmaceutical ad­
vertising to the health professions, so that it may continue 
to serve the ultimate best interest of the patient.
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SURGEON: ON — Listowel, serving a referral 
population o f 1 8 000 people in the north end of 
Perth County o f Ontario, will require a general sur­
geon in 1986 to  replace retiring surgeon who has 
been in the community for 15 years. The town has 
a population o f 5000 people and is the centre of 
commerce for a prosperous dairy and cattle area. 
The hospital is well equipped and operates 87 
beds. There are nine family physicians in Listowel. 
Excellent golf and curling facilities. One hour's 
drive to Lake Huron and the University of Western 
Ontario, and 1V2 hours' to Georgian Bay and Blue- 
Mountain skiing. Time to establish practice is flex­
ible. New office facilities under construction. Con­
tact: Dr. F. Ellingham, Administrator, The Listowel 
Memorial Hospital, 255 Elizabeth St. E., Listowel, 
ON N4W 2P5. S86-02
ICU RESEARCH FELLOW: — Ewart Angus Inten­
sive Care Unit, The Wellesley Hospital. Available 
July 1, 1986 for a one year period in an academic 
Medical-Surgical Unit. Research areas include clin­
ical epidemiology of ICU care, nutrition and 
respiratory muscle physiology. Reply to: Dr. I.M. 
Fraser, Director EAICU, 247 The Jones Bldg., 160 
Wellesley St. E., Toronto, ON M4Y 1J3 (416) 
926-7747. -S86-04
TRANSPLANTATION SURGEON: ON -  The
University o f Toronto seeks a surgeon to direct its 
multiorgan transplant program at one of its univer­
s ity based hospitals. Full training in general sur­
gery plus formal clinical training in multiorgan 
transplantation surgery is required. The success­
fu l candidate w ill also be expected to  have ob­
tained research training which will enable him/her 
to  conduct an independent research program and 
interact w ith  other faculty in the areas of trans­
plant immunology and infectious diseases relat­
ed to transplantation. This will be an annual ap­
pointment, at the rank of Assistant Professor. 
Salary to commensurate w ith qualifications and 
experience. Qualifications: MD, FRCSC. Effective 
date of appointment: Open. Closing date of appli­
cations: February 28, 1986. Enquiries, curriculum 
vitae and three letters of reference should be sent 
to: Dr. R.M. Stone, Surgeon in Chief, Toronto 
Western Hospital, 399 Bathurst St., Toronto, ON 
M5T 2S8. In accordance with Canadian Immigra­
tion requirements, this advertisement is directed 
to  Canadian citizens and permanent residents.
-S86-03
EXPERIENCED GENERAL SURGEON: -  re­
quired in a unique lucrative setting. Extensive and 
varied surgical material available. Please forward en­
quiries to: PO Box S110 CJS. -S85-32
HEAD 
DIVISION OF 
PLASTIC SURGERY
Required for 698 (rated) bed pediatric teach­
ing hospital w ith cross-appointment in the Di­
vision of Plastic Surgery, University of 
Toronto. The Division provides plastic surgery 
services for approximately 1800 inpatient and 
outpatient surgical procedures each year.
Applicants must have academic standing and 
interest in research as well as aptitude for 
pediatric service and departmental manage­
ment. Full-time appointment and academic 
rank commensurate w ith  qualifications and 
experience.
Apply to:
&  
HSC
Mr. C.D. Germano 
Administrative Assistant, and 
Secretary, Plastic Surgery Search 
Committee
The Hospital for Sick Children 
555 University Avenue 
Toronto, Ontario, Canada M5G 1X8
* This advertisement is directed to persons 
who are eligible to work in Canada S86-01
THE HOSPITAL FOR SICK CHILDREN
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An effective combination to relieve 
the pain and itch of hemorrhoids 
and other anorectal disorders
•  Relieves pain, itch and inflammation
•  Lubricating petrolatum base
•  Colorless ointment and ^
suppositories ^ s g m k
A n u s o l - H C
PARKE DAVIS
•  Soothing medicated cleansing pads
•  Prevents m echanical irritation from 
K S lw  toilet tissue
•  Helps promote proper hygiene
i i 11 h i  M  hi  ' i i f 1 1  * * J
TUCKS
MEDICATED PADS
PAAB
CCPP
PARKE-DAVIS
Parke-Davis Canada Inc., Scarborough, Ontario 
•Reg. T.M. Parke, Davis & Company, Parke-Davis Canada In c .a u th . user G
Meet some members 
of our family
The third i*cncrali< hi < >f 
n< )iiahs4 >rbable 1114 >n< >fi lament 
sutures has just begun...
AJam$&
—
The New Standard of Excellence
DISPOSABLE SKIN STAPLER
No hang ups!
Staples are now 
immediately, automatically 
and completely released 
regardless of direction of 
stapler movement.
...from the b + G  wound closure system
DEXON* PLUS
Excellent knot security plus superior handling 
and smoother tissue passage.
r
Davis +  Geek Introducess r r a r
Surgical Ovomc Suture
Something 
you’re used to 
without 
the problems 
you’re used to
V
\ !
You told us that you liked using catgut but you didn't like its 
problems. So we took catgut and made it 
• soft and supple 
.  easy to tie
.  less likely to curt. “ pigtail” and tangle 
« easy to handle and control
quality professional products from
DAVIS+GECK A TRADITION OF INNOVATION
Cyanamid Canada Inc. Atria North, 2255 Sheppard Avenue East, Willowdale, (Ontario) M2J 4Y5
